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Approximately 3.5 million individuals are diagnosed with diabetes in the UK, with 90% of cases 
attributed to type 2 diabetes mellitus (T2DM). The worldwide prevalence of T2DM has rapidly 
increased, rising from 108 million in 1980 to 422 million in 2014. In addition to the well-recognised 
microvascular and macrovascular complications, emerging evidence suggests that T2DM is also 
associated with an increased risk of cognitive dysfunction. Considering the increasing prevalence, in 
addition to the increasing life expectancy of older adults, the development of cognitive dysfunction in 
this population may seriously challenge future health services. Therefore, there is an urgent need to 
identify effective strategies that may lead to improved therapy in the future. Whilst exercise, cognitive, 
and dual-task interventions have previously been identified as successful strategies for targeting 
cognition in other population groups, little is known regarding the effect of these types of interventions 
in T2DM. The primary aim of this doctoral thesis was to develop and evaluate exercise, cognitive, and 
dual-task interventions for targeting cognitive dysfunction in individuals with T2DM. 
 
The series of studies presented in this thesis (chapters 2-5) were conducted using a systematic phased 
approach in accordance with the MRC’s framework for the development and evaluation of complex 
interventions. The initial study (chapter 2) involved conducting a systematic review and meta-analysis 
and identified only a limited number of exercise, cognitive, and dual-task trials in T2DM. The overall 
quality of included trials was mixed, with the majority of trials having a moderate to high risk of bias.  
Meta-analyses of exercise trials showed small to moderate effects of exercise on executive function 
(0.31) and memory (0.20), but were not statistically significant. Due to the limited number of cognitive 
and dual-task trials identified, a narrative synthesis was conducted which showed a positive effect of 
these types of interventions for improving tasks of global cognition, executive function and memory. It 
was concluded that larger, more robust trials were needed to further understand the impact of these 
types of intervention in T2DM. The subsequent study (chapter 3) piloted exercise, cognitive, and dual-
task interventions in T2DM to help identify a suitable intervention to test for feasibility and 
acceptability. The findings of this intervention development study found cognitive training was the most 
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enjoyable and preferred. Together, the accumulated evidence identified in study 1 and 2 was used to 
develop a suitable cognitive training study ready to be evaluated for its feasibility and acceptability in 
T2DM.  
 
The final study as part of this doctoral thesis aimed to explore the feasibility (chapter 4) and 
acceptability (chapter 5) of a cognitive training study in T2DM. Feasibility was shown in important 
aspects of the study including the adherence, retention and motivation of participants whilst only minor 
amendments were recommended to the study design, recruitment pathways, and data collection.  
Improvements in several cognitive domains including executive function, visual memory, and reaction 
time were also observed following cognitive training in which serum levels of BDNF were shown to 
unexpectedly reduce following cognitive training. The acceptability findings suggest that participants 
found the cognitive training study highly enjoyable and that the study components were well accepted 
in this population. However, recommendations were made for clearer communication of the study aims 
and processes in addition to greater involvement for those allotted to the control group. Evidence 
derived from both the quantitative (chapter 4) and qualitative (chapter 5) elements of this study were 
used to develop a set of important recommendations that should be considered prior to undertaking a 
future definitive trial. Overall, the findings from this doctoral thesis provide systematic and convincing 
evidence for the potential feasibility, acceptability, and efficacy of a randomised controlled trial to 
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1.1 Type 2 diabetes mellitus  
 
1.1.1 Definition and diagnosis  
 
Diabetes Mellitus is a group of chronic metabolic disorders characterised by hyperglycemia resulting 
from defects in insulin secretion, insulin action or both (ADA, 2019; Kahn et al., 2014; Fonsesca, 2009). 
The global prevalence of individuals diagnosed with diabetes has risen rapidly from approximately 
4.7% (108 million) in 1980 to an estimated 8.5% (422 million) in 2014 (WHO, 2018a). Type 2 diabetes 
mellitus (T2DM), the most prevalent form of diabetes, accounts for 90-95% of diabetes cases whilst 
type 1 diabetes mellitus (T1DM) and other rare forms of diabetes account for the remaining 5-10% of 
cases. Unlike T1DM, an autoimmune disease characterised by loss of insulin producing beta cells 
(Simmons & Michels, 2015; Atkinson et al., 2014), T2DM is caused predominantly by impaired insulin 
action, also known as ‘insulin resistance’ in combination with varying degrees of insulin deficiency 
(ADA, 2019, WHO, 2018a). Although genetics do play a role in the pathophysiology of T2DM, in most 
cases the development of T2DM is attributable to lifestyle factors including physical inactivity and poor 
nutrition (Wu et al., 2014; Bellou et al., 2018; Dendup et al., 2018). Previously referred to as adult-
onset diabetes or non-insulin dependent diabetes, T2DM typically manifests in late adulthood (aged 
45+); however, this traditional paradigm is no longer accurate with cases becoming more frequent 
amongst younger adults, adolescents, and children  (Alberti et al., 2004; Lascar et al., 2018; Reinehr, 
2013; Koopman et al., 2005; Fazeli & Farsani et al., 2013).  
Due to the inability of the body to produce or use insulin, the hormone responsible for regulating glucose 
homeostasis, the diagnosis of T2DM may be established using several different diagnostic methods that 
measure blood glucose levels. Plasma glucose tests directly measure glucose levels at a single point in 
time and can be assessed using either the fasting plasma glucose test (FPG) > 126mg/dL (7.0mmol/L) 
or the 2-hour plasma glucose (2-h PG) during a 75g oral glucose tolerance test (OGTT) > 200mg/dL 
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(11.1 mmol/L). Alternatively, the analysis of glycated haemoglobin (HbA1c) can also be used which 
measures an individual’s average blood glucose level over the previous 2-3 months providing an 
indication of long-term glycaemic control (Sherwani et al., 2016; Florkowski, 2013). A criteria of 
HbA1c >6.5% (48mmol/mol) is used to diagnose T2DM (ADA, 2019). The FPG, OGTT, and HbA1c 
are all suitable for diagnostic testing of T2DM. Using the HbA1C test has several advantages over the 
FPG or OGTT as patients are not required to fast (greater convenience) and generally patients 
experience less day to day perturbations. In addition, the HbA1c test is also found to have superior pre-
analytical stability compared to FPG and OGTT. However, the greater cost and limited availability of 
HbA1c may offset these advantages (ADA, 2019).  
1.1.2 Pathophysiology   
 
During normal glucose homeostasis, blood glucose levels are maintained through a feedback loop 
involving the intricate crosstalk between pancreatic β-cells and insulin sensitive tissues (Kahn et al., 
2014; Roder et al., 2016). In response to an increase in blood glucose levels, pancreatic β-cells secrete 
the peptide hormone insulin, enhancing the uptake of glucose in target tissues whilst also reducing 
glucose output from the liver and suppressing fatty acids released from adipose tissue (Kahn et al., 
2014; Roder et al., 2016). Upon entering the bloodstream, insulin exerts its major biological effect by 
binding to and activating insulin receptors located in peripheral target tissues. Insulin then facilitates 
the transfusion of glucose into the target tissues by translocating glucose transporter-4 from intracellular 
sites to the cell surface (Huang & Czech, 2007; Lin & Sun, 2010). In response, insulin sensitive tissues 
relay information back to β-cell islets regarding the further requirement or cessation of insulin (Kahn et 
al., 2014; Roder et al., 2016). The amount of insulin secreted to maintain normal glucose homeostasis 
is determined by prevailing insulin sensitivity (Kahn et al., 2014). It is this feedback loop involving the 
coordinated regulation of insulin secretion and its uptake that regulates glucose metabolism to maintain 
blood glucose homeostasis within a narrow physiological range (Roder et al., 2016). 
Under conditions of chronic hyperglycaemia, as observed in pre-diabetic and diabetic states, the 
feedback loop involving the crosstalk between β-cells and insulin sensitive tissues is disrupted (Kahn 
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et al., 2014). The two primary mechanisms involved are β-cell dysfunction and insulin resistance, see 
Figure 1.1 (Cerf, 2013; Del Prato & Marchetti, 2004; Kahn et al., 2003). Initially, the development of 
insulin resistance occurs whereby insulin-induced glucose uptake is inhibited in target tissues, primarily 
as a result of defects in the insulin signalling pathway. Despite the occurrence of insulin resistance, 
glucose tolerance may remain normal due to compensatory hyperinsulinemia in which β-cell islets 
increase insulin secretion to maintain normal blood glucose levels (Kahn et al., 2014; Cerf, 2013). 
However, it is the eventual deterioration of β-cell function, compounded by insults including cytokine-
induced inflammation, obesity and insulin resistance, which is the critical determinant of T2DM (Cerf, 
2013). The continuous compensatory secretion of insulin in response to insulin resistance eventually 
causes a decline in β-cell mass and function leading to β-cell exhaustion and consequently β-cell 
destruction. As β-cell dysfunction and insulin resistance exacerbate, hyperglycaemia amplifies leading 
to the progression of T2DM (Cerf, 2013). 
 




Whilst β-cell dysfunction and insulin resistance are the two fundamental pathogenic mechanisms, a 
number of biochemical and clinical features are also evident that contribute to the development of 
T2DM (Cerf, 2013; Del Prato & Marchetti, 2004; Kahn et al., 2003). Risk factors including a sedentary 
lifestyle, central and abdominal obesity, hypertension, dyslipidemia, and atherosclerosis have all been 
observed in T2DM patients. The clustering of these factors, also referred to as metabolic syndrome, 
metabolic syndrome X, or insulin resistance syndrome is known to increase the risk of developing 
cardiovascular disease, T2DM and all-cause mortality (Bano & Batool, 2007; Gupta & Gupta, 2010; 
Shin et al., 2013). One factor in particular that has been proposed to play a critical role in mediating 
insulin resistance is obesity-induced inflammation (Fuster et al., 2016; McArdle et al., 2013; Shoelson 
et al., 2007). During obesity, white adipose tissue functions by storing triglycerides during states of 
excessive energy whilst also acting as an endocrine organ that releases chemoattractants and pro-
inflammatory mediators (McArdle et al., 2013). Chronic excess energy leads to the expansion of white 
adipose tissue causing an increase in the secretion of chemoattractants and pro-inflammatory cytokines, 
leading to the infiltration of immune cells in adipose tissue (McArdle et al., 2013). Immune infiltration 
subsequently leads to the disruption of adipose lipid metabolism through lipolysis causing an increase 
in free fatty acids, initiating inflammatory signal cascades in the presence of infiltrating immune cells 
(McArdle et al., 2013). Subsequently, a feedback loop involving pro-inflammatory cytokines further 
exacerbates this pathological state, driving additional immune cell infiltration and cytokine secretion 
and thus further disrupting insulin signalling cascade (McArdle et al., 2013). It is the disruption in the 
function of adipose tissue that causes a defect in hepatic and skeletal muscle glucose homeostasis that 
results in systemic insulin resistance thus precipitating T2DM (Johnson et al., 2012; McArdle et al., 
2013). 
1.1.3 Associated complications  
 
T2DM is a complex condition that can affect several organs and systems of the body if poorly managed 
or untreated. The majority of diabetes complications are categorised as either microvascular (due to 
damage to small blood vessels such as capillaries) or macrovascular (due to damage to large blood 
vessels such as arteries and veins) (Cade, 2008), see Figure 1.2. Microvascular complications include 
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retinopathy with the risk of potential blindness, nephropathy with the potential of renal failure, 
neuropathy with risk of foot ulcers, amputation, Charcot joints, and features of autonomic dysfunction 
including sexual dysfunction. Macrovascular complications include cardiovascular disease, 
cerebrovascular disease, and peripheral vascular disease (Fowler, 2008; WHO, 2019). Cardiovascular 
disease in particular is a leading cause of death in individuals with T2DM (Baena-Diez, 2016). 
Specifically, individuals with diabetes have been shown to have a 3-fold increased risk of 
cardiovascular mortality compared to those without diabetes (Taylor et al., 2013). In extreme cases, if 
left untreated, severe chronic hyperglycaemia may lead to ketoacidosis or a hyperosmolar 
hyperglycaemic state that may lead to coma or death (Maletkovic & Drexler, 2013). Whilst 
macrovascular and microvascular complications of diabetes are well recognised there is still a lack of 
awareness regarding other associated conditions that are often exacerbated by vascular complications 
such as cognitive dysfunction (Munshi et al., 2017).   
 
 
Figure 1.2 Microvascular and macrovascular complications of T2DM (Bate & Jerums, 2003) 
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1.1.4 Management of type 2 diabetes mellitus  
 
The management of T2DM and the prevention of diabetes associated complications is complex, and 
often involves a combination of lifestyle changes and pharmacological treatment (Nyenwe et al., 2011; 
Marin-Penalver et al., 2016). Prior to use of diabetes medication, lifestyle changes are recommended 
for those at risk or newly diagnosed with diabetes. Diabetes self-management education (DSME), 
exercise and nutrition are considered the three cornerstones of lifestyle changes for the prevention and 
management of T2DM (Nyenwe et al., 2011; Praet & van Loon, 2008; Pozzilli & Fallucca, 2014; 
Shrivastava et al., 2013). DSME is one of the most important cornerstones used for the management of 
T2DM and its associated complications (Shrivastava et al., 2013; Chester et al., 2018; Powers et al., 
2016). DSME refers to the process of acquiring the knowledge, skills, and ability required for competent 
diabetes self-management care (Powers et al., 2016). Specifically, DSME interventions are designed to 
target the patient’s current knowledge, practical skills, health beliefs, cultural needs, and emotional 
concerns that affect each participant’s ability to execute adequate diabetes self-management (Powers et 
al., 2016), see figure 1.3 showing the framework for DSME interventions.  
DSME interventions have previously been shown to improve blood glucose levels in individuals with 
T2DM (Steinsbekk et al., 2012; Norris et al., 2002) in addition to enhancing diabetes knowledge, 
improving systolic blood pressure, reducing body weight and reducing the need for diabetic medication 
(Deakin et al., 2005). Furthermore, when combined with other diabetes management techniques, DSME 
has been shown to reduce the onset and progression of diabetes complications (Nathan et al., 1993). 
Consequently, DSME interventions have been shown to reduce both hospital admissions and 
readmissions as well as reducing the costs placed upon health care systems (Healy et al., 2013; Duncan 
et al., 2011). Furthermore, DMSE interventions have also been shown to be important in influencing 
positive disease management behaviours including exercise / physical activity and healthy eating 
(Powers et al., 2016). Exercise and nutrition are also key cornerstones with respect to diabetes 
management whereby evidence suggests that greater engagement in both may lead to improvements in 
key metabolic and cardiovascular outcomes including improved glucose control, reduced blood 
pressure, improved lipid profile, and reduced weight. (Colberg et al., 2016; Kirwan et al., 2017; Ley et 
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al., 2014; Pozzilli & Fallucca, 2014; Nyenwe et al., 2011; Esposito et al., 2009; Esposito & Giugliano, 
2014; Bhatt et al., 2007). However, whilst there is evidence of the importance of non-pharmacological 
interventions for improving several outcomes related to diabetes management, there is nothing included 
in DSME with respect to the benefits of exercise and cognitive training on cognition in T2DM.  
 
Figure 1.3 Framework for DSME interventions in T2DM (Jack et al., 2004) 
 
1.2 Diabetes mellitus and cognitive dysfunction   
 
1.2.1 Diabetes-associated cognitive dysfunction  
 
There is substantial epidemiological evidence that supports an association between T2DM and cognitive 
dysfunction (Biessels & Despa, 2018). It is proposed that cognitive dysfunction is not a unitary concept 
in T2DM but instead is categorised into distinct stages in accordance with the severity of cognitive 
deficits presented including; diabetes-associated cognitive decrements, mild cognitive impairment 
(MCI), and dementia (Biessels & Despa, 2018; Koekkoek et al., 2015). Whilst the effects of each stage 
may be additive, it is suggested that these stages should not be regarded as a continuum but instead 
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viewed as separate entities that have different underlying mechanisms attributed to the marked 
differences in age groups affected and trajectories of cognitive decline (Biessels & Despa, 2018; 
Kokkoek et al., 2015). Diabetes-associated cognitive decrements (the least severe stage) is the term 
used to describe the subtle cognitive deficits in cognition that may be evident in one or more cognitive 
domains, including attention/concentration, executive function, memory, and processing speed 
(Monette et al., 2014; Palta et al., 2014). These subtle cognitive deficits are typically observed to be 
0.3-0.5 standard deviations (SD) lower compared to individuals without diabetes and may affect 
individuals of all ages ranging from adolescents and young adults through to older adults (Kokkoek et 
al., 2015). Diabetes-associated cognitive decrements progress gradually over a period of several years 
at a rate that is only slightly quicker than normal cognitive ageing, and most likely begin to develop 
during the pre-diabetic stages (Biessels et al 2014; Pappas et al 2017; Yaffe et al 2012; Bangen et al 
2015). Individuals with diabetes-associated cognitive decrements may experience minor impairments 
in day-to-day activities e.g. lack of concentration, increased cognitive effort, however diabetes self-
management is generally unaffected (Biessels & Despa, 2018; Biessels et al., 2014). Due to the subtle 
changes in cognition at this stage, individuals would not qualify as impaired on formal testing making 
it difficult for clinicians to actually determine whether a patient’s cognition is affected at an individual 
level (Biessels & Despa, 2018; Koekkoek et al., 2015).  
The next stage proposed in diabetes-associated cognitive dysfunction is MCI (the intermediate stage) 
and identifies as the point between diabetes-associated cognitive decrements and dementia (Biessels & 
Despa, 2018; Koekkoek et al., 2015). Although the proposed pathophysiology for MCI and dementia 
are similar in both individuals with and without T2DM, the impairment of cognitive function in T2DM 
is observed to be typically 1-1.5 SDs lower compared to individuals without diabetes (Biessels & Despa, 
2018; Koekkoek et al., 2015). In addition, the prevalence of MCI is shown to be higher in those with 
T2DM. Gao et al. (2016) reported that out of a total of 1109 participants diagnosed with T2DM, 62.2% 
(mean age 74.3 ± 3.5) were diagnosed with MCI. Furthermore, the prevalence of MCI was shown to 
be significantly higher in T2DM across all age groups measured apart from ages 85+ compared to those 
without T2DM (Gao et al., 2016), see Figure 1.4. In a more recent study, Albai et al. (2019) also 
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observed a high prevalence reporting that out of a total of 207 patients diagnosed with T2DM, 42.03% 
(mean age 63.00, 95% confidence interval (CI) 57.00-71.00) presented with MCI. Furthermore, MCI 
can be subdivided into either amnestic MCI (impaired memory) or non-amnestic MCI (preserved 
memory, but other domains affected) (Csukly et al., 2016; Petersen, 2016). Evidence from two 
prospective population-based studies reporting hazard ratios (HR), that is the ratio showing the 
probability of an event occurring in a treatment group compared to the control group at any point in 
time, observed similar outcomes regarding the risk of MCI in patients with diabetes. One study reported 
a HR of 1.5 (95% CI 1.0-2.2) for those with amnesic MCI and a HR of 1.2 (95% CI 0.9-1.8) for non-
amnesic MCI (Luchsinger et al., 2007) with the most recent study reporting a HR of 1.6 for amnesic 
MCI and 1.4 for non-amnesic MCI (Roberts et al., 2014a). A previous meta-analytical study also 
reported an increased risk of dementia in individuals with T2DM with any type of MCI compared to 
those with diabetes but without MCI reporting a relative risk, that is the probability of an event occurring 
in an exposed group compared to unexposed group, for the conversion to dementia of 1.7 (95% CI 1.1-
2.4) (Cooper et al., 2015). This is further supported by longitudinal data that reports the conversion rate 
of MCI to dementia was higher in individuals with T2DM (57.4%) compared to those without diabetes 
(42.6%) over a two year period (Ciudin et al., 2017). MCI typically occurs in individuals over the age 
of 60-65 in which cognitive complaints are usually expressed by either the patients or carers/clinicians, 





Figure 1.4 The prevalence of MCI in individuals diagnosed with T2DM (blue) compared to those 
without T2DM (pink). The prevalence of MCI in T2DM was shown to be significantly higher in all age 
groups except ages 85+. *P<0.05, **P<0.01 (Gao et al., 2016).  
 
The final and most severe stage proposed in diabetes-associated cognitive dysfunction is dementia. This 
stage is generally distinguishable from the less severe stages of diabetes-associated cognitive 
dysfunction in that there is a clear deviation in cognition both in terms of the impact on quality of life 
and deficits observed in neuropsychological task performance (Biessels & Despa, 2018). Cognitive 
function is generally impaired across multiple cognitive domains during dementia resulting in cognitive 
complaints in either the patient or carers/clinicians which affect both day-to-day activities and diabetes 
self-management (Biessels & Despa, 2018; Koekkoek et al., 2015). The prevalence of dementia in 
individuals with T2DM is also higher when compared to those without diabetes (Figure 1.5). Out of 
1109 participants diagnosed with T2DM, Gao et al. (2016) reported a total of 132 participants (11.9% 
mean age 77.4 ± 4.5) to have dementia. Li et al. (2016) observed similar prevalence of dementia in 
T2DM, showing that out of 197 T2DM participants 33 participants (16.8% mean age 79.76 ± 5.990) 
were shown to have dementia. Dementia typically manifests in individuals over the age of 60-65 years, 
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although the risk of young-onset dementia, that is, before the age of 65 is increased in individuals with 
T2DM (Biessels & Despa, 2018; Koekkoek et al., 2015). A meta-analysis of 28 prospective 
observational studies reported an estimated risk ratio of 1.73 for all types of dementia, a 1.53 risk ratio 
for Alzheimer’s disease, and a 2.27 risk ratio for vascular dementia for patients with diabetes compared 
to those without diabetes (Gudala et al., 2013; Zhang et al., 2017). Furthermore, there is evidence to 
suggest that the risk of dementia is already elevated in individuals with newly diagnosed diabetes (HR 
1.16) (Haroon et al., 2015). Cognitive decline at this stage is generally progressive over time, and is 
typically characterised by progressive, year-on-year, cognitive decline (Koekkoek et al., 2015).  
 
 
Figure 1.5 The prevalence of MCI and dementia in individuals with T2DM (pink) compared to 
individuals without T2DM. A significant difference (P<0.001) in the prevalence of MCI and dementia 




1.2.2 Cognitive domains affected 
 
Evidence identified in previous studies suggest that cognitive deficits are present even in those that 
exhibit early indications of T2DM such as impaired glucose (Lamport et al., 2009) and metabolic 
syndrome (Crichton et al., 2012); in which domains including executive function, memory, attention, 
and psychomotor speed appear most affected. Furthermore, findings reported in studies investigating 
cognitive performance in adolescents with T2DM (Yau et al., 2010), in addition to those newly 
diagnosed with T2DM (Ruis et al., 2009), also show worse cognitive performance compared to non-
diabetic controls. Whilst worse cognitive performance was observed across all cognitive domains in 
T2DM the most notable deficits were shown in executive function, memory, psychomotor efficiency, 
and general intellectual ability (Yau et al., 2010; Ruis et al., 2009). Together, these findings show that 
decrements in important cognitive domains are already present in the early stages of T2DM and 
contribute to the growing evidence that suggests the development of cognitive dysfunction in T2DM 
may manifest even in the earliest alterations in glucose metabolism (Biessels et al., 2014).  
A more recent meta-analysis also reported deficits in similar cognitive domains in middle aged T2DM 
patients (aged 65 and under) (Pelimanni et al., 2018). Worse cognitive performance was observed across 
several cognitive domains compared to healthy controls in which information processing speed 
(Hedge’s g (g) = -0.68), attention/concentration (g = -0.55), executive functions (g = -0.51), and 
working memory (g = -0.51) showed the largest deficits (Pelimanni et al., 2018). Furthermore, whilst 
the direction of associations varied across domains, regression analysis revealed that age was 
significantly associated with the effect sizes (ES) observed in information processing speed, language, 
verbal memory, and visual memory; indicating that the worsening of these cognitive domains is 
significantly influenced by age (Pelimanni et al., 2018). Similar deficits in key cognitive domains are 
also shown in older adults with T2DM. A meta-analysis that evaluated cognitive performance in 
predominantly older adults observed worse performance in every cognitive domain measured whereby 
processing speed (Cohen’s d (d) = -0.33),  attention / set shifting (d = -0.36) and motor function (d = -
0.37) (Monette et al., 2014) presented the largest decrements, see Figure 1.6. This is further supported 
by a similar meta-analysis that also showed worse performance decrements in similar cognitive domains 
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including attention/concentration (d = -0.19), visual memory (d = -0.26), verbal memory (d = -0.28), 
processing speed (d = -0.33), executive function (d = -0.33), and motor function (d = -0.36) in older 
adults with T2DM (Palta et al. 2014). Whilst diabetes-associated cognitive decrements, MCI, and 
dementia affect different age groups and are proposed to have differing pathological development 
(Biessels et al., 2014; Biessels & Despa, 2018); evidence suggests that the cognitive domains affected 
are consistent across the cognitive dysfunction spectrum in T2DM, regardless of age or severity of 
impairment and include executive function, memory, attention, processing speed and motor function. 
 
 
Figure 1.6 Meta-analysis showing the average effect (d) and 95% CIs for cognitive performance in 
T2DM compared to non-diabetes controls (Monette et al., 2014). The number of participants included 





The difficulties associated with daily self-management tasks are often overlooked by individuals 
involved in patient care, and for those with diabetes-associated cognitive dysfunction performing daily 
self-care tasks can become challenging (Hopkins et al., 2016). Clinical diabetes guidelines that include 
the recommendations for the detection of diabetes-associated cognitive dysfunction and how it may 
affect diabetes management have only recently been described for clinicians (Hopkin et al., 2016; 
Moulton, 2016; Munshi, 2017). The identification and management of diabetes associated cognitive 
dysfunction is not as straightforward as a ‘one size fits all approach’ (Biessels & Despa, 2018). For 
example, an individual who presents with memory loss may forget to monitor glucose, forget to take 
medication or forget medical appointments; whereas an individual who presents with executive 
dysfunction may remember important tasks but is unable to integrate them into practice (Munshi et al., 
2017). Furthermore, the different stages proposed in diabetes-induced cognitive dysfunction may have 
differing clinical features that may affect patients in different ways so that each stage requires a unique 
clinical approach (Biessels & Despa, 2018). Self-management tasks that are frequently affected by 
diabetes-associated cognitive dysfunction include glycaemic monitoring, medication management, 
coordination of health care services and appointments, personal hygiene, mobility, physical activity, 
and nutrition (Hopkins et al., 2016). A previous review concerning cognition and diabetes self-
management reported deficits in several cognitive domains in T2DM, including global cognition, 
executive function, and memory, in which decrements in global cognition were significantly associated 
with several diabetes self-management tasks (Tomlin & Sinclair, 2016). It was concluded that 
alterations in cognition may negatively affect disease management in T2DM (Tomlin & Sinclair, 2016). 
Neglecting daily self-management tasks may lead to a vicious spiraling cycle whereby cognitive 
impairment is worsened causing individuals to further neglect important daily management tasks, 
eventually leading to the exacerbation of a patient’s diabetes including the development or worsening 
of vascular complications.  Currently, the annual UK cost of diabetes is estimated at around £10 billion 
pounds, in which £8 billion pounds (80%) is attributed to treating complications (Diabetes UK, 2014). 
The growing prevalence of diabetes-associated cognitive dysfunction may further add to the already 
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high economic burden placed on health care systems. Furthermore, both T2DM and dementia impose a 
significant social burden on family and caregivers with high rates of psychological morbidity, social 
isolation, physical ill-health, and financial hardship (Li et al., 2018; Brodaty & Donkin, 2009).  
1.3 Mechanisms associated with cognitive dysfunction in T2DM 
 
Diabetes-associated cognitive decrements, MCI, and dementia most likely involve different underlying 
mechanisms attributed to the marked differences in age-groups affected and trajectory of cognitive 
decline (Biessels & Despa, 2018). The mechanisms linked to diabetes-associated cognitive dysfunction 
have predominantly been investigated in the context of MCI and dementia, whilst the mechanisms 
linked to the initial subtle cognitive decrements have not yet been elucidated (Biessels & Despa, 2018). 
It is important to understand that each mechanism outlined, although discussed separately, most likely 
overlaps and integrates with other mechanisms and involve neurodegenerative and vascular pathologies 
(Biessels & Despa, 2018).  
1.3.1 Advanced glycation end-products formation   
 
The detrimental effect that hyperglycaemia exerts on the brain may occur through several mechanisms. 
One proposed mechanism is that chronic elevated levels of blood glucose may lead to the development 
of advanced glycation end products (AGEs) (Umegaki 2014; Biessels & Despa, 2018). The formation 
of AGEs are a result of proteins and lipids that are exposed to sugars and eventually become glycated. 
They are known to cause neuronal injury along with the over stimulation of microglia, the resident 
innate immune cells that play an important role in central nervous system functioning (Umegaki, 2014; 
Luchsigner, 2012). Whilst the initial response of microglial cells during neural damage is often 
neuroprotective (Nayak et al., 2014), the over activation of these cells further mediates the inflammatory 
response leading to the release of several neurotoxic factors e.g. tumour necrosis factor alpha, 
interleukin-1beta, and reactive oxygen species that drive neuronal damage (Lull & Block 2010; 
Umegaki, 2014; Block et al., 2007). In environments of chronic hyperglycaemia, such as T2DM, tissues 
have been shown to contain elevated expressions of AGEs in which the sustained activation of its 
receptors (RAGE) signalling pathways has been proposed to further stimulate the formation and 
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accumulation of AGEs creating a positive feedback loop (Yamagishi & Matsui, 2018). AGEs are known 
to elicit oxidative stress generation, and consequently evoke inflammatory, thrombogenic, and fibrotic 
reactions contributing to atherosclerosis, microvascular complications, and pancreatic β-cell apoptosis 
(Yamagishi & Matsui, 2018; Yamagishi, 2012). Although the formation of AGEs is a clinical feature 
observed in the pathology of dementia and Alzheimer’s, a greater expression of AGEs and microglial 
activation has been observed in individuals with dementia who have T2DM compared to those with 
dementia alone (Valente et al., 2010).  
1.3.2 Amyloid beta deposition 
 
A fundamental pathological mechanism that has been identified in the development of dementia and 
Alzheimer’s, and is also implicated in the development of diabetes-associated cognitive dysfunction, is 
the accrual of amyloid beta (AB) (Farris et al., 2003; Umegaki, 2014; Feinkohl et al., 2015; Biessels & 
Despa, 2018). The overexpression of AB is known to result in the formation of amyloid plaque and 
neurofibrillary tangles, both hallmark manifestations of dementia and Alzheimer’s disease. One 
possible mechanism implicated in the buildup of AB is the reduction of the protein insulin degrading 
enzyme (IDE) resulting in a decrease in AB clearance (Umegaki, 2014). IDE plays a critical role in 
degrading AB levels thus preventing amyloid plaque aggregation and neuronal loss that contribute to 
cognitive impairment. Previous research has shown that insulin regulates the production of IDE in the 
brain (Umegaki, 2014). The reduced sensitivity of insulin receptors located on target tissues, as 
observed in insulin resistance, is shown to diminish the production of numerous key proteins, including 
IDE (Umegaki, 2014). Thus, the decrease in IDE is proposed to contribute directly to the overexpression 
of AB. Several studies have observed the presence of AB deposits in individuals with T2DM (Beeler et 
al., 2009; Janson et al., 2004; Miklossy et al 2010). In one study, the increased number of AB plaques 
observed in individuals with T2DM compared to controls were shown to correlate with the diabetes 
duration (Janson et al., 2004). Furthermore, impairments of IDE have even been shown to play a role 
in the development of T2DM (Tang, 2016), and the gene encoding it has been identified as a susceptible 
gene in both T2DM and Alzheimer’s disease (Costes & Butler, 2014).    
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1.3.3 Hyperphosphorylation of tau proteins 
 
Another mechanism involving the dysregulation of insulin is the hyperphosphorylation of tau proteins 
(Umegaki, 2014; Luchsigner, 2012). Tau proteins are microtubule-associated proteins found in neurons 
that facilitates the assembly of tubulin into microtubules in the brain (Gong & Iqdal, 2008). They are 
shown to modify post-transitionally in several ways including through phosphorylation. The 
hyperphosphorylation of tau proteins is detrimental, leading to the development of neurofibrillary 
tangles, a common pathological feature observed in dementia and Alzheimer’s disease (Gong & Iqdal, 
2008). In the context of diabetes, insulin is a crucial regulator of tau protein phosphorylation in neurons 
(El Khoury et al., 2014; Goncalves et al., 2019). Impaired insulin signalling, as a result of insulin 
resistance, has been observed to provoke the hyperphosphorylation of tau through the increased activity 
of various signalling pathways leading to the formation of neurofibrillary tangles (Umegaki, 2014). 
This proposed mechanism is further enhanced by previous evidence showing that the administration of 
intranasal insulin treatment may reverse the hyperphosphorylation of tau in T2DM (Yang et al., 2013; 
Chatterjee et al., 2019).  
1.3.4 Chronic low-grade inflammation  
 
Chronic low-grade inflammation plays a key role in the pathogenesis of insulin resistance and is an 
archetypal feature of both T2DM and dementia (Mushtaq et al., 2015; Calle & Fernandez, 2012). 
Elevated circulating levels of inflammatory markers, including interluekin-6, tumour necrosis factor – 
alpha, and c-reactive protein have previously been observed in individuals with T2DM, and were found 
to be associated with poor cognitive performance (Gorska-Ciebiada et al., 2015). A more recent study 
also reported an increased expression of interleukin-6 and c-reactive protein along with tumour necrosis 
factor-alpha in individuals with T2MD and MCI compared to controls, in which the elevated levels of 
these inflammatory markers were also shown to correlate with cognitive scores (Marioni et al., 2010). 
In the context of diabetes-associated cognitive dysfunction, it has been proposed that the inflammatory 
response may play a central role that both facilitates and aggravates AB pathology and the development 
of neurofibrillary tangles (Kitazawa et al., 2005; Kitazawa et al., 2004; Meraz-Rios et al., 2013; Nisbet 
et al., 2015; Rhein et al., 2009). Furthermore, a recent study in T2DM observed that inflammation was 
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correlated with a reduction in both vasoreactivity and vasodilation, suggesting that inflammation may 
influence the vasoregulation of the brain thus contributing towards vascular pathologies associated with 
cognitive dysfunction in T2DM and increased cardiovascular risk (Chung et al., 2015).  
1.3.5 Vascular dysfunction and ischemia  
 
The endothelium plays an important role in maintaining vascular integrity that allows whole organ 
metabolic homeostasis (Galley & Webster, 2004). The entire circulatory system is lined with vascular 
endothelial cells ranging from small capillaries vessels through to large arteries (Rajendran et al., 2013). 
These cells have important functions that are integral to vascular biology, including fluid filtration, 
blood vessel tone, organ homeostasis, immune cell recruitment, and hormone trafficking (Rajendran et 
al., 2013). Endothelial dysfunction represents a key aetiological factor leading to moderate to severe 
vasculopathies observed in T2DM and dementia (Umegaki et al., 2014). Studies have shown that 
markers of endothelial dysfunction e.g. microalbuminuria (Umegaki et al., 2014) are present in 
individuals with T2DM and are associated with accelerated cognitive decline (de Bresser et al., 2010a; 
Kawamura et al., 2014; Umegaki et al., 2012; Umemura et al., 2013). It is proposed that a reduction in 
vascular endothelial cells may impair the coordinated response of the vascular supply in a timely manner 
that is required by the demand generated by nervous activity (Umegaki et al., 2014). Neural activity 
demands enhanced blood flow to the brain in addition to elevations in neuronal glucose, in which 
haemodynamic neurovascular coupling facilitates these links (Umegaki et al., 2014). Age related 
impairments in cerebral regulation coupled with pathological alterations in blood vessels due to T2DM 
may therefore damage the functioning of neurovascular units thus reducing cerebral blood flow 
(Umegaki et al., 2014). Furthermore, the formation and accrual of toxic lipids, AGE products and other 
aggregated proteins in the vasculature may also occur as a result of endothelial dysfunction in T2DM  
(Bissels & Despa, 2018). The accumulation of proteins on blood vessel walls damages endothelial cells, 
enhancing the formation of reactive oxygen species, and reduces the production of vasodilatory factors; 
resulting in a reduction of cerebral blood flow leading to neurovascular uncoupling and thus neuronal 
injury (Bissels & Despa, 2018).  
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1.3.6 Deterioration of the blood brain barrier 
 
The blood brain barrier (BBB) is a semipermeable barrier that divides the blood flow of the brain from 
the extracellular fluid in the central nervous system (Prasad et al., 2014; Ballabh et al., 2004). It is 
comprised of compact junctions located between endothelial cells and astrocytic projections that control 
cellular flow into the central nervous system (Prasad et al., 2014; Umegaki, 2014; Ballabh et al., 2004). 
Alterations in barrier and transport functions have been observed as a result of diabetes that may be 
associated with impairments in cognition (Umegaki, 2014). Early pioneering research demonstrated 
that specific transport processes of the BBB alter under conditions of chronic hyperglycaemia (McCall 
et al., 1982; Gjedde & Crone, 1981; Mooradian & Morin, 1991), reporting a decrease in glucose 
transport in the BBB as well as reduced density of specific glucose transporters. Similar previous work 
also reports alterations in BBB transport, highlighting a decrease in amino acids transport, including 
tryptophan, phenylalanine, methionine, and lysine (Mans et al., 1987). Several mechanisms have been 
proposed with respect to the deterioration of the BBB, including pathological alterations such as 
decreased capillary density and increased basement membrane thickness, as well as haemodynamic 
alterations including reduced vascular reactivity and artriovenous shunting (Mooradian, 1997). Other 
mechanisms previously described in the development of diabetes-associated cognitive dysfunction have 
been shown to play a role in the deterioration of the BBB. For example, the dysfunction of vascular 
endothelial cells has been proposed to induce inflammatory mediators which may disturb the BBB 
(Bissels & Despa, 2018).  Furthermore, alterations in the BBB may expose brain tissue to toxic proteins, 
fibrin, plasma, and haemoglobin, leading to neuronal injury (Bissels & Despa, 2018). Previous studies 
also show that AB may also contribute to alterations in the BBB integrity leading to BBB leakage (Hartz 
et al., 2012). Similar findings have also proposed a link between taupathies and BBB deterioration 
(Blair et al., 2015). 
1.3.7 Reduced availability of neurotrophins   
 
Neurotrophins are a family of functionally and structurally related proteins that play a crucial role in 
the regulation of neural survival, development, function and plasticity (Huang & Reichardt, 2001; 
Skaper, 2012). The neurotrophin family comprises of four neurotrophins including, brain-derived 
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neurotrophic factor (BDNF), nerve growth factor, neurotrophin 3 and neurotrophin 4 (Huang & 
Reichardt, 2001). BDNF is one of the most extensively researched neurotrophins and is shown to play 
a fundamental role in the development of cognitive decline. BDNF is initially synthesized as a precursor 
protein as pro BDNF within the endoplasmic reticulum which is then transported through the Golgi 
apparatus and into the trans-Golgi network (Bathina & Das, 2015). Pro BDNF is then transported to the 
regulated pathway, where through the actions of carboxy peptidase E and protein convertase enzyme, 
mature BDNF is formed which is then released outside the plasma membrane (Bathina and Das, 2015). 
The reduced availability of BDNF, especially in older adults, may contribute towards a decline in 
cognitive abilities, neurodegeneration, and various other cognitive impairments (Zuccato & Cattaneo, 
2009).   
BDNF plays a crucial role in a wide range of biological processes that are essential in the regulation of 
memory, learning and other cognitive processes. One of the earliest identified in vivo functions of 
BDNF is its role in promoting synaptic plasticity (Bathina & Das, 2015; Ho et al., 2011; Allen & 
Dawbarn, 2006). Synaptic plasticity can be described as the experience-dependent alterations in 
connectivity between neurons that facilitates learning and memory (Ho et al., 2011). It is understood to 
be a mechanism through which individuals learn about the surrounding environment and adapt to it 
(Allen & Dawbarn, 2006). Previous evidence has shown that the application of BDNF in neurons and 
muscle cells elicits neurotransmitter release at presynaptic terminals and potentiates excitatory synaptic 
transmission in hippocampal neurons (Kang & Schuman, 1995; Lessmann et al., 1994). Furthermore, 
BDNF has been shown to play a critical role in learning outcomes in several studies, whilst also 
contributing to hippocampal cognitive performance (Tokuyama et al., 2000; Croll et al., 1998). Another 
key function of BDNF in the context of learning, memory and synaptic plasticity is its role in promoting 
neuronal differentiation and survival in the hippocampus (Bathina & Das, 2015). An increased 
expression of BDNF has been associated with greater long-term potentiation of neurons and synaptic 
plasticity, and could be why increased levels of BDNF are associated with enhanced memory including 
spatial memory, verbal memory, and recognition ability (Korte et al., 1995; Scharfman et al., 2005; Lu 
et al., 2013; Karpova, 2014; Leal et al., 2015).  
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T2DM is strongly associated with the development of cognitive dysfunction in which the reduced 
availability of BDNF has been proposed as a potential pathological mechanism that contributes to the 
development of diabetes-associated cognitive dysfunction. Several previous studies exploring the role 
of BDNF in glucose metabolism show reduced levels of serum and plasma BDNF in individuals with 
T2DM (Krabbe et al., 2007; Fujinami et al., 2008, Zhen et al., 2013; Sun et al., 2018). A recent cross-
sectional study involving 715 patients with T2DM revealed that for each one unit increase in serum 
BDNF, the unadjusted and adjusted risk of MCI reduced by 9% and 6% respectively (Sun et al., 2018). 
This association was suggested to be even stronger in obese diabetics compared to non-obese diabetics 
(Sun et al., 2018). There is also evidence to suggest that changes in BDNF directly influences cognitive 
performance. Zhen et al. (2013) reported significantly reduced levels of serum BDNF in individuals 
with T2DM compared to healthy controls in which individuals with T2DM performed significantly 
worse in tasks of global cognition, immediate memory, delayed memory, and language. No correlations 
between cognitive performance and serum levels of BDNF were observed in the healthy control group 
whilst serum BDNF was shown to positively correlate with delayed memory in individuals with T2DM 
(Zhen et al., 2013). Together these findings suggest that the reduced levels of serum BDNF may play 
an important role in the pathophysiology of T2DM and diabetes related cognitive dysfunction. 
1.4. Structural changes  
 
1.4.1 Cerebral atrophy 
 
Cerebral atrophy is a term used to describe the shrinking of brain tissue due to neurodegenerative 
processes including the loss of neurons and their interconnections (Jobst et al., 1994). Several previous 
studies, using different structural magnetic resonance imaging (MRI) techniques, have observed 
accelerated global and regional cerebral atrophy in individuals with T2DM. (Moran et al., 2013; Liu et 
al., 2017; Fang et al., 2018; Groeneveld et al., 2018; Hayashi et al., 2011; den Heijer et al., 2003; de 
Bresser et al., 2010b). Although the morphological variability at each stage of diabetes-associated 
cognitive dysfunction remains unclear, cerebral atrophy is shown to be worse in individuals who present 
more severe cognitive deficits (Biessels & Despa, 2018). A recent study reported lower grey matter 
volume in individuals with T2DM who were identified with MCI and early dementia compared to those 
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with T2DM but without any cognitive impairment (Groeneveld et al., 2018). The greatest reductions in 
grey matter were observed in the right temporal cortex and subcortical grey matter regions (Groeneveld 
et al., 2018). A similar longitudinal study also observed that T2DM patients who presented with a more 
accelerated cognitive decline over a 4 year period had a higher rate of ventricular expansion and reduced 
white matter volume compared to those with a slower rate of cognitive decline (Reijmer et al., 2011). 
These findings are further supported by evidence that show atrophic changes in the brain even in the 
earliest stages of T2DM. A previous cross-sectional study showed a greater expansion in the lateral 
ventricles in T2DM patients (mean age 46.4) whose illness duration was less than 1 year compared to 
age matched healthy individuals (Lee et al., 2013a). Furthermore, there is evidence to suggest that 
individuals with T2DM may be vulnerable to cerebral atrophy even in the absence of peripheral 
microvascular pathologies associated with other target organs (Fang et al. 2018). Associations between 
cerebral atrophy and poor cognitive performance have been observed in individuals with T2DM across 
several cognitive domains including executive function (Moran et al., 2013; Zhang et al., 2014a), visual 
memory (Moran et al., 2013), speed of processing (Moran et al., 2013), delayed recall, attention (Zhang 
et al., 2014a), and global cognitive performance (Tiehuis et al., 2009; Hayashi et al., 2013). In addition, 
the worsening of cerebral atrophy has been shown to be associated with longer diabetes duration, poor 
glycaemic control, and worse insulin resistance (Bryan et al., 2014; Lee et al., 2018; Willette et al., 
2013). Previous evidence investigating the regional distribution of cerebral atrophy in individuals with 
T2DM compared to those without T2DM showed that the loss of cortical grey matter was mainly 
observed in the temporal, parahippocampal, cingulate, precuneus, insula, and medial frontal regions, 
whilst loss of subcortical grey matter was most evident in the caudate nucleus and putamen in those 
with T2DM (Moran et al., 2013). Interestingly, the left cerebral hemisphere demonstrated greater grey 
matter loss compared to the right (Moran et al., 2013). White matter loss was mostly associated in the 
frontal and temporal regions and atrophy was shown in both the left and right hippocampal in T2DM 




1.4.2 Small vessel disease 
 
Cerebral small vessel disease is an umbrella term used to describe the different pathological 
progressions that affect the small vessels of the brain including arteries, arterioles, venules and 
capillaries (Wardlaw et al., 2013). This includes white matter hyperintensities (WMH), microbleeds, 
silent brain infarcts, and lacunar abnormalities, all of which have been observed in individuals with 
T2DM (van Bussel et al., 2017). WMHs are lesions that manifest as areas of intense, high signal 
intensity in regions of white matter when using computed topography or brain MR (Wardlaw et al., 
2013). The underlying mechanisms surrounding the development of WHMs remains unclear but have 
been associated with demyelination and axon loss within white matter regions that are suggested to 
arise through inflammatory or vascular mechanisms (Fazekas et al., 1998; Bissels & Despa, 2018). 
WMHs can manifest as either periventricular WMHs, which are observed close to ventricles, or as deep 
WMHs located in subcortical grey matter (Wardlaw et al., 2013), both of which have been observed in 
individuals with T2DM, and have been shown to be associated with impaired performance in domains 
of processing speed, motor speed, attention and executive function (Manshot et al., 2006; Jongen et al., 
2007; van Harten et al., 2007; Imamine et al., 2011). Microbleeds are also implicated with small vessels 
disease but do not seem to be worsened by T2DM (Moran et al., 2013; Brundel et al., 2014). They are 
observed as small leakages on brain MRIs and are thought to play an important role in cognitive decline 
(Wardlaw et al., 2013). Silent brain infarcts are another manifestation of small vessel disease, and are 
clinically asymptomatic that typically remain unnoticed, but are observable as focal lesions on brain 
MRIs (Vermeer et al., 2007). Individuals with T2DM commonly display silent brain infarcts and have 
been associated with impaired cognitive performance (Manschot et al., 2006; Imamine et al., 2011). 
The increased number of silent brain infarcts has previously been shown to correlate with worse 
performance in tasks of executive function (Imamine et al., 2011). Lacunar abnormalities are another 
type of infarction associated with small vessel disease and manifest as small visible areas that develop 
from an occlusion of small penetrating branches of larger cerebral arteries (Wardlaw et al., 2013). These 
types of infarcts are often progressive (Umegaki, 2010; van Harten et al., 2006; van Bussel et al., 2017) 
in which ischemic mechanisms are proposed to be involved (van Bussel et al., 2017). Cerebral infarcts, 
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including lacunar infarcts, have been identified in individuals with T2DM and have been associated 
with impaired performance in several cognitive domains including global cognition, executive function, 
processing speed, sensory speed, and memory (Manshot et al., 2006; Moran et al., 2013). See Figure 
1.7 for an overview of the structural abnormalities observed in T2DM. 
 
Figure 1.7 Overview of the structural changes which may manifest in individuals with T2DM (b-g). 
(a) MRI image of a healthy young brain. (b) cerebral atrophy, (c) white matter lesions, (d) aneurysm, 
(e) microbleeding, (f) macrobleeding, (g) lacunar infarct. Advanced MRI techniques used to detect 






1.5 Functional changes 
 
1.5.1 Impaired cerebral perfusion 
 
There is a growing evidence base documenting the functional alterations of the brain as a result of 
T2DM. Whilst findings from functional studies that use different methodologies are not as consistent 
as those observed in structural studies, they do contribute to a growing evidence base concerning 
functional alterations, cognitive dysfunction and T2DM (Ryan et al., 2014). Alterations in cerebral 
perfusion have previously been proposed to reflect a significant functional marker of impairment in 
T2DM, although findings from studies have been mixed. Cerebral perfusion is defined as the quantity 
of blood passing through a definitive volume of tissue in a given time (Fantini et al., 2016), and can be 
quantified using several methods including computed tomography, phase contract MRI, intravoxel 
incoherent motion imaging, and arterial spin labelling (van Bussel et al., 2017). Earlier studies using 
single photon emission computed tomography observed a lower cerebral blood flow in individuals with 
T2DM compared to control group findings (Nagamachi et al., 1994; Sabri et al., 2000). More recent 
studies, using phase contrast MRI and arterial spin labelling, did not identify any differences between 
those with T2DM and controls in global cerebral perfusion (Tiehuis et al., 2008; Rusinek et al., 2015), 
suggesting that changes in brain haemodynamics do not play a pathophysiological role in diabetes-
associated cognitive dysfunction. However, studies have reported regional differences in cerebral 
perfusion, showing a reduction in blood flow across numerous areas including the frontal cortices, 
inferior temporal and parietal lobe, precunes and bilateral occipital lobe, posterior cingulate cortex and 
the hippocampus in T2DM relative to controls (Novak et al., 2014; Xia et al., 2015; van Bussel et al. 
2015; Runsinek et al., 2015). Interestingly, individuals with T2DM who were administered with insulin 
were shown to increase regional perfusion in the insular cortex as well as improving performance in 
visuospatial memory and verbal fluency (Novak et al., 2014). These findings suggest improvements in 
regional perfusion that appear to improve cognition may be mediated by a potential insulin related 
vasoreactivity mechanism in T2DM. Similarly, a more recent study observed that improvements in 
cerebral blood flow in areas of grey matter, including the cingulate gyrus and middle temporal gyrus, 
were positively associated with improvements in verbal fluency, but improvements in hippocampal 
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blood flow were found to be negatively associated with memory performance, pointing towards a 
potential vascular mechanism that may be region dependent (Runsinek et al., 2015).  
1.5.2 Neuronal dysfunction  
 
Neuronal dysfunction is a term used to describe the impairments associated with the neuronal system, 
including alterations in functional activity and connectivity between different regions of the brain (Zhou 
et al., 2010). The default mode network (DMN) is a group of functionally and structurally connected 
brain regions that generally show strong functional connectivity at rest and frequently increase and 
decrease in activity synergistically in response to a broad range of cognitive stimulations (Lin et al., 
2017; Smith et al., 2018). The core regions of the DMN include the left and right parietal lobes, the left 
and right hippocampi, the medial prefrontal cortex, and the posterior cingulate cortex (Buckner et al., 
2008). Disruptions in the connectivity of the DMN have previously been shown to contribute to 
cognitive decline in MCI and Alzheimer’s disease (Jones et al., 2011; Cha et al., 2013). Regarding 
T2DM, a previous study that used resting state function MRI showed that individuals with T2DM had 
reduced functional connectivity between the hippocampus and specific regions of the DMN compared 
to controls, including the inferior and medial temporal lobes and the anterior cingulate cortex (Zhou et 
al., 2010). In addition, individuals with T2DM were also observed to perform worse in tasks of memory 
and executive functions but no correlational analysis was performed (Zhou et al., 2010). Alterations in 
DMN connectivity have also been observed in middle aged individuals with T2DM, specifically 
between the posterior cingulate and regions of the DMN including the middle temporal, medial frontal, 
and inferior frontal gyri (Musen et al., 2012). These alterations in functional connectivity were also 
shown to be inversely related to insulin resistance, pointing towards a potential insulin related 
mechanism in T2DM (Musen et al., 2012). This proposed mechanism is further supported by evidence 
that shows an acute increase in functional connectivity between the hippocampus and regions of the 
DMN following the administration of intranasal insulin (Zhang et al., 2015).  
Other potential functional alterations associated with diabetes-related cognitive dysfunction may 
include alterations in signal fluctuations and brain activation (Belfort-Deaguiar et al., 2014). 
Fluctuations in signals are a key characteristic of the resting brain, and their existence is fundamental 
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in quantifying correlated activity between brain regions (Wang et al., 2019). The extent of these 
fluctuations in signals can vary between individuals and can therefore be used as an indicator of 
individual differences of dysfunction. In individuals with T2DM, amplitude of low frequency 
fluctuations, a related measure of signal fluctuations, have been observed in several regions of the DMN 
(Xia et al., 2013; Cui et al., 2014; Zhou et al., 2014). For example, Xia et al. (2013) showed that 
compared with healthy controls, individuals with T2DM showed decreased amplitude of low frequency 
fluctuations in several brain regions including the occipital gyrus, fusiform gyrus, and temporal gyrus 
whilst also showing increased values in middle cerebellum posterior lobe and right cerebellum culmen. 
Similarly, Ciu et al. (2014) reported decreased amplitude of low frequency fluctuations in several brain 
regions including the occipital lobe and postcentral gyrus compared to healthy controls. These observed 
fluctuations were shown to be linked to deficits in cognitive performance, most notably in tasks of 
global cognition, executive function, attention, speed of processing, and memory (Xia et al., 2013; Cui 
et al., 2014; Zhou et al., 2014).  
1.6 Proposed interventions for targeting cognition in T2DM 
 
1.6.1 Exercise training and associated mechanisms 
 
Acute effects of aerobic exercise for improving cognition has previously been shown in middle age and 
older adults (Chang et al., 2012). Chang et al. (2012) conducted a meta-analysis of 79 trials and showed 
an overall small but positive effect (g = 0.097) of acute exercise for improving tasks of executive 
function, reaction time, crystallised intelligence, and short-term memory. This evidence is consistent 
with previous narrative reviews that report positive effects of acute exercise on cognition (Brisswalter 
et al., 2002; McMorris & Graydon, 2000; Tomporowski, 2003; Etnier et al., 1997; Wilke et al., 2019; 
McSween et al., 2019). Likewise, a recent meta-analysis (Wilke et al., 2019) of 12 trials regarding the 
effects of acute bouts of resistance training also showed immediate improvements in several cognitive 
domains including inhibitory control (standardised mean difference (SMD) = 0.73) and cognitive 
flexibility (SMD = 0.36), but not working memory or attention. McSween et al. (2019) also reported 
that acute aerobic exercise did improve measures of cognitive flexibility, executive control, working 
memory and audio-visual perception in healthy adults; however, it was suggested that the limited 
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domains of cognition measured in addition to the large variability between trial protocols and low 
overall quality of studies limits the conclusions that can be drawn from acute exercise studies. Chronic 
aerobic exercise has also been shown to have a positive effect on cognition. An early meta-analysis 
(Colcombe & Kramer, 2003) showed exercise to have a positive impact on several domains of cognition 
including executive function (g = 0.68), spatial tasks (g = 0.42), and speed tasks (g = 0.27). Further 
analysis also revealed that combined strength and aerobic interventions improved cognition to a greater 
extent compared to aerobic exercise, and that longer-term training interventions produces a greater 
effect compared to shorter interventions (Colcombe & Kramer, 2003). Interestingly, no effects on 
cognition were shown as a result of acute bouts of exercise (< 30 minutes) (Colcombe & Kramer, 2003). 
In agreement, Sanders et al. (2019) also show exercise training to improve executive function (d = 0.27) 
and memory (d = 0.24) in healthy older adults. However, in older adults with cognitive impairment, 
shorter interventions with higher session frequency were shown to predict greater improvements in 
cognition (Sanders et al., 2019). In addition, a recent meta-analysis of 24 studies (Landrigan et al., 2019) 
showed positive effects of resistance exercise on composite cognitive scores (SMD = 0.71), cognitive 
screening tools (SMD = 1.28) in addition to executive functions (SMD = 0.39) but not on working 
memory.  
With respect to the effects of exercise training for targeting cognition in T2DM the evidence is 
inconclusive (Hsieh et al., 2013; Podolski et al., 2017; Zhao et al., 2018; Dyer et al., 2019). Two early 
narrative reviews provide evidence to support exercise in producing a beneficial effect on cognition in 
T2DM. Hsieh et al. (2013) identified 3 experimental studies (Baker et al., 2010a; Yanagawa et al., 2011; 
Anderson-Hanley et al., 2012) and concluded that with the appropriate and valid prescription, exercise 
training may have a beneficial impact on cognition, most notably executive function, in those with 
T2DM. Specifically, the positive impact of exercise training was reported to be most advantageous in 
specific regions of the brain, most notably the frontal lobe, a brain region that is particularly sensitive 
to cognitive deterioration (Hsieh et al., 2013). Similar conclusions were also made in a more recent 
review (Podolski et al., 2017) that included a plethora of study designs. The review reported that all 
cross sectional and observational studies were shown to indicate a positive effect of regular exercise on 
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cognition in T2DM (Podolski et al., 2017). Of the 9 interventional studies, beneficial effects of exercise 
were observed among 6 studies showing improvements in tasks of global cognition, executive function, 
verbal memory and learning, and reaction time (Podolski et al., 2017). However, the two most recent 
narrative reviews (Zhao et al., 2018; Dyer et al., 2019) suggest there is still insufficient evidence to fully 
assess the impact of exercise training on cognition in T2DM. Zhao et al. (2018) included six trials that 
were of moderate quality. Overall, four of the six studies reported benefits of greater exercise/physical 
activity participation on certain aspects of cognition, but only 26% of cognitive outcomes were 
significant across all trials. Dyer et al., (2019) included only two trials, the Look-AHEAD study (Rapp 
et al., 2017; Espeland et al., 2018; Espeland et al., 2017a) and the LIFE study (Look Ahead Research 
Group, 2013). Whilst the LIFE study did show greater improvements in global cognition and delayed 
memory as a result of a physical activity, no between group differences were observed in overall 
cognitive scores or in any domain specific cognitive tests in the Look-AHEAD trial (Dyer et al., 2019). 
Considering the inconsistencies in the methods and outcomes of previous reviews, and in light of 
emerging evidence, it may be timely to conduct a systematic review and meta-analysis to further assess 
the effects of exercise on cognition in T2DM.  
Several mechanisms have been identified that potentially govern exercise induced improvements in 
cognition. Exercise has previously been shown to positively influence the structural integrity of the 
brain through reducing the rate of cerebral atrophy and maintaining grey and white matter integrity 
across several brain regions (Best et al., 2015; Colcombe et al., 2006). Enhanced levels of cerebral blood 
flow in addition to other functional mechanisms such as enhanced neurogenesis, angiogenesis and 
synaptogenesis have also been observed following exercise training (Kleinloog et al., 2019; Rhodes et 
al., 2003; Dietrich et al., 2008). Exercise has also been suggested to maintain cognitive integrity by 
protecting the cerebral vasculature and neural tissue through reducing circulating levels of inflammatory 
biomarkers (Cotman et al., 2007; Petersen and Pedersen, 2005). The adaptations in the structure and 
function of the brain as a result of exercise also manifest as improvements in cognition (Pereira et al., 
2007; Erickson et al., 2011), and are particularly significant in the context of executive functions that 
regulate cognitive flexibility, working memory and decision making behaviours in constantly changing 
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environments (Smith et al., 2010; Chang et al., 2012; Verburgh et al., 2014). Whilst a wide range of 
exercise mechanisms have been proposed to play a role in regulating cognition and facilitating cerebral 
plasticity, the enhanced availability of neurotrophins and growth factors, specifically BDNF is 
suggested to be one of the more central mechanisms that governs exercise-induced brain plasticity and 
cognitive development (Berchtold et al., 2005; Cotman et al., 2007; Intlekofer et al., 2013). 
A recent meta-analysis Szuhany et al. (2015) reported that an acute bout of aerobic exercise produced 
a moderate effect on both serum and plasma BDNF (g = 0.46). Likewise, a similar meta-analysis 
comprised of 55 studies (session duration ranging from 7 minutes to 240 minutes) observed a moderate 
effect (g = 0.59) of acute exercise training in enhancing BDNF levels (Dinoff et al., 2017). Furthermore, 
sub-analyses revealed a similar effect in both aerobic and resistance exercise in addition to greater 
positive associations between changes in BDNF and cardiorespiratory fitness, exercise intensity, and 
duration (Dinoff et al., 2017). These findings fall in agreement with more recent studies that show 
enhanced levels of BDNF following acute bouts of exercise (Hung et al., 2018; Dominguez-Sanchez et 
al., 2018). There are also positive findings with respect to the effects of chronic exercise on BDNF 
(Szuhany et al., 2015; Dinoff et al., 2016). The same meta-analysis conducted by Szuhany et al., (2015) 
reported that the effect of regular chronic exercise is also shown to enhance resting BDNF (g = 0.28) in 
a sample of 13 studies (intervention length ranging from 3 weeks to 2 years) in which regular exercise 
was shown to further intensify the effect of a single session of exercise on BDNF levels (g = 0.58). A 
similar meta-analysis comprised of 29 exercise studies (intervention length ranging from 5 weeks to 1 
year) also reported significantly higher levels of peripheral BDNF following chronic exercise training 
(SMD = 0.39) (Dinoff et al., 2016). Sub-analyses of intervention characteristics showed no association 
between changes in BDNF concentrations and number of sessions, session duration, session intensity 
and programme length (Dinoff et al., 2016). These findings are also supported by more recent evidence 
showing positive effects of chronic exercise on BDNF (Nilsson et al., 2020; Hirsch et al., 2018).   
Only a limited number of studies have investigated the effects of exercise training on BDNF in 
individuals with T2DM (Baker et al., 2010a; Swift et al., 2012; Lee et al., 2014; Parsa et al., 2018). An 
earlier study by Baker et al. (2010a) showed no significant differences in plasma BDNF levels in 
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individuals who completed a 6-month aerobic exercise intervention (age 71 ± 7.5) compared to an active 
control group (age 66 ± 6.0) in older adults with T2DM and glucose intolerance. Lee et al. (2014) 
investigated the effects of aerobic exercise training on serum levels of BDNF in juveniles with either 
obesity or T2DM. Twenty six participants were randomised to either an obesity group (age 16.3 ± 0.91), 
T2DM group (age 15.5 ± 2.14) or control group (age 16.45±1.36) and completed a 12-week aerobic 
exercise intervention. Findings showed an increase in serum levels of BDNF in juveniles with obesity 
but not in those with T2DM. Swift et al. (2012) examined the effects of different training modalities on 
serum levels of BDNF in T2DM, including aerobic exercise, resistance exercise, and the combination 
of both. The intervention was conducted over a nine-month period. The aerobic group completed 150 
minutes of physical activity per week whilst the resistance group performed exercise comprising of 2 
sets of 4 upper body exercises, 3 sets of 3 lower body resistance exercises and 2 sets of abdominal and 
back exercise for 10-15 reps. Findings showed no significant differences in serum levels of BDNF in 
any of the training modality groups compared to the control group. Similar findings were also observed 
in a more recent study by Parsa et al. (2018), who reported no significant changes in serum levels of 
BDNF following a 16-week combined aerobic and resistance training programme in T2DM individuals 
with peripheral neuropathy. 
1.6.2 Cognitive training and associated mechanisms 
 
There are several meta-analyses and narrative reviews that provide strong evidence that support the 
effects of cognitive training for improving cognition in both healthy (Lampit, et al. 2014; Kueider et 
al., 2012; Chiu et al., 2017) and cognitively impaired cohorts (Zhang et al., 2019). Chiu et al., (2017) 
conducted a meta-analysis comprised of 31 randomised controlled trials (RCT) and reported small to 
moderate effects of cognitive training for improving cognition in healthy older adults. A moderate effect 
was observed on executive function (g = 0.42) whilst small effects were evident in visual spatial ability 
(g = 0.18), attention (g = 0.21), and memory (g = 0.35) (Chiu et al., 2017). Sub-group analysis signalled 
that intervention characteristics including >24 total training sessions, >8 total training weeks and >3 
training sessions per week yielded the greatest effect (Chiu et al., 2017). Lampit et al. (2014) also 
demonstrated a small to moderate effect of cognitive training across several domains in healthy 
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individuals as part of a meta-analysis of 52 studies. Improvements were observed in working memory 
(g = 0.22), non-verbal memory (g = 0.24), processing speed (g = 0.31) and visuospatial skills (g = 0.30). 
Sub-group analysis showed greater cognitive effects in interventions that included <20 hours of total 
training, training sessions performed 1-3 times a week, and training sessions lasting approximately 31-
60 minutes in duration, see Figure 1.8. There is also evidence that supports the effects of different types 
of cognitive training for improving brain health. An earlier systematic review by Kueider et al. (2012) 
also reported a positive effect of cognitive training interventions from studies in healthy populations 
that used different cognitive training modalities including traditional paper-and-pencil cognitive 
training (ES 0.06 – 6.32), computerized cognitive training (ES 0.19 -7.14), and video game 
interventions (ES 0.09 to 1.70). Cognitive improvements were reported across several domains 
including global cognition, reaction time, speed of processing, working memory, executive function, 
memory, visual spatial ability, and attention (Kueider et al., 2012). The positive effects of cognitive 
training have also been observed within cognitively impaired populations. Zhang et al. (2019) 
conducted a meta-analysis comprising of 18 studies in older adults with MCI and reported small to 
moderate effects across several domains. Moderate effects were observed in working memory (g = 0.39) 
and memory (g = 0.30), whilst small effects were shown in global cognition (g = 0.23), and executive 




Figure 1.8. Sub-group analyses of the moderators of overall effectiveness of cognitive training in older 
adults (Lampit et al., 2014). 
 
Research concerned with exploring the effects of cognitive training in T2DM is still an emerging area 
of research and to date very few studies have been conducted (Paulo & Yassuda 2012; Whitelock et al., 
2018; Bahar-Fuchs et al., 2020). An earlier study by Paulo & Yassuda (2012) investigated the effects 
of a cognitive psychoeducational programme in elderly individuals with T2DM compared to controls. 
The programme consisted of 8 cognitive training sessions in which the intervention length, frequency, 
duration, or difficulty of training were not specified. Significant improvements were observed that 
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favoured the cognitive training group in several tasks related to global cognition and memory. 
Whitelock et al., (2018) examined the impact of an online working memory training programme on 
cognition in individuals with T2DM. The intervention required participants to complete 25 online 
working memory training sessions within 25 to 50 days. Compared to the control group, greater 
improvements were observed in the working memory training group in both trained tasks (working 
memory span) and non-trained tasks (updating ability). The authors concluded that working memory 
training may be effective in producing cognitive gains in T2DM, especially in domains closely related 
to working memory (Whitelock et l., 2018). A more recent study by Bahar-Fuchs et al., (2020) evaluated 
the effects of an 8 week adaptive tailored computerised cognitive training intervention compared to 
generic computerised cognitive training on cognition in individuals with T2DM. Equal improvements 
in global and memory composite scores were observed in both groups in which scores were shown to 
improve even further at the 6 month follow up (Bahar-Fuchs et al., 2020). It was suggested that 
cognitive training may be effective in improving cognition in T2DM but task tailoring and adaptive 
difficulty may not be important constructs of cognitive training interventions in this population (Bahar-
Fuchs et al., 2020). Whilst the evidence concerning cognitive training in T2DM is limited, findings 
point towards this type of intervention as a potential strategy for targeting cognitive dysfunction in 
T2DM. To clarify the effects of cognitive interventions in T2DM further studies are warranted.   
Several mechanisms that potentially elicit enhancements in cognitive performance and neuroplasticity 
through cognitive training have previously been reported. For instance, cognitive training has been 
proposed to enhance the functional connectivity in several regions of the brain including within the 
DMN, central executive network and hippocampus (Lin et al., 2014; Chapman et al., 2015 Chapman et 
al., 2017; Ten Brinke et al., 2017). Furthermore, evidence suggests that cognitive training may also 
allow for greater organisation of local functional connections in older adults potentially reflecting 
higher efficiency of local functional connectivity networks (Deng et al., 2019). Cognitive training is 
also proposed to enhance the thickness and volume of neurons whilst also enhancing neural activity 
throughout the brain (Park, 2013), but further work is needed to confirm this potential mechanism. 
There is also evidence that points towards shared mechanistic pathways between cognitive and exercise 
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training. For example, studies show cognitive training to also enhance cerebral blood flow (Chapman 
et al., 2015; Mozolic et al., 2010) in addition to improved structural correlates of the brain such as 
increased white matter integrity (Chapman et al., 2015). Most notably, the increased availability of 
BDNF is also proposed as a central mechanism that potentially underpins cognitive training 
improvements. 
Several studies have previously demonstrated a positive impact of both acute and chronic cognitive 
training on BDNF in several populations. Kim et al. (2018) reported significant improvements in serum 
levels of BDNF and short-term memory in healthy individuals as a result of a single 50-minute cognitive 
enhancement fitness session. Arazi et al. (2019) also observed acute improvements in serum levels of 
BDNF after a single session of standard chess matches in both novice and elite chess players, with the 
greatest improvements reported in the elite chess players. Enhancements in levels of BDNF have also 
been reported as a result of chronic structured cognitive training. For instance, Rahe et al. (2015) showed 
significant improvements in tasks of figural memory in addition to peripheral levels of BDNF as a result 
of 7 weeks of cognitive training in healthy older adults. Similar findings have also been observed in 
several patient populations including Parkinson’s disease (Angelucci et al., 2015), heart failure (Pressler 
et al., 2015) and MCI (Damirchi et al., 2018). Interestingly, previous studies in both healthy and 
cognitively impaired populations suggest that structured cognitive training may potentially improve 
levels of BDNF to a greater extent compared to exercise training (Ledreux et al., 2019; Damirchi et al., 
2018). Damirchi et al. (2018) reported significantly greater improvements in working memory and 
processing speed in addition to serum levels of BDNF in individuals with MCI who completed 8 weeks 
of cognitive training compared to those who completed an 8-week multicomponent exercise 
programme. Ledreux et al. (2019) showed no significant improvements in serum levels of BDNF in a 
cohort of healthy older adults who undertook 5 weeks of exercise training whilst those who completed 





1.6.3 Dual-task training and associated mechanisms 
 
Whilst both exercise and cognitive training are recognised as potential strategies for targeting cognition, 
it is possible that the simultaneous combination of the two (dual-task) may have shared or 
complementary mechanisms that allow greater cognitive benefits compared to the single underlying 
component. Dual-task training has shown superior improvements in cognition compared to exercise 
and cognitive training alone (Theill et al., 2013; Eggenberger et al., 2015 Yokoyama et al., 2015). Theill 
et al. (2013) investigated the effects of dual-task training comprising of simultaneous treadmill walking 
and working memory against single working memory training and a passive control group. Whilst the 
findings showed greater improvements in executive function in both training groups compared to the 
control group, larger improvements were observed in visual memory and new learning in the dual-task 
group compared to the single working memory training group (Theill et al., 2013). Similar findings 
were also observed when comparing dual-task training against exercise training (Yokoyama et al., 2015; 
Eggenberger et al., 2015). Yokoyama et al. (2015) evaluated dual-task training comprised of concurrent 
cognitive tasks performed during aerobic and resistance exercise against an exercise training group 
only. The authors reported greater cognitive performance in the dual-task group in several cognitive 
domains including registration and recall, attention, verbal fluency and understanding, and visuospatial 
skills whilst no changes were observed in measures of executive function between the two groups 
(Yokoyamma et al., 2015). In agreement, Eggenberger et al. (2015) reported similar findings in that 
treadmill walking simultaneously combined with memory training produced greater improvements in 
attention shifting compared to exercise training alone. These findings are further supported by more 
recent systematic reviews that suggest greater cognitive benefits through simultaneous exercise and 
cognitive training compared to sequential or single component training (Lauenroth et al., 2016; Tait et 
al., 2017). 
Whilst dual-task training has been widely studied in healthy cohorts, only a limited number of trials 
have been conducted concerning the effects of this type of training for targeting cognition in T2DM. 
Shellington et al., (2018) examined the feasibility of a 6 month square stepping intervention consisting 
of visuospatial working memory cued with a stepping response in older adults with T2DM against a 
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concurrent control group. The findings showed significant improvements that favoured dual-task 
training in tasks of planning, a sub-domain of executive function, between 12 -24 weeks when compared 
to the control group (Shellington et al., 2018). Whilst this study showed preliminary evidence of the 
effects of dual-task training for improving cognition in T2DM, specifically executive function, 
challenges were experienced in several aspects of feasibility most notably the recruitment and retention 
of participants. It was concluded that further dual-task interventions should be conducted in T2DM to 
further improve its feasibility and elucidate the effects of this type of intervention on cognition 
(Shellington et al., 2018). 
Whilst numerous mechanisms have been explored that potentially underpin exercise and cognitive 
induced improvements in cognition, the potential mechanisms concerning dual-task training are yet to 
be identified (Laueroth, et al., 2016; Tait et al., 2017). One hypothetical mechanism has previously been 
proposed and coined the theoretical framework of “guided plasticity facilitation” (Fissler et al., 2013). 
This framework suggests that exercise “facilitates” a biological response such as synaptogenesis and 
neurogenesis caused by enhanced availability of neurotrophins and growth factors e.g. increased BDNF 
and insulin-like growth factor-1. In turn, cognitive training successively “guides” this facilitated plastic 
potential by moderating the formation of synapses and increasing neuronal cell survival (Fissler et al., 
2013). Thus, the combined effects of physical and cognitive training may augment the ability to 
restructure neuronal networks, precipitating an enhanced processing efficiency and thus elicit greater 
cognitive benefits compared to single task interventions (Fissler et al., 2013). It is clear that a greater 
number of dual-task interventions are warranted that explore the potential mechanisms that underpin 
simultaneous exercise and cognitive training in both healthy and T2DM populations.  
 
1.7 Theoretical underpinning of study designs  
 
1.7.1 MRC’s framework for developing and evaluating complex interventions 
 
To identify and develop an appropriate exercise, cognitive, or dual-task intervention targeting cognition 
in T2DM, a systematic phased approach will be used based on the medical research council’s (MRC) 
framework for developing and evaluating complex interventions, Figure 1.9 (MRC, 2000; Craig et al., 
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2008). The methodological progression from the conception and development phase through to the 
execution of a large-scale evaluation of a complex intervention may take many diverging paths. The 
key phases recommended by the MRC and their main functions are summarised in Figure 1.9, and the 
interactions between each phase are indicated by arrows. It is logical to view these as linear or cyclical 
phases, although it is common to not follow a linear or cyclical sequence (MRC, 2000; Craig et al., 
2008). The research of the current thesis will focus on the development and feasibility/piloting phase 
of the MRC’s framework and will be conducted over 3 phases including: 1) a systematic review and 
meta-analysis (identifying existing evidence and theory), 2) an intervention development study 
(modelling processes and outcomes) and 3) a feasibility study (feasibility and pilot testing) as described 
below.  
 
Figure 1.9 MRC’s framework for the development and evaluation of complex interventions (Craig et 
al., 2008). 
 
Phase 1 – Systematic review and meta-analysis (Identifying existing evidence and 
developing theory) 
 
Prior to undertaking a large-scale evaluation, the intervention needs to be developed to the stage where 
the research team can be confident that it will have a worthwhile effect (MRC 2000; Craig et al., 2008).  
The first step should establish the theoretical basis by identifying what is already known from similar 
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previous interventions and which methods have been employed to evaluate them (MRC 2000; Craig et 
al., 2008). The justification for the development and evaluation of a complex intervention, the changes 
that might be expected, and how such changes are accomplished may not be fully understood at the 
beginning of the research journey. It is important to therefore develop a theoretical understanding of the 
probable course and cause of change by identifying existing literature and theory (MRC 2000; Craig et 
al., 2008). A systematic review, and if possible, a meta-analysis, of the relevant evidence should be 
conducted at this stage and continuously updated as the evaluation proceeds (MRC 2000; Craig et al., 
2008).  
Phase 2 – Intervention development study (modelling processes and outcomes)  
 
Modelling the processes and outcomes prior to conducting a substantial evaluation can provide crucial 
information regarding the intervention design and evaluation. The modelling process can be conducted 
through several research avenues including small pilot studies or intervention development studies that 
increasingly refine the design of an intervention before initiating a large-scale evaluation (MRC, 2000; 
Craig et al., 2008). An intervention development study is designed to help define the rationale, describe 
the decision making processes and develop the methods and outcomes which materialise between the 
initial conception of an intervention and the formal feasibility, pilot or efficacy testing before 
undertaking a large scale evaluation (Hoddinott, 2015). Put simply, an intervention development study 
helps describe the what, when, how, and why decisions that underpin the design of an intervention 
(Hoddinott, 2015).  
Phase 3 – Feasibility study (feasibility/pilot testing)  
 
A feasibility study is generally conducted before undertaking a large-scale evaluation and intends to 
answer the question “can the study be done?” (NIHR, 2019). Feasibility studies are commonly 
employed to estimate important parameters that are required to develop the design of an intervention 
(NIHR, 2019). Eldridge et al. (2016) propose a conceptual framework for defining pilot and feasibility 
studies that focus on exploratory research in preparation for conducting a RCT, see Figure 1.10. The 
framework proposes that feasibility is the overarching concept within which three distinct types of 
studies exist including randomised pilot studies, non-randomised pilot studies and feasibility studies 
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that are not pilot studies (Eldridge et al., 2016). A randomised pilot study, also known as an internal 
pilot study or randomised feasibility study, is a type of study in which the main RCT, either in its 
entirety or parts of it, is conducted on a smaller scale, including the randomisation of participants to 
determine whether a large scale trial should be conducted (Eldridge et al., 2016). A randomised pilot 
study will largely reflect the design of a future large scale RCT, but if needs be may seek and employ 
alternate strategies to address any outstanding uncertainty (Eldridge et al., 2016). Non-randomised pilot 
studies are almost identical to randomised pilot studies with the exception that the randomisation of 
participants does not take place (Eldridge et al., 2016). Feasibility studies that are not pilot studies are 
those in which researchers investigate whether the components of the future RCT can be achieved but 
do not conduct intervention evaluation or other procedures as part of a future RCT; although 
intervention development may be addressed in some way (Eldridge et al., 2016). As no part of the future 
RCT is being conducted on a smaller scale, this type of study cannot be referred to as a pilot study 
within the conceptual framework but should identify entirely as a feasibility study (Eldridge et al., 
2016). 
 
Figure 1.10. Framework for defining pilot and feasibility studies (Eldridge et al., 2016). 
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A crucial stage in any research process involving an internal pilot study is the progression towards 
conducting a large-scale evaluation (Avery et al., 2017). This phase is key, as a definitive decision must 
be made by formally reviewing and reflecting on the viability of the study as to whether it is correct to 
advance and conduct a main RCT; or whether it is appropriate to adjust operational components of the 
intervention design to bolster success (Avery et al., 2017). Prior to undertaking an internal pilot study, 
the research team should ideally identify a pre-specified ‘progression’  or ‘decision’ criteria that will 
provide an indication as to whether the study targets have been met and whether a definitive RCT can 
proceed (Avery et al., 2017). Instead of employing a simply stop/go criteria it would be more useful to 
employ a red/ amber/ green traffic light progression criteria to explore whether the main RCT can 
proceed with modifications e.g. stop/red (when there are major issues that cannot be resolved), 
amend/amber (where there are resolvable issues, thereafter proceeding with caution) or continue/green 
(where no concerns have arisen that threaten the success of the RCT) (Avery et al., 2017). This 
progression criteria can be used to assess the viability of completing the main RCT within the specified 
timings and costs and is also useful in addressing the main areas of uncertainty or risk that may affect 
the success of the study (Avery et al., 2017). The final experimental phase of this thesis will be 
concerned with conducting a randomised feasibility study using a traffic light progression criteria that 
indicates whether targets have been met and a definitive RCT can proceed. 
1.8. Thesis aims and objectives 
 
The overarching aim of this doctoral thesis was to develop and evaluate exercise, cognitive, and dual-
task interventions for targeting cognitive dysfunction in individuals with T2DM. To achieve this aim 
three studies were conducted in line with the MRC’s framework.  
1.8.1 Study 1 (Chapter 2) 
 
Title: Effects of exercise, cognitive, and dual-task interventions on cognition in type 2 diabetes mellitus: 
A systematic review and meta-analysis. 
Aim: To systematically review the evidence, and estimate the effects of exercise, cognitive, and dual-




A) Systematically search and identify existing RCTs that investigate the effects of exercise, 
cognitive, and dual-task interventions on cognition in T2DM 
B) Extract and analyse data from included trials and critically appraise the overall quality of trials. 
C) Estimate the size and direction of the effects of exercise, cognitive, and dual-task interventions 
on study specific cognitive variables in T2DM. 
 
1.8.2 Study 2 (Chapter 3) 
 
Title: Walking, cognitive, and dual-task interventions in type 2 diabetes mellitus: An intervention 
development study.  
Aim: To conduct a series of treadmill walking, cognitive training, and dual-task sessions to help identify 
and inform the development of a suitable intervention for targeting cognitive dysfunction in T2DM 
Objectives: 
A) Model the process and outcomes to refine the design of a future intervention aiming to improve 
cognition in T2DM 
B) Compare two different cognitive testing platforms and construct a meaningful test battery for 
evaluation in a T2DM population 
C) Evaluate the acceptability of walking, cognitive, and dual-task activities in individuals with 
T2DM. 
D) Design an intervention and provide recommendations for further feasibility testing based on 
previous research and outcomes from this intervention development study. 
 
1.8.3 Study 3 (Chapters 4 & 5) 
 




Aim: To determine the feasibility (chapter 4) and acceptability (chapter 5) of a cognitive training study 
in individuals with T2DM.  
Feasibility objectives (chapter 4): 
A) To investigate the feasibility of a cognitive training study in individuals with T2DM. 
B) To investigate the effect of a cognitive training study on cognition in individuals with 
T2DM.  
C) To investigate the effect of a cognitive training study on BDNF in individuals with T2DM.  
Acceptability objectives (chapter 5):  
A) To explore the perceptions of the participant’s experience of taking part in the cognitive 
training study.  

















Study 1 - Effects of exercise, cognitive, and dual-task interventions on cognition 
in type 2 diabetes mellitus: A systematic review and meta-analysis 
2.1 Introduction 
 
Diabetes mellitus is a group of metabolic disorders characterised by hyperglycaemia and caused by 
defects in insulin production, insulin action or both (ADA, 2010). The number of diabetes cases 
worldwide have rapidly increased over the last four decades, rising from 108 million in 1980 to 422 
million in 2014 (WHO, 2018a). Diabetes is a leading cause of mortality (WHO, 2018b) and is a strong 
risk factor for both microvascular and macrovascular complications with growing evidence suggesting 
an association with cognitive dysfunction (Chatterjee et al., 2016; Guadala et al., 2013; Reijmer et al., 
2011; Ruis et al., 2009; Strachan et al., 2011).   
Deficits in several cognitive domains that are affected in MCI and dementia have been observed in 
those with T2DM (Mansur et al., 2018; Monette et al., 2014; Palta et al., 2014; Pelimanni et al., 2018; 
van de Berg et al., 2006). For example, a previous meta-analysis that included a total of 26,137 
participants across 24 trials (Palta et al., 2014) reported that, compared to those without diabetes, 
individuals with T2DM showed an overall worse performance in tasks of attention/concentration (d = 
-0.19), visual memory (d = -0.26), verbal memory (d = -0.28), processing speed (d = -0.33), executive 
function (d = -0.33), and motor function (d = -0.36). The exact underlying mechanisms precipitating 
cognitive dysfunction in T2DM remain unclear. Evidence has shown poor glycaemic control to be 
strongly associated with the development of cognitive dysfunction (Alosco & Gunstad, 2014; Munshi 
et al., 2006). Cerebral and peripheral vascular complications that develop as a consequence of chronic 
exposure to hyperglycaemia (e.g. neuropathy, white matter disease, stroke, myocardial infarcts, 
peripheral artery disease) have been linked to cognitive impairment in T2DM (Koekkoek et al., 2015; 
Luchsigner et al., 2012). Other proposed mechanisms such as chronic low-grade inflammation, insulin 
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dysregulation, and vascular dysfunction have also been implicated in the development of diabetes-
associated cognitive dysfunction (Biessels & Despa, 2018; Umegaki, 2014).  
Numerous strategies to prevent cognitive dysfunction have been explored in healthy cohorts. Amongst 
these, several meta-analytic studies have shown both exercise (Chang et al., 2012; Colombe & Kramer, 
2003) and cognitive training (Keuider et al., 2012; Lampit et al., 2014; Mowszowski et al., 2016) to 
provide important cognitive benefits. Exercise has been shown to have a positive effect on T2DM 
related outcomes, including improving glucose control, reducing inflammation, improving insulin 
sensitivity, and reducing cardiovascular risk (Colberg et al., 2010), all of which are factors known to 
affect cognition (Umegaki, 2014; Albai et al., 2019). Other mechanisms through which exercise has 
been proposed to improve cognition involve anatomical and biochemical adaptations such as reduced 
cerebral atrophy, increased neurogenesis, improved insulin signalling, enhanced cerebral blood flow, 
and the increased availability of neurotrophins and neurotransmitters (Alfini et al., 2019; Cotman et al., 
2007; Erickson et al., 2011; Hamilton et al., 2015; Park et al., 2019). Similar physiological mechanisms 
are also evident as a result of cognitive training alongside neural mechanisms including improved 
resting state neural activity and enhanced functional connectivity in the DMN and central executive 
network (Chapman et al., 2015 Chapman et al., 2017; Ten Brinke et al., 2017). The engagement in 
simultaneous exercise and cognitive training (dual-task training) has been shown to improve cognition 
beyond the effects of the single underlying components (Eggenberger et al., 2015; Theill et al., 2013; 
Yokoyama et al., 2015), suggesting that the combined effects of these tasks may have a potential 
additive effect on brain and physiological function.  
Whilst no previous review has evaluated the effects of cognitive or dual-task training in T2DM, 
researchers have reviewed the effects of exercise training in this patient population. Two previous 
reviews (Hsieh et al., 2013; Podolski et al., 2017) present findings that support the effects of exercise 
on cognition in T2DM, reporting improvements in several cognitive domains including executive 
function, memory, attention, language, visuospatial ability and global cognition. One review (Hsieh et 
al., 2013) concluded that the beneficial effects of exercise may be most significant in brain regions that 
are most vulnerable to the process of ageing, specifically regions associated with executive function 
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such as the prefrontal and frontal lobe. Conversely, the two most recent reviews (Dyer et al., 2019; Zhao 
et al., 2018) suggest that the strength of the current available evidence does not support these 
conclusions. A limitation of these previous reviews was that they included a broad range of study 
designs and not one statistically quantify the effects of interventions. The current review will be the 
first to synthesis data from interventional trials. Conducting a robust synthesis of available evidence 
will reduce uncertainty about the effects of exercise, cognitive, and dual-task interventions on cognition 
in T2DM. This will inform future interventions with respect to non-pharmacological prevention 
strategies, targeting cognitive impairment in diabetic populations. 
2.1.1 Aim and objectives 
 
The primary aim of this research was to systematically review the evidence, and estimate the effects of 
exercise, cognitive, and dual task interventions on cognition in T2DM. This study aimed to meet the 
following objectives:  
A) Systematically search and identify existing RCTs that investigate the effects of exercise, 
cognitive, and dual-task interventions on cognition in T2DM. 
B) Extract and analyse data from included trials and critically appraise the overall quality of trials. 
C) Estimate the size and direction of the effects of exercise, cognitive, and dual-task interventions 
on study specific cognitive variables in T2DM 
2.2 Method 
 
Methods of analysis and eligibility criteria were specified in advance and documented in a protocol 
(CRD42017058526) registered on the PROSPERO (International Prospective Register of Systematic 
Reviews; www.crd.york.ac.uk/PROSPERO/) (Appendix C). This systematic review and meta-analysis 
was conducted in accordance with the PRISMA checklist (Appendix D) 
2.2.1 Eligibility criteria  
 
Trials were considered for inclusion in this review subject to the following criteria being met. 
Participants: adults aged 18+ diagnosed with T2DM. Intervention: Any structured exercise, 
cognitive, or dual-task intervention. The design of the trial must have been such that the independent 
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effects of either exercise, cognitive, or dual-task training on cognition could be analysed. Dual-task 
trials were eligible only if the intervention consisted of the simultaneous engagement of exercise and 
cognitive activities (e.g. treadmill walking whilst performing a memory task) and not the combination 
of the two single underlying components (e.g. treadmill walking followed by memory training). 
Comparison: Any concurrent control group was eligible, including no contact/usual care, waiting list, 
sham exercise, passive training, or alternative active treatment. Outcome: Any validated 
neuropsychological test of cognition reported at baseline and follow up after exposure to either an 
exercise, cognitive, or dual-task intervention. Study design: Any trials that allocated individuals to 
either an intervention or concurrent control group.  
2.2.2 Search strategy 
 
The following electronic databases were searched for completed trials: PubMed, EMBASE, CINAHL, 
PsycINFO, SPORTDiscus, MEDLINE, and Health Technology Assessment (HTA). ClinicalTrial.gov 
and Cochrane Register of Controlled Trials were searched for ongoing trials. Conference Papers Index 
was searched for conference papers and abstracts, and Cochrane, PROSPERO, and the Database of 
Abstracts of Reviews of Effects (DARE) were searched for completed or ongoing systematic reviews. 
Database searching was supplemented by contact with study authors and research groups, forward and 
backward citation tracking from included trials or previous relevant reviews, with further searching via 
Google Scholar. Searches were conducted from database inception to March 2020. No limits on 
language or publication status were set.  
Key search terms for database searching included the following (“Type 2 diabetes mellitus” OR “Non-
insulin dependent diabetes mellitus” OR “Adult-onset diabetes mellitus,”) AND (“Exercise” OR 
“Physical activity” OR “Cognitive training” OR “Brain training” OR “Dual-task” OR “Motor-
cognitive”) AND (“Cognition” OR “Neurocognitive function” OR “Brain function)”. An example 
search strategy for PubMed is provided in Appendix E. All key search terms were combined, where 
possible, with medical subject headings (MeSH) and indexed terms to identify potentially relevant 
studies. Retrieved trials were collated and stored using Endnote referencing software (EndNote X8, 
Clarivate Analytics, Philadelphia, USA). Duplicate citations were removed prior to the independent 
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screening of title and abstract in accordance with the pre-specified eligibility criteria (S.C). Full text 
articles were retrieved for all trials that were not excluded based on title and abstract before 
independently screened for final eligibility (S.C & F.C). All discrepancies were resolved through further 
discussion, or where required, a third reviewer (K.P). 
2.2.3 Data abstraction 
  
Data were extracted using an adapted Cochrane Data Extraction Template for interventions. Trial 
characteristics were extracted from each included trial based upon 1) Trial characteristics (trial aim, 
trial design, inclusion/exclusion criteria, sample size and methods of allocation), 2) Participant 
characteristics (diabetes diagnosis, age, sex, body mass index (BMI), length of diabetes diagnosis, 
medication), 3) Intervention/comparison (type, duration, frequency, intensity, length, delivery of 
intervention/control, site of delivery), and 4) Outcome measurements (all relevant cognitive outcomes 
and measurement tools). S.C undertook data extraction for each trial, with cross checking taking place 
by F.C. All discrepancies between reviewers in certain trials were resolved through further discussion, 
or where required, a third reviewer (K.P). 
2.2.4 Risk of bias assessment 
 
S.C and F.C independently assessed the risk of bias for included trials using the Cochrane Risk of Bias 
assessment tool with the following domains: random sequence generation, allocation concealment, 
incomplete outcome data, blinding of outcome assessment and selective outcome reporting. Each 
domain was categorised as either low, unclear, or high with the risk of bias for each trial classified using 
the following criteria 1) low risk of bias (all criteria graded as low), 2) moderate risk of bias (one 
criterion graded as high or two criteria graded as unclear), and 3) high risk of bias (more than one 
criterion graded as high, or more than two graded as unclear) (Bridle et al., 2012). Disagreements 
between reviewers were resolved through further discussion, or where required, a third reviewer (K.P).  
2.2.5 Data analysis 
 
Trials were pooled based on the intervention type (e.g. exercise, cognitive, or dual-task) and a separate 
set of analyses performed to quantify their effect on cognition in T2DM. Cognitive outcomes were 
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grouped based on the cognitive domain measured (e.g. global cognition, executive function, memory, 
attention) and meta-analyses conducted on subdomains using compatible neuropsychological tasks (e.g. 
the Victorian Stroop task and the Stroop task were used to measure inhibition response, a subdomain 
of executive function). Change from baseline values were used to conduct meta-analyses as it allowed 
the comparison of more trials. Where trial data were presented as pre and post, change from baseline 
scores were calculated by deducting the baseline score from the follow up score. Standard error (SE) 
scores were converted to SD scores using the following equation (Higgins et al., 2011). 
SD = SE x √N 
Change from baseline SD was calculated using the following correlation coefficient equation (Higgins 
et al., 2011).  




E/final – (2 x 0.5 x SDE/baseline x SDE/final) 
All meta-analyses were performed using Review Manager Version 5.3. Data were quantified using 
SMD and 95% CIs for continuous outcomes. A higher score that reflected a greater task performance 
was represented by a positive effect estimate. A lesser score that reflected a greater task performance 
was represented by a negative effect estimate. A random-effects model was chosen due to the expected 
heterogeneity between trial protocols. Heterogeneity was measured using Higgins I2 statistic (Higgins 
et al., 2002). An I2 threshold of >40% was set to detect heterogeneity. 
2.3 Results  
 
2.3.1 Search results 
 
The search of all electronic databases provided a total of 17,400 distinct citations with an additional 18 
citations identified through other sources, see Figure 2.1. After adjusting for duplicated citations, 10,999 
citations remained. Of these, 10,958 citations were discarded after reviewing for title and abstract as 
these records did not meet the pre-specified eligibility criteria. Of the remaining 41 citations, full texts 
were obtained and examined in detail for inclusion in this review. In total, 32 of these trials did not meet 
the pre-specified inclusion criteria for reason including non-randomised design (n=12), irrelevant 
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intervention (n=8), non-diabetic/no concurrent control (n=6), ongoing trial (n=2), study protocol (n=2), 
and outcome data not reported (n=2), (Figure 2.1). Nine trials met the pre-defined inclusion criteria; six 
trials investigated the effect of an exercise intervention (Baker et al., 2010a; Callisaya et al., 2017; 
Espeland et al., 2017b; Kour et al., 2015; Pisabarro et al., 2018; Yanagawa et al., 2011), two trials 
investigated the effect of a cognitive intervention (Paulo & Yassuda, 2012; Whitelock et al., 2018), and 
one trial investigated the effect of a dual-task intervention (Shellington et al., 2018) on cognitive 
function in T2DM. 
 
Figure 2.1. Study flow chart (Moher et al., 2009) 
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2.3.2 Characteristics of studies 
  
The six included exercise trials were published between 2010 and 2018, see Table 2.1. In total, 604 
participants (43.7% males) were allocated to either an exercise intervention or concurrent control. Study 
sample sizes ranged between 16 and 415. All trials (Baker et al., 2010a; Callisaya et al., 2017; Espeland 
et al., 2017b; Kour et al., 2015; Pisabarro et al., 2018; Yanagawa et al., 2011) recruited patients with 
T2DM. Three trials (Callisaya et al., 2017; Espeland et al., 2017b; Kour et al., 2015) used a multimodal 
exercise design incorporating aerobic exercise, resistance/strength training, flexibility and balance 
training. The remaining three trials (Baker et al., 2010a; Pisabarro et al., 2018; Yanagawa et al., 2011) 
used aerobic training only. The duration of exercise interventions ranged from 2 to 6 months with the 
exception of one trial (Espeland et al., 2017b) which lasted 24 months. The frequency of exercise 
training ranged from 2 to 8 sessions per week, with the duration of training sessions lasting between 30 
minutes and 60 minutes. Further details of all exercise trials are given in Table 2.1   
The two included cognitive trials were published in 2012 and 2018, see Table 2.1. One trial (Whitelock 
et al., 2018) randomised 81 individuals diagnosed with T2DM (60% males) to either a working memory 
training intervention or a concurrent control. The trial intervention required participants to complete 25 
online working memory training sessions within 25 to 50 days. Training tasks included letter span task, 
backwards digit span task, and a visuospatial task. The training was individualised whereby the 
difficulty would increase for every two correct answers or decrease for every two incorrect answers. A 
follow up assessment was included 3 months post intervention. The remaining trial (Paulo & Yussada, 
2012) allocated 34 individuals (59% male) to either a psychoeducational training intervention or 
concurrent control. The intervention consisted of 8 cognitive psychoeducational training sessions. The 
cognitive training components included tasks based upon auditory memory, visual attention, verbal 
fluency, memory and ordination. The intervention length, frequency, duration, or difficulty of training 
was not specified.  
The only dual-task trial (Shellington et al., 2018) randomised 25 individuals (68% males) aged >50 
diagnosed with T2DM to either an intervention or concurrent control see, Table 2.1. The intervention 
consisted of a 6-month squared stepping exercise involving a visuospatial working memory task cued 
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with a stepping response. Participants were shown a stepping pattern across a gridded mat containing 
40 squares in which they were required to memorise and repeat the demonstrated pattern 4 times before 
moving on to a novel pattern. Sessions were performed twice a week lasting 1 hour in duration. The 
task difficulty progressed when 80% of participants performed the task correctly. No follow up 

























Study (country) Population Intervention Comparison Cognitive outcomes 
Exercise trials      
 








Con: n=9  
Males: n=10 
Age: 71 ± 7.5 (Int) 




4 x/wk  
45-60 mins 
75-85% HR reserve 
 
Stretching and balance 
exercise.  
 






















Age: 65.3 ± 5.0 (Int) 







Resistance 14-17 RPE  
Aerobic 12-13 - 14-16 
RPE 
 




Global composite scores 
Victoria Stroop test  
Trail making test 
DSC 
Digit span (WAIS-III) 
HVLT-R 






















50 mins  
Aerobic 13 RPE 









DSC (WAIS-III),  
HVLT-R 
n-back task 
Task switching paradigm 
Eriksen flanker task 











Age 35.6 ± 3.72 (Int) 
36.4 ± 3.89 (Con) 
 
2 months  
Multimodal exercise 
Aerobic - 5 x/wk 
30 mins 
70-80% HRmax 
Resistance - 3 x/wk, 3 
sets, 8-10 reps 
 
Dietary and medication Stroop test (congruent) 
Stroop test (Incongruent) 
 









Age 64.06 ± 5.45 (Int) 
62.68 ± 7.09 (Con) 
5 months 




intensity   
Advised to walk Adenbrooke cognitive exam 
(ACE) – Spanish version 
 
 











Age: 71.56 ± 3.84 (Int) 














Japanese Stroop test, 
Word recall 
digit symbol 
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Table 2.1 Continued 
T2DM= Type 2 diabetes mellitus, IGT=Impaired glucose tolerance, Int= Intervention group, Con= control group, x/wk = times per 
week, RPE=Rate of perceived exertion scale, mins = Minutes, HRmax = Maximum heart rate, HR reserve = HR reserve, WM = 
Working memory, DSC= Digit symbol coding, WAIS-III= Wechsler adult intelligence scale – third edition, HVLT-R=Hopkins 
verbal learning test-revised, 3MSE= Modified mini-mental state examination, SOPT= Self-ordered pointing test, RBMT=Rivermead 




Only two out of the six exercise trials (Callisaya et al., 2017; Espeland et al., 2017b) reported on exercise 
adherence. In one study (Callisaya et al., 2017) attendance to exercise classes was 79% in the 
intervention group, whilst the attendance of control participants to the light stretching and gentle 
movement programme was 75%. Of those who attended exercise classes in the intervention group, only 
75% adhered to the full 60 minutes of exercise. In the remaining exercise study (Espeland et al., 2017b), 
the attendance of individuals in the exercise group and health education control were 67% and 81%, 
respectively. Only one out of the two cognitive trials reported on adherence (Whitelock et al., 2018), 
reporting that only two participants completed <20 out of 25 working memory training sessions in the 
intervention group and only one participant completed <20 out of 25 passive working memory training 
 














8 training sessions  
 
Did not specify  
 
Verbal fluency 
The short cognitive test  
RBMT 
 










Age: 59.69 ± 8.77 (Int) 




25 sessions  
Completed in 25-50 
days. 
Difficulty closely 




Working memory capacity 
Attention switching task 
Paired associated learning 
Spatial span 
Spatial working memory 
 
Dual-task trials     
 












Age: 65,9 ± 5.2 (Int) 
71.2 ± 6.9 (Con)  
 
6 months 
Square stepping exercise 






Memory (Monkey ladder, 
spatial span, digit span, 
paired associates) 
 
Reasoning (Verbal reasoning, 
double trouble, odd one out) 
 
Concentration (Rotations 
featured match, interlocking 
polygons) 
 







sessions. In the one dual-task trial (Shellington et al., 2018) only 4 of the 12 participants in the 
intervention group attended >50% of the square stepping exercise programme, the remaining 8 attended 
<40% of sessions. The average attendance of those participants who attended >50% of sessions was 
70.2%. 
2.3.4 Measurements of cognition 
 
For the purpose of our analysis, this section will focus on outcomes included in meta-analyses only. 
Three trials investigated the effects of exercise on sub-domains of executive function. Inhibition 
response was measured in three trials using the Victoria Stroop task (Callisaya et al., 2017), the Japanese 
version of the Stroop color-word test (Yanagawa et al., 2011), and the Stroop test (Kour et al., 2015). 
Working memory was measured in two trials using the digit symbol test ( Yanagawa et al., 2011) and 
digit symbol coding (Callisaya et al., 2017). General executive function was measured in two trials 
using the trail making test part A and part B (Callisaya et al., 2017; Yanagawa et al., 2011). Two trials 
investigated the effects of exercise on explicit memory, a sub-domain of memory, using paragraph recall 
(Yanagawa et al., 2011) and the Hopkins verbal learning (Callisaya et al., 2017) test for both immediate 
and delayed recall. Outcome measures of trials that were included in the review but excluded from 
meta-analyses can be found in Table 2.1.   
2.3.5 Risk of bias assessment 
 
The overall risk of bias varied across included trials, see Table 2.2. Only one trial (Callisaya et al., 2017) 
was judged to have had a low overall risk of bias. The remaining eight trials were deemed to have had 








Table 2.2 Risk of bias assessment of included trials  
 
2.3.6 Exercise interventions 
 
Three trials (Callisaya et al., 2017; Kour et al., 2015; Yanagawa et al., 2011) reported the effect of 
exercise on the Stroop task. There were 65 individuals in the experimental group and 61 in the control 
group. The point estimate of effect indicated a greater reduction in the time taken to complete the Stroop 
task in two of the included trials (Kour et al., 2015; Yanagawa et al., 2011). Pooled analysis from the 
three trials demonstrated a small, favourable but not statistically significant effect of exercise on the 
time taken to complete the Stroop task (SMD = -0.31, 95% CI -0.71 – 0.09, P=0.13, Figure 2.2). A low 
level of statistical heterogeneity was detected among trial level effect (I2=17%). Compared to other 
trials included in the meta-analysis, one trial had a high risk of bias (Yanagawa et al., 2011). Removal 
of Yanagawa et al. did not change the overall effect (SMD = -0.28, -0.85 – 0.30, P=0.35).  
Two trials (Callisaya et al., 2017; Yanagawa et al., 2011) reported the effect of exercise on the trail 
making test part A and B, digit symbol, immediate recall, and delayed recall. There were 35 individuals 
in the experimental group and 31 in the control group. Pooled analysis indicated no significant effects 
of exercise on the trail making part A (SMD = 0.28, -0.20 – 0.77, P=0.25, Figure 2.3), the trail making 
part B (SMD = -0.15, -0.64 – 0.34, P=0.54, Figure 2.4), digit symbol coding (SMD = 0.09, -0.39 – 0.57, 
P=0.72, Figure 2.5), immediate recall (SMD = 0.20, -0.28 – 0.69, P=0.41, Figure 2.6) or delayed recall 
(SMD = -0.06, -0.55 – 0.42, P=0.80, Figure 2.7). There was no evidence of heterogeneity across all 










Selective bias Overall 
Baker et al.   Unclear Unclear  Low Unclear High High 
Callisaya et al.  Low Low Low Low Low Low 
Espeland et al.  Low Unclear Low Unclear High High 
Kour et al.  Low Unclear Unclear Low Low Moderate 
Paulo & Yassuda  Unclear Unclear Unclear Unclear High High 
Pisabarro et al.  Low Low Unclear Unclear Low Moderate 
Shellington et al.  Low Unclear High Low Low Moderate 
Whitelock et al.  Low Unclear Low Unclear Low Moderate 
Yanagawa et al. Unclear Unclear Unclear Low Low High 
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measures (I2 = 0%). Only two trials (Callisaya et al., 2017; Yanagawa et al., 2011) provided post 
intervention outcome data (the Stroop task) for inclusion in a meta-analysis. The Synthesised data from 
these two studies demonstrated a significant between group effect favouring exercise on the time taken 
to complete the Stroop task (SMD -0.85, 95% -1.24 - -0.45, P=0.0001). However, a substantial level of 
statistical heterogeneity was detected (I2=69%).  
Three of the six exercise trials retrieved (Baker et al., 2010a; Espeland et al., 2017b; Pisabarro et al., 
2018) were not included in the meta-analyses due to the absence of means and SDs or group mean 
differences, and the lack of comparable cognitive outcomes. Individual trials reported statistically 
significant effects of exercise on cognitive tasks including the trail making test part B (P=0.04), task 
switching (P=0.03), the Stroop task (P=0.04) (Baker et al., 2010a), digit symbol coding (P =0.05), 
Hopkins verbal learning test-revised (P =0.005), the Ericksen flanker test (congruent and incongruent 
P=0.005, P=0.006) (Espeland et al., 2017b), and the Adenbrooke cognitive exam Spanish edition 





























Figure 2.7 Trial level data, effect estimates and forest plot for the effects of exercise on the delayed recall. 
 
 
2.3.7 Cognitive interventions 
 
Two cognitive trials were retrieved but a meta-analysis could not be conducted due to differences in 
reported outcomes. The two trials reported statistically significant effects of cognitive training on 
cognitive tasks including trained working memory capacity (ES = 0.99, 0.53 – 1.46), updating ability 
(ES = -0.41, -0.85 – 0.03) (Whitelock et al., 2018), the short cognitive test memory score (ES = -0.54, 
-1.22 – 0.14) and total score (ES = -0.92, -1.63 - -0.22) (Paulo & Yassuda, 2012).  
 
2.3.8 Dual-task interventions 
 
Only one dual-task was retrieved. The trial reported statistically significant effects of dual-task training 
on tasks of planning, including the tree task (ES = -0.41, -1.30 – 0.48) and token search (ES = 0.92, -
0.01 – 1.85) between weeks 12 and 24 only. No other cognitive outcomes were statistically significant 





The review identified nine trials that met the study inclusion criteria, including one dual-task trial 
(Shellington et al., 2018), two cognitive trials (Paulo & Yassuda, 2012; Whitelock et al., 2018) and six 
exercise trials (Baker et al., 2010a; Callisaya et al., 2017; Espeland et al., 2017b; Kour et al., 2015; 
Pisabarro et al., 2018; Yanagawa et al., 2011). The overall quality of included trials was mixed, with 
the majority of trials having a moderate to high risk of bias. A lack of common outcomes and insufficient 
number of trials limited the meta-analysis to exercise trials only. Small to moderate ESs that favoured 
the experimental group were identified in tasks of executive function and memory including the Stroop 
task (-0.31) and immediate recall (0.20), but were not statistically significant. Whilst a meta-analysis 
could not be conducted using cognitive trials (Paulo & Yassuda, 2012; Whitelock et al., 2018) or dual 
task trials (Shellington et al., 2018), individual trial data were shown to favour these interventions on 
tasks of global cognition, executive function, and memory.  
2.4.1 Comparison with other reviews 
 
The author is aware of four recent systematic reviews (Hsieh et al., 2013; Podolski et al., 2017; Dyer et 
al., 2019; Zhao et al., 2020) that critically appraised the effects of exercise on cognition in T2DM but 
did not statistically quantify the findings of studies into a single numerical estimate of effect. Two 
reviews (Hsieh et al., 2013; Podolski et al., 2017) present findings to support the effects of exercise for 
improving cognitive performance in T2DM, whereas, the two most recent reviews (Dyer et al., 2019; 
Zhao et al., 2018) suggest that the strength of the current available evidence does not support these 
conclusions. The inconsistencies in the findings between previous reviews are most likely attributed to 
the variations in eligibility criteria, in which the inclusion of trials with differing trial designs is evident. 
The current review is the first to synthesise quantitative data from interventional trials assessing the 
effects of exercise training on cognition in T2DM. Whilst we have identified additional studies 
(Callisaya et al., 2017; Kour et al., 2015; Pisabarro et al., 2018) in comparison to previous reviews, 
limited availability of data resulted in only a small number of studies being included within the meta-
analyses. The present meta-analyses do provide an indication of the ES of exercise interventions on 
cognition in T2DM. Small to moderate effects that favoured the experimental group were shown in 
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tasks of executive function and memory including the Stroop task (SMD = -0.31) and immediate recall 
(SMD = 0.20). The observed ESs may be practically important in this population (Bridle et al., 2012), 
but were not significant due to the small sample size of included trials (the Stroop task n=126 and 
Immediate recall n=66). It could be argued that the effect (magnitude) of trials are evident, but the 
power (precision) to detect them as statistically significant is lacking. Interestingly, individual findings 
from the exercise trials included in the present meta-analyses indicate that the improvements observed 
in blood glucose levels, HbA1c, and BMI were significantly associated with improvements in tasks of 
executive function (Kour et al., 2015; Yanagawa et al., 2011). In agreement with previous reviews 
(Hsieh et al., 2013), our findings also suggest that the beneficial effects of exercise on cognition may 
be most significant in domains of executive function, which are possibly mediated through 
improvements in glucose control and body mass. Previous evidence has shown exercise training to have 
a beneficial impact on cognition through several mechanisms directly and indirectly related to glucose 
control. For example, Baker et al. (2010a) reported improvements in executive function and insulin 
sensitivity after a 6 month of aerobic exercise training, reflecting the potential benefit of improved 
glucose metabolism on cognitive processes (Baker et al., 2010a). Other mechanisms identified through 
which exercise may improve cognition, indirectly related to improvements in glucose control, include 
enhanced cerebral perfusion, increased neurogenesis and synaptogenesis, reduced inflammation, 
increased availability of neurotrophins and neurotransmitters, and reduced cerebral atrophy (Alfini et 
al., 2019; Cotman et al., 2007; Erickson et al., 2011; Hamilton et al., 2015).  
2.4.2 Strengths and limitations  
 
The review followed a pre-specified protocol using appropriate methods to identify, examine and 
synthesise relevant evidence. A rigorous search for published and unpublished trials, involving several 
electronic databases and scanning of bibliographies, yielded six exercise trials (Baker et al., 2010a; 
Callisaya et al., 2017; Espeland et al., 2017b; Kour et al., 2015; Pisabarro et al., 2018; Yanagawa et al., 
2017), two cognitive trials (Paulo & Yassuda, 2012; Whitelock et al., 2018), and one dual-task trial 
(Shellington et al., 2018). A strength of the review is that it is the first to provide a meta-analysis 
synthesising the effects of exercise on cognition in T2DM. The review is also the first comprehensive 
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search and evaluation of trials investigating the effect of cognitive and dual-task training on cognition 
in T2DM. The authors recognise that three exercise trials (Baker et al., 2010a; Espeland et al., 2017b; 
Pisabarro et al., 2018) and two cognitive trials (Paulo & Yassuda, 2012; Whitelock et al., 2018) met the 
pre-specified eligibility criteria but were not included in the meta-analyses. The reason for the exclusion 
of these trials included a lack in common outcome measures and/or the absence of means and SDs or 
group mean differences. In the case of missing data, all authors were contacted and the retrieval of 
additional data beyond the published literature is considered a strength of the review.  
The lack of common outcome measures was identified as a limitation of the current review that 
restricted the number of outcomes included in the meta-analyses of exercise trials and precluded the 
combination of trial findings by meta-analysis in cognitive trials. As addressed in several previous 
reviews in T2DM (Podolski et al., 2017; Zhao et al., 2018, Strachan et al., 1997; Wong et al., 2014), 
there is a need for consensus on cognitive assessments. The use of cognitive tasks that differ in format 
but measure the same cognitive domain makes it difficult to directly compare the results from different 
trials. The authors are aware that there are a range of cognitive measures available for a comprehensive 
assessment of cognition, however, the overwhelming number of neuropsychological tests available 
(varying in format and complexity) and the lack of guidelines for researchers make comparative analysis 
of trials difficult. A further limitation were the inconsistencies in the methods used to report data, which 
precluded the inclusion of trials in the meta-analyses. Baker et al. (2010a) reported data using Cohen’s 
F value whereas Espeland et al. (2017b) reported adjusted data only and so could not be compared with 
trials that reported data as means and SDs or group mean differences (Baker et al., 2010a; Espeland et 
al., 2017b).  
The small sample sizes of included studies in the meta-analyses reduces the precision of findings and 
widened the CIs for the point estimate of effect. This combined with the limited number of trials 
included in the meta-analyses reduces the strength of our conclusions with respect to the effect of 
exercise. In addition, the overall quality of evidence was considered poor. All of the trials included in 
the review were classified as having an overall moderate to high risk of bias, with the exception of one 
(Callisaya et al., 2017). The majority of risk of bias domains were graded as unclear and was primarily 
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a result of poor reporting practice. In addition, the adherence to interventions was also underreported, 
with only four out of the nine trials (Callisaya et al., 2017; Espeland et al., 2017b; Whitelock et al., 
2018; Shellington et al., 2018) included in this review reporting adherence rate. Providing adherence 
data is important in the context of interpreting trial findings, as it can affect the magnitude of treatment 
effect and also provide an indication of the acceptability of an intervention (Zhang et al., 2014b).  
The differences in trial design is also a limiting factor that may have contributed to non-significant 
findings of the current meta-analyses of exercise trials. The intervention length of some trials was short 
(Kour et al., 2015; Yanagawa et al., 2011), and may have lacked the sufficient programme length needed 
to elicit neuropsychological adaptations. A previous meta-analysis (Colcombe & Kramer, 2003) 
evaluated the relationship between exercise and cognition and reported that interventions lasting 6 
months or more are most likely to have a greater effect on cognitive performance compared to shorter 
interventions. In addition, the type of exercise used also differed between exercise trials, with previous 
research indicating that combined aerobic and resistance training may produce greater benefits on 
cognition, fasting blood glucose, insulin sensitivity, and body mass compared to aerobic or resistance 
training alone (Colcombe & Kramer, 2003; Oliveira et al., 2012; Snowling et al., 2006). The age of 
participants was also shown to vary between trials, ranging from young adults (Kour et al., 2015) to 
older adults (Callisaya et al., 2017; Yanagawa et al., 2011). Age is a significant factor that drives 
cognitive decline with task performance shown to be worse in older adults (Murman, 2015). It is 
plausible that the non-significant findings observed in the current study may have been influenced by 
the differences in participant age between trials. Finally, there was also a lack of follow up assessments 
across included trials. To date, limited evidence exists regarding the continued effects on cognition 
following the termination of exercise, cognitive, or dual-task training in T2DM.  
2.4.3 Implications for future research 
 
The precision of study estimates in the meta-analyses were considered low, primarily as a result of the 
small sample size of included trials, causing wider CIs for the point estimate of effect. Only one trial 
(Whitelock et al., 2018) included in the review reported a priori power analysis. When exploring the 
effect of working memory training on measures of cognition, Whitelock et al. conducted a sample size 
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calculation which predicted a sample size of 48 participants in total (24 per group). Future trials should 
aim to conduct and report an appropriate a priori power sample size calculation. Based on a small to 
moderate ES (0.3) (Cohen, 1988), as shown in the present meta-analyses of exercise trials on the Stroop 
task, a sample size of 352 (176 in each group) is suggested to detect between group differences in future 
trials using a power of 0.8 and significance level of 0.05. The duration of exercise trials included in the 
meta-analyses were relatively short, and discrepancies in the modality of exercise used was evident 
between trials. Recommendations for the design of future trials include exploration of intervention 
duration with the incorporation of both aerobic and resistance training performed at a moderate 
intensity. Future researchers should also look to develop a set of core guidelines to help standardise 
cognitive outcomes in diabetes research. The lack of homogeneity across cognitive outcomes identified 
in the current review made it difficult to compare trial findings. Attention should be given to those 
domains that have been shown to be clinically important in a T2DM population e.g. executive function, 
visual and verbal memory, attention, processing speed and motor function (Monette et al., 2014; Palta 
et al., 2014; Pelimanni et al., 2018). Furthermore, a notable problem associated with T2DM is the lack 
of intervention to prevent or slow the progression of cognitive decline, especially in those who present 
premorbid cognitive deficits but do not differ statistically from those without diabetes. It is therefore 
important to identify the cognitive domains and neuropsychological tests that are most sensitive to 
cognitive decline in T2DM, as well as those that are most sensitive to change in response to non-
pharmacological interventions such as exercise and cognitive training. In addition, previous evidence 
has shown that exercise and cognitive training may improve cognition in healthy cohorts through 
several mechanism including an increase in neurotrophins and neurotransmitters, enhanced cerebral 
blood flow, reduced inflammation, and through adaptations to the structure of the brain (Alfini et al., 
2019; Cotman et al., 2007; Erickson et al., 2011; Hamilton et al., 2015; Park et al., 2019; Chapman et 
al., 2015). Future studies would also greatly benefit from elucidating the response of biomarkers and 
neuroimaging correlates of brain health in response to exercise and cognitive training in T2DM. Finally, 
the overall risk of bias of the evidence was considered moderate to high. This may be a result of poor 
reporting practices. Future research should be reported using appropriate reporting guidelines (e.g. 





There is a growing evidence base regarding trials investigating the effect of exercise, cognitive, and 
dual-task interventions on cognition in T2DM. Due to a small number of studies retrieved, a meta-
analysis was limited to exercise trials only. Synthesised data from exercise trials showed small to 
moderate ESs for improving tasks of executive function and memory, which whilst not significant 
warrants further investigation into the practical implications of these findings. Despite no meta-analysis, 
individual cognitive and dual-task trials reported a positive effect of these types of interventions on 
cognition in T2DM. Further exploration into the effects of exercise, cognitive, and dual-task on 
cognition is needed in T2DM to help further clarify their effects in this population. Future trials should 
be developed that include an RCT design that are sufficiently powered to detect small but potentially 














Study 2 - Walking, cognitive, and dual-task interventions in type 2 diabetes 
mellitus: An intervention development study 
3.1. Introduction 
 
With the limited evidence available exploring the effects of exercise, cognitive, and dual-task 
interventions targeting cognition in T2DM (Cooke et al., 2020; Dyer et al., 2019; Zhao et al., 2018) 
there is a need to conduct a preliminary intervention development study. The developmental process is 
an opportunity to challenge critical thinking, validate decisions, and develop the rationale and methods 
which materialise between the conception of an idea prior to the implementation of a feasibility study 
or definitive RCT (Hoddinott, 2015). Conducting intervention development will help to refine the 
proposed intervention(s) by repeatedly modifying their design based on preliminary feasibility and 
acceptability evidence (O’Cathain et al., 2019a).  
A common approach to intervention development involves evaluating each study component using an 
experimental design to help determine the active components of an intervention and to optimise its 
efficiency (O’Cathain et al., 2019a; O’Cathain et al., 2019b). The study components should ideally be 
informed by previous evidence and existing theory (O’Cathain et al., 2019a). Previous meta-analytical 
evidence regarding the moderators of the effectiveness of computerised cognitive training in both 
healthy and cognitively impaired cohorts points towards greater cognitive effects in interventions that 
last <20 hours, with training performed 1-3 times a week, lasting between 31-60 minutes in duration 
(Lampit et al., 2014; Kueider et al., 2012). Similarly, previous evidence from exercise and dual-task 
trials have also shown positive effects on cognition using aerobic exercise (e.g. treadmill walking) 
performed 2-5 times a week, lasting between 30-60 minutes at low to moderate intensity (Cooke et al., 
2020; Thiell et al., 2013; Eggenberger et al., 2015). 
Intervention development is also an opportunity to pilot key study processes such as recruitment 
pathways and eligibility in addition to evaluating key outcomes (Hoddinott, 2015; O’Cathain et al., 
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2019a; O’Cathain et al., 2019b). Refining the study components, processes, and outcomes at this stage 
is imperative as the effectiveness of future interventions depends as much on developing their design 
as their evaluation (Wight et al., 2016), and a poorly designed trial may lead to the implementation of 
an inadequate intervention, wasting public resources through high-cost evaluations (Chalmers et al., 
2014; Wight et al., 2016). The presentation of a set of recommendations summarising the proposed 
study and how it should be delivered should be provided as an indication of the end of the developmental 
phase (Hoddinott, 2015).  
3.1.1 Aim and objectives 
 
The overarching aim of this research is to conduct a series of treadmill walking, cognitive training, and 
dual-task sessions to help identify and inform the development of a suitable intervention for targeting 
cognitive dysfunction in T2DM. This study aimed to meet the following objectives: 
A) Model the process and outcomes to refine the design of a future intervention aiming to improve 
cognition in T2DM 
B) Compare two different cognitive testing platforms and construct a meaningful test battery for 
evaluation in a T2DM population 
C) Evaluate the acceptability of walking, cognitive, and dual-task activities in individuals with 
T2DM. 
D) Design an intervention and provide recommendations for further feasibility testing based on 
previous research and outcomes from this intervention development study. 
3.2 Methods 
 
3.2.1 Study design  
 
This intervention development study used an exploratory research design to pilot treadmill walking, 
cognitive, and dual-task training in individuals with T2DM. The study consisted of a four-week 
programme, see Table 3.1, in which participants were required to complete two treadmill walking 
sessions, two cognitive sessions, two dual-task sessions, and a neuropsychological test battery. 
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3.2.2 Study participants 
 
Upon gaining ethical approval from the School of Psychology Research Ethics Committee, University 
of Lincoln (Appendix F - M), 7 individuals diagnosed with T2DM provided both written and verbal 
consent to take part in this study (Appendix H). Individuals were included in this study if they met the 
following inclusion criteria 1) self-reported T2DM, 2) aged 18 above, and 3) currently work/study or is 
a relative/friend of an individual working or studying at the University of Lincoln. Individuals were 
excluded from this study if they met any the following exclusion criteria 1) diagnosed with T1DM or 
any other significant medical condition/complication including heart disease, cancer and respiratory 
disorders etc. or any significant physical limitation identified using the physical activity readiness-
questionnaire (PAR-Q) form (Appendix J), 2) identified as cognitively impaired using the mini-mental 
state examination (MMSE) (Appendix K)  3) are not aged 18 and above, and 4) do not work/study or 
know anybody who works/studies at the University of Lincoln. 
3.2.3 Recruitment 
 
Participant recruitment took place internally through the University of Lincoln. Recruitment strategies 
included the dissemination of posters and flyers (Appendix I) around the University of Lincoln Brayford 
Pool campus, digital posters advertised on staff and student news feeds, invitation emails sent to staff 
and student emails, contact with the University of Lincoln diabetes support group, and external 
recruitment through word of mouth e.g. friends and family. 
3.2.4 Study protocol 
 
The study protocol consisted of an initial preliminary study visit followed by a four-week programme 
comprising of two treadmill sessions (week 1), two computerised cognitive training sessions (week 2), 
two dual-task training sessions (week 3), and a neuropsychological test battery (week 4). Details of each 
visit are given below in Table 3.1. The frequency (45-60 minutes) and duration (2x/week) of training 
sessions were chosen based on previous studies and reviews in both healthy and T2DM populations 
(Colcombe & Kramer, 2003; Callisaya et al., 2017; Espeland et al 2017; Yanagawa et al., 2011; Baker 
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et al., 2010a; Theill et al., 2013; Eggenberger et al., 2015; Tse et al., 2015; Lampit et al., 2014; Kueider 
et al, 2012), see Table 3.1. 





Verbal and written informed consent 
PAR-Q form  
MMSE 
 
Week 1 - Walking 
 
2 x treadmill walking sessions 
45-60 minutes duration, walking intensity 12-13 RPE 
 
Week 2 - Cognitive 2 x cognitive training sessions  
Session 1 – CANTAB test battery 
Session 2- PEBL test battery 
45-60 minutes duration 
 
Week 3 – Dual-task 2 x dual-task training sessions  
Session 1 - walking and cognitive training using CANTAB battery  
Session 2 - walking and cognitive training using PEBL battery 
45-60 minute duration, walking intensity 12-13 RPE 
 
Week 4 - Evaluation Neuropsychological test battery 45-60 minutes duration 
Evaluation questionnaire 10-15-minute duration 
 
PAR-Q = Physical Activity Readiness Questionnaire, MMSE= Mini-mental state examination, RPE = RPE exertion, 




Preliminary study visit 
 
The purpose of this visit was to obtain informed consent, and for participants to complete pre-study 
screening. This visit was conducted in a psychology laboratory at the University of Lincoln. Upon 
arrival, participants were given the opportunity to have any questions answered before being invited to 
provide both written and verbal informed consent. Participants then completed the PAR-Q form and 
MMSE in order to screen for any medical or cognitive complications that may prevent them from 
participating in the study. If participants answered yes to one question or more on the PAR-Q form, 
then they were required to contact their general practitioner (GP) prior to undertaking physical activity 
as part of this study. If participants scored 23 or below on the MMSE, which was indicative of cognitive 
impairment, they were excluded from participating in the study and were recommended to contact their 
local GP for further information.  
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Treadmill walking (week 1) 
  
Participants completed two treadmill walking sessions in a physiology laboratory at the University of 
Lincoln. Upon arrival, participants were instructed on how to use the treadmill and were familiarised 
with the Rating of Perceived Exertion (RPE) scale, a tool used to measure physical activity intensity 
level (Williams, 2017). It was explained to the participants that the RPE scale is a tool used to reflect 
how intense and strenuous the exercise feels to them, based on their sensations of fatigue, effort, and 
physical stress. The scale ranges from 6 to 20, where 6 equates to “no exertion at all” and 20 equates 
“maximal exertion” (Williams, 2017). Participants were told that the RPE scale would appear in front 
of them at 5-minute intervals during the treadmill walking protocol and were instructed to try to walk 
continuously at a perceived exertion rate of 10-12, which has been shown to correspond to a low 
intensity of exercise (Stamford, 1976). Following a 5-minute warm up, participants then treadmill 
walked for 45 minutes at a perceived exertion rate of 10-12, followed by a 5 minute cool down.  
Cognitive training (week 2) 
 
Participants completed two computerised cognitive training sessions in a psychology laboratory at the 
University of Lincoln. The first training session consisted of a cognitive training battery comprised of 
a series of neuropsychological tests derived from the Cambridge Neuropsychological Test Automated 
Battery (CANTAB), see Table 3.2, and was conducted using a touch screen laptop and press pad. The 
second training session involved a cognitive training battery comprising of a series of 
neuropsychological tests developed by the Psychology Experiment Building Language (PEBL), see 
Table 3.3, and was conducted using a standard laptop. Both the CANTAB and PEBL cognitive batteries 
comprised of six neuropsychological tests which were designed to train the following cognitive 
domains; reaction, processing speed, verbal memory, new learning, executive function, attentional set 
shifting, visuospatial working memory, response inhibition, spatial planning, and working memory. 
Initially, instructions were provided on how to use the study equipment. Participants then completed 
either the CANTAB or PEBL test battery lasting approximately 45-60 minutes in duration. Instructions 
on how to conduct each task was provided at the start of each task, along with an opportunity to ask 
questions before starting the task. Cognitive tasks included in the CANTAB battery were explained to 
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participants using a script provided by Cambridge Cognition whilst on screen instructions were given 
for each task during the PEBL battery.  
Table 3.2 CANTAB cognitive training battery 
Task Duration Domain measured 
 





Reaction time & motor speed 
Verbal recognition memory (VRM) 
 
~ Verbal memory & new learning 
Attention switching task (ATS) 
 
5 minutes Attentional set shifting 
Spatial span (SSP) 
 
~ Visuospatial working memory 
Stop signal task (SST) 
 
20 minutes Response inhibition 
One touch stockings of Cambridge 
(OTS) 
 
~ Spatial planning & working memory  
~ denotes tasks that were not strictly time defined  
 Table 3.3 PEBL cognitive training battery  
Task Duration Domain measured 
 





Reaction time  
Maths processing task (MP) 
 
10 mins Working memory 
Match to sample (MTS) 
 
4 mins Visual memory 
Colour Stroop task (CST) 
 
7 mins  Attentional set shifting 
Digit span (DS) 
 
~ Working memory  
Item order (IO) ~ Visual memory  
 
~ denotes tasks that were not strictly time defined  
Dual-task (week 3) 
 
Participants completed two dual-task sessions in a physiology laboratory at the University of Lincoln. 
Dual-task sessions required participants to treadmill walk whilst simultaneously performing 
computerised cognitive training. In the first dual-task session, each participant treadmill walked whilst 
simultaneously performing the CANTAB test battery previously described in the first session of week 
2. For this session, dual task training was conducted using a specialist touch screen laptop and press 
pad which was strapped securely to the front of a treadmill, see Figure 3.1. In the second dual-task 
session, each participant treadmill walked whilst simultaneously performing the PEBL test battery as 
previously described in the second session of week 2. For this session, dual-task training was conducted 
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using a keyboard that was securely attached to the front of the treadmill and was connected to a 
computer desktop that was displayed on a television monitor placed in front of the treadmill, see Figure 
3.2. Participants were reminded how to use the study equipment and were given time to familiarise 
themselves with the treadmill and cognitive intervention equipment. It was then explained to the 
participants that instructions on how to conduct each task would be provided at the start of each task, 
and they would have an opportunity to ask questions before starting the task. Participants then 
completed a 5-minute warm up at a self-selected intensity and then completed the dual-task training 
lasting approximately 50-60 minutes in duration. This was then followed by a 5-minute cool down at a 
self-selected intensity. 
 
Figure 3.1 Study set up for dual-task training session 1. 
 





Neuropsychological test battery (week 4) 
 
Participants completed a computerised neuropsychological test battery and an evaluation questionnaire. 
Both the test battery and questionnaire were completed on two separate occasions in a psychology 
laboratory, University of Lincoln. T2DM is a risk factor for dementia and Alzheimer’s disease (Biessels 
& Despa, 2018; Koekkoek et al., 2015), therefore, a prodromal Alzheimer’s/MCI test battery pre-
specified by CANTAB was chosen, see Table 3.4. This test battery comprised of six neuropsychological 
tests and was completed using a touch screen laptop and touch pad. Upon arrival, a brief outline of the 
session was given along with an opportunity to have any questions answered. Following this, it was 
then explained to the participant that instructions on how to conduct each task would be provided at the 
start of each task, and that they would have an opportunity to ask questions before starting the task. 
Participants then completed the test battery lasting approximately 45-60 minutes in duration. The final 
visit of the study involved participants completing an evaluation questionnaire that was designed to 
assess the participant’s acceptability of all elements of the programme including time, duration, 
modality, intensity, delivery, and study location. The questionnaire took approximately 10 minutes to 
complete.  
 
 Table 3.4. Tasks included in the neuropsychological test battery 
Task Duration Domain measured 
 




Reaction time & motor response 
 
Paired associated learning (PAL) 
 
~ Visual memory & new learning 
Spatial working memory (SWM) 
 
~ Visuospatial working memory 
 
Pattern recognition memory (PRM) 
 
4 minutes Visual pattern recognition memory 
Delayed match to sample (DMS) 
 
7 minutes Visual matching ability 
Rapid visual information processing 
(RVP) 
 
7 minutes Sustained attention 














Cognitive status was screened using the MMSE (Folstein et al., 1975). The MMSE is a screening tool 
used by clinicians/researchers to help screen for cognitive impairment and monitor the progression of 
cognitive decline. It consists of a series of questions and tasks, each of which scores points if answered 
correctly (Folstein et al., 1975). The MMSE tests a number of different mental abilities, including an 
individual’s memory, attention and language (Folstein et al., 1975). An individual can score between 0 
and 30 with the cut off score for MCI being <23.  
Recruitment rate and method 
 
The number of individuals who expressed initial interest in the study and by which recruitment pathway 
(e.g. poster, advertisement email, word of mouth etc.), the number of individuals who enrolled onto the 
study, and reasons why individuals did not enrol onto the study were recorded.  
Uptake, adherence, and maintenance 
 
The number of individuals who attended the first session compared to the number of individuals invited, 
as well as the number of cognitive training sessions completed. 
Questionnaire feedback 
 
Acceptability of the study was measured using an evaluation questionnaire (Appendix L). The 
questionnaire consisted of 24 likert scales that evaluated each of the study components (e.g. walking, 
cognitive, dual-task sessions, study location, study investigators) specifically focusing on the 
participant’s experience of the frequency, duration, intensity, modality, and delivery of each 
component. In addition, a comment box was provided as part of the questionnaire in which participants 





Cognitive data was collected using three different cognitive batteries as previously described (section 
3.2.4). The CANTAB and PEBL training batteries were performed during both normal and dual-task 
conditions. The neuropsychological test battery was performed during normal conditions only.  
3.2.6 Statistical analysis 
 
All statistical analyses were performed using SPSS (IBM SPSS statistics for Windows, version 22.0, 
Armonk, New York, USA). Due to the small sample size, the median score for each individual cognitive 
task is presented along with the overall median score during cognitive and dual-task training. Between 
subject differences in task performance during cognitive training and dual-task training in both the 
CANTAB and PEBL battery were assessed using the Wilcoxon signed ranked test. Spearman’s rank 
correlational coefficient was performed to identify associations between demographic variables and 





Seven individuals diagnosed with T2DM (self-reported) provided both written and verbal consent and 
were enrolled onto the study. Participant demographics are described below, see Table 3.5.  
 
Table 3.5 Demographic characteristics of study population 






















174 179 165 147 181 168 173 173 
Weight (kg) 
 
78 111 58 51 92 91 118 91 
BMI 
 
25.8 34.6 21.3 23.6 28.1 32.2 39.4 28.1 
Sex 
 
M F F F M M M - 
MMSE 
 
30 28 29 27 30 30 28 29 






3.3.2 Recruitment rate and method   
 
Thirteen individuals expressed interest in the study. Of those 13 individuals, 6 chose not to enroll, 
equating to a 54% successful recruitment rate. Reasons for individuals not enrolling onto the study 
included; too much of a commitment (n=3), too far to travel to the university (n=2), and expressing an 
interest outside of the recruitment window (n=1). Of the thirteen individuals who expressed interest, 
recruitment pathways included email advertisements (n=6), Flyer/posters (n=4), and word of mouth 
(n=3). 
 
3.3.3 Adherence rate and maintenance 
 
Five out of the seven participants who enrolled on the study achieved a 100% adherence rate, 
completing all 8 sessions of the 4-week programme. The remaining two participants completed 6 out 
of the 8 sessions only, specifically missing the two dual-task sessions. Reasons for this were due to the 
participants experiencing difficulty whilst treadmill walking as well as experiencing physical 
discomfort during exercise.  
 




The majority of participants indicated no issues with completing the treadmill walking protocol. 
Participants found the duration and frequency of treadmill walking to be appropriate and were accepting 
of the modality of exercise and the intensity. Two participants indicated that the exercise protocol was 
too difficult to complete and struggled with the modality and intensity of exercise. 
Quote 1 “Based on my personality type and physical capabilities, I am not naturally drawn to 
physical activity.” 
Computerised cognitive training 
 
Participants indicated no issues in completing the cognitive training elements of the study and found 
the duration and frequency of cognitive training acceptable. Feedback indicated that the cognitive 
training elements were more enjoyable and engaging compared to exercise and dual-task training. 
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Cognitive training was suggested to be more engaging when using the touch screen and press pads as 
part of the CANTAB battery compared to using the keyboard and desktop as part of the PEBL battery. 
Findings also indicated that participants found the CANTAB cognitive tasks more challenging 
compared to the PEBL cognitive tasks.  
Quote 2 “The most enjoyable part was the brain training but overall the whole process was an 
enjoyable experience.” 




Participants indicated that dual-task training was more challenging than treadmill walking or cognitive 
training alone. Two participants could not complete the dual-task protocol due to difficulties exercising 
whilst executing cognitive tasks. The experience varied regarding the use of the touch screen/press pad 
or keyboard and desktop for conducting the cognitive tasks. The majority of participants found the touch 
screen/press pad set up easier to use, and found the keyboard set up as part of the PEBL battery 
challenging. No issues were indicated regarding the frequency, duration, and intensity of the dual-task 
protocol. 
Quote 4 “The dual-task was a little tricky trying to maintain balance/focus whilst performing 
tasks. Different people may respond differently due to their physical/balance capabilities.”  
Quote 5 “Using the keyboard during the second dual-task session was difficult to work with 
and ended up giving me cramps. This ultimately meant that I pressed keys that I did not intend to press.” 
Study design 
 
Participants indicated that they clearly understood the purpose and aims of the study, and that each 
session was explained clearly along with clear instructions on how to use study equipment. Participants 
found the study locations used for conducting each component of the programme to be suitable and had 
no issues regarding travelling to/from and finding the study locations. Two participants raised 
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comments regarding comorbidities that affected their cognitive performance and suggested that this 
should be taken into consideration when developing the eligibility criteria in future trials. 
Quote 6 “I think this is a really interesting concept to understand how physical activity and 
cognitive stimulation could improve cognitive function and potentially rejuvenate brain health.”  
Quote 7 “I have glaucoma and find it difficult to observe all of the screen. Perhaps this is 
something you should consider for participant selection.” 
Quote 8 “Issues I had was the tapping of the keyboard in quick succession caused by ticks as 
a result of the complications associated with my diabetes. This resulted in a series of incorrect 
occurrences.” 
3.3.5 Evaluation of cognitive data 
 
Task performance for each outcome included in the neuropsychological test battery is presented in 
Table 3.6. Large variations in task scores were evident in several tasks including the RTI five choice 
reaction time, SWM total error, SWM between error, DMS correct latency, and RVP total hits. 
Compared to normative data (Abbot et al., 2019; Robbins et al., 1994), participants scored below 
average in several tasks including SWM between errors (Figure 3.3) RTI simple reaction time (Figure 
3.4), and RTI five choice reaction time (Figure 3.5). Correlational analysis revealed significant 
correlations between BMI only and cognitive tasks, see Table 3.8. Significant positive correlations were 
observed between BMI and RTI five choice reaction time and DMS latency indicating that as BMI 
increased, scores in these tasks worsened. A significantly negative correlation was observed between 
BMI and SWM total errors, suggesting that as BMI increases the number of errors made in the task 
reduces. There was no indication of any ceiling effects in any of the tasks. Missing data was evident in 







Table 3.6 Outcomes of the neuropsychological test battery  




















 Five choice reaction time (ms) 291.5 495.5 403 - 369.5 420.5 543 
 
PAL Total errors (adjusted) 6 1 2 14 11 11 13 
 
 Total trials (adjusted) 9 9 10 12 12 13 11 
 
PRM Percent correct (%) 87.5 100 95.83 95.83 83.33 87.5 83.33 
 
 Latency (ms) 2043 1202 1318 2029 1220 1839 2074 
 
SWM Total error  41 10 60 54 40 20 18 
 
Between errors  
 
41 10 58 51 38 20 17 
Strategy 39 20 36 35 37 25 26 
 
DMS Percent correct (all delays) (%) 96.66 100 96.66 80 86.66 86.66 86.66 
 
 Correct latency (all delays) (ms) 2270.0 3349.5 1799.0 2944.5 3089.5 2504.0 4813.5 
 
RVP Total hits 19 26 29 - 20 18 24 
 
 RVP A 0.9192 0.9242 0.9722 - 0.8866 0.8747 0.9054 
 
RTI = reaction time, PAL= paired associate learning, PRM = pattern recognition memory, SWM = spatial working memory, DMS = 
delayed match to sample, RVP = rapid visual perception, ms= milliseconds, P= participant 
 
 
Figure 3.3 Normative data for SWM between errors (Abbot et al., 2019). Above average performance 
is represented by the blue and purple lines; below average performance is represented by the green, 






Figure 3.4 Normative data for RTI simple reaction time (Abbot et al., 2019). Above average 
performance is represented by the blue and purple lines; below average performance is represented by 
green, yellow, and red lines. 
 
 
Figure 3.5 Normative data for RTI five choice reaction time (Abbot et al., 2019). Above average 
performance is represented by the blue and purple lines; below average performance is represented by 
the green, yellow, and red lines. 
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Task performance for each outcome included in the CANTAB training battery during both cognitive 
training and dual-task conditions are presented in Table 3.9. Performance in tasks of reaction time and 
latency were worse during dual-task training including CRT latency and SST correct reaction time on 
go trials. In addition, treadmill walking speed were also shown to worsen under dual-task conditions, 
see Table 3.7. However, the latency until correct score in the OTS task indicated a greater speed of 
processing during dual-task training compared to cognitive training, which was shown to be significant. 
A potential explanation for this observation could be due to a learning effect. Repeating the same task 
within a short period of time, it may be reasonable to expect significant improvements in the time taken 
to complete the task. The SST task appeared most challenging during dual-task training showing worse 
reaction time scores in addition to a worse proportion of successful stops. Task performance in the CRT 
correct response, VRM percent correct and ATS percent correct showed few errors made, whereby little 
variation was shown between participants indicating a ceiling effect. It may be unnecessary to include 
outcomes of certain tasks that show a ceiling effect when developing a training battery for a future trial. 
Task performance for each outcome included in the PEBL training battery during both cognitive and 
dual-task training is presented in Table 3.10. Reaction time was worse in each task during dual-task 
training, with significant differences observed in SRT, MTS, IO, and MP trial 2. It is important to 
consider whether reaction time during dual-task training was affected by the equipment setup. As 
reported in the qualitative feedback (section 3.3.4), the PEBL dual-task setup was difficult to use. Other 
tasks that were shown to be challenging under dual-task conditions included the MP task showing worse 
scores in both the reaction time and number of correct responses.  Few errors were made in the CST, 
MTS and IO task, with little variation observed between participants pointing towards a ceiling effect. 
Missing data was evident for two participants in both the CANTAB and PEBL batteries and was a result 







Table 3.7. Treadmill walking speed during walking and dual-task sessions 




















































































Table 3.8 Correlations between age, BMI and cognitive outcomes included in the neuropsychological test battery conducted in week 4. 
 Age BMI Simple 
RT 




















































- - .657 .829* .054 .018 -0.330 .071 -.964** -.607 0.75 .821* -.086 -.371 
Simple RT 
 
- - - .208 .148 .036 .381 .787 .266 .266 .092 .266 .468 0.72 
Five choice RT 
 
- - - - .700 .784 .912 .872 .072 .042 .862 .111 .544 .957 
PAL total correct 
 
- - - - - .688 -.500 .613 .126 .072 -.963* .288 -.493 -.754 
PAL total trials 
 
- - - - - - -.402 .073 .073 -.145 -.829* .055 -.464 -.812* 
PRM total correct 
 
- - - - - - - -.459 .128 -.385 .442 -.257 .441 .677 
PRM latency 
 
- - - - - - - -  .143 .250 -.430 .000 -.371 -.257 
SWM total errors 
 
- - - - - - - - - .679 -.255 -.786* .029 .257 
SWM strategy 
 
- - - - - - - -  - - -.075 -.500 -.200 .029 
DMS total correct 
 
- - - - - - - - - - - -.168 .525 .833* 
DMS latency 
 
- - - - - - - -  - - - - 0.29 -.314 
RVP total hits 
 
- - - - - - - -  - - - - - .829* 
RVP A 
 
- - - - - - - -  - - - - - - 
 






Table 3.9 Task performance during cognitive and dual-task training using CANTAB training battery 
OUTCOME MEASURE 
P01 P02 P03 P04 P05 P06* P07* Median P value 









































 Correct response (ms) 
 
100 99 100 98 100 100 99 99 100 100 99 - 100 - 100 99 0.18 
VRM Free recall total correct 
 
8 11 10 10 10 10 8 9 11 10 8 - 8 - 10 10 0.41 
 Free recall total novel 
 
2 0 0 0 0 0 0 1 2 0 0 - 1 - 0 0 0.27 
 Recognition - total correct 
 
24 24 24 24 24 24 23 24 24 24 24 - 23 - 24 24 0.31 




0 0 0 0 0 0 0 0 - 1 - 0 0 1.00 
ATS Percent correct (%) 
 
94.375 96.25 99.375 97.5 93.125 98.125 98.75 98.7
5 
98.75 99.375 97.5 - 98.125 - 98.75 98.12 0.35 
 Switch cost 
 
288.5 192 185.5 146 263.5 98.5 324.5 207 117 222.5 191.5 - 331.5 - 263.5 192 0.25 
 Congruency cost 
 
25 38 81 33.5 152.5 109 22 88 108 94.5 130.5 - 121.5 - 81 88 0.68 
SSP Span length  
 
6 8 8 8 5 6 7 6 6 6 5 - 5 - 6 6 0.14 
 Total errors 
 




- 6 - 15 19 0.41 
SST  Successful stops  
 
0.625 0.675 0.8 0.6 0.775 0.775 0.525 0.62
5 
0.675 0.6 0.575 - 0.65 - 0.67 0.62 0.71 
 Correct RT on GO trials 
 
763.5 843 1028 867 1001.5 882 798 933.
5 
776 819.5 836.5  749.5  798 867 0.89 
OTS Problems solved 1st choice 
 
21 20 22 19 10 19 18 14 18 22 17 - 21 - 18 19 0.78 
 Latency until correct (ms) 
 
10512 8054.5 7721.5 7105 16710 10260.5 11048.5 6746 13444 6196 14130 - 17160.5 - 11048.5 7105 0.04 
 
CRT= controlled reaction time, VRM= verbal recognition memory, AST= attention switching task, SSP= spatial span, SST= stop signal task, OTS= one touch stockings of Cambridge, CT= 





Table 3.10 Task performance during cognitive and dual-task training using PEBL training battery. 
OUTCOME MEASURE 
P01  P02  P03  P04  P05  P06*  P07*  Median P value 








































CST Correct response  163 151 124 153 146 130 159 149 156 146 156 - 155 - 156 138 0.49 
 
 Reaction time (ms) 823.5 840 1038 1021.5 1045.5 1238.5 1047 1087.5 971.5 1148 1068.5 - 843 - 1045 1087 0.22 
 
MP Correct response trial 1  113 86 94 94 93 84 89 81 106 93 87 - 90 - 93 86 0.71 
 
 Correct response trial 2  67 64 57 61 62 55 62 56 50 68 42 - 64 - 62 61 0.89 
 
 Correct response trial 3 48 48 33 38 50 39 42 49 35 50 30 - 50 - 42 48 0.46 
 
 Reaction time trial 1 
(ms) 
727 1066 974.5 911 963 1033.5 984 1002 742 844.5 994 - 1072 - 963 1002 0.13 
 
 Reaction time trial 2 
(ms) 
1525 1606 1637.5 1705 1601.5 1769 1764 1912 1563 1634 1997 - 1731 - 1601 1705 0.04 
 
 Reaction time trial 3 
(ms) 
2102 2187 2887 2836 2250.5 2504 2506.5 2903 2381 2509 2555 - 2644 - 2381 2509 0.08 
 
MTS Correct response  28 30 30 29 25 28 28 27 24 26 24 - 26 - 28 28 0.22 
 
 Reaction time (ms) 1603.5 1877.5 1120.5 2135.5 1287 1865 1286 1463 1730 2283 1241.5 - 1653 - 1287 1887 0.04 
 
IO Correct response  29 34 34 31 30 30 28 30 28 35 28 - 33 - 29 31 0.27 
 
 Reaction time (ms) 1865.5 2072.5 2241 2897,5 1180 1782 1740.5 1953.5 2097.5 2182.5 1355 - 1467.5 - 1865.5 2072.5 0.04 
 
DS Span length  7 8 7 7 9 7 10 8 10 10 7 - 8 - 9 8 0.27 
 
 
SRT= simple reaction time, CST= colour Stroop task, MP= maths processing, MTS= match to sample, IO= item order, DS= digit span, CT= cognitive training. DT= dual-task, ms= milliseconds, P= 
participant, *not included in statistical analysis
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3.4 Discussion  
 
The overarching aim of this intervention development study was to pilot exercise, cognitive, and dual-
task training in addition to the key study processes and outcomes to help identify and inform the 
development of an intervention for targeting cognitive dysfunction in T2DM. The findings revealed 
that cognitive training was performed competently whilst exercise training was found to be challenging 
by several participants, consequently leading to their exclusion from dual-task training. Evaluative 
feedback suggested that cognitive training was the most enjoyable and preferred type of intervention 
whilst difficulty in conducting exercise and dual-task training were expressed. The previous systematic 
review (Cooke et al., 2020, chapter 2) confirmed that there is very limited research in relation to the 
effects of cognitive training in this population, and the findings from the current pilot study showed 
potentially greater adherence and acceptability associated with cognitive training. As there is already 
more established evidence in relation to exercise (Cooke et al., 2020), in addition to the concerns for 
adherence to exercise interventions as shown in the present study, it would be prudent to establish 
further evidence for cognitive training in T2DM at this point. Once optimum exercise and cognitive 
interventions have been defined, future research should then explore the potential additive effects of 
dual-task interventions in this population. The use of both CANTAB and PEBL cognitive platforms 
was shown to be practical in measuring and training key cognitive domains in T2DM. Worse 
performance was shown using the PEBL battery especially during dual-task training and evaluative 
feedback pointed towards the use of CANTAB as an easier and more engaging platform. The 
recruitment and eligibility data suggest that a greater number of recruitment pathways should be 
considered in future trials along with incorporating a more restrictive eligibility criteria to better reflect 
the study population. The findings presented in this study will be used to inform recommendations for 
the development of a cognitive training study for feasibility and acceptability testing.  
3.4.1 Piloting study processes 
 
Recruitment of participants resulted in a total of 13 individuals expressing interest in the current study, 
of which 7 individuals (54%) provided informed consent. Additional recruitment pathways will need to 
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be explored to attain a larger sample size for future research. Bracken et al. (2019) evaluated the cost 
and efficacy of strategies used to recruit males into a large T2DM prevention trial. Of the 1007 
individuals enrolled, the most effective recruitment pathways included radio advertisement (42%), 
television news coverage (20%), and mass mail-outs (17%) (Bracken et al., 2019). Miller et al. (2016) 
evaluated strategies used for recruiting older adults with T2DM into a community-based exercise and 
nutritional trial. Of the 198 individuals enrolled, the most successful recruitment approaches included 
mass mail-out (39%), state (27%) and local (14%) print media (Miller et al., 2016). Similarly, Johnson 
et al., (2015) reported that a targeted mail out approach yielded a greater number of potential 
participants compared to more conventional recruitment strategies including posters/flyers and clinician 
referrals when recruiting individuals with T2DM into a physical activity RCT (Johnson et al., 2015). 
Future trials should consider employing further recruitment pathways based around more targeted 
strategies such as targeted mass mail outs, newspaper and media prints, and radio advertisement.  
 The cognitive training components were performed successfully, whilst difficulties were experienced 
during the exercise and dual-task training. Two participants struggled with treadmill walking expressing 
discomfort and consequently did not participate in dual-task training. Poor adherence to exercise and 
physical activity interventions have previously been highlighted in T2DM cohorts (Cooke et al., 2020). 
For example, Espeland et al. (2017b) investigated the effect of a 24-month physical activity intervention 
on cognition in T2DM and reported that the average attendance of participants in the physical activity 
group was 67% (Espeland et al., 2017b). Likewise, Shellington et al. (2018) examined the effect of a 
24 week square stepping intervention on cognition in T2DM and reported that only 4 of the 12 
participants attended more than 50% of training sessions (average attendance 70.2%), whilst the 
remaining 8 participants attended less than 40% of training sessions (Shellington et al., 2018). Previous 
studies have described several barriers that may affect the participation in physical activity and exercise 
in T2DM (Thomas et al., 2004; Egan et al., 2013; Advika et al., 2017; Alzahrani et al., 2019; Pati et al., 
2019), in which physical restrictions and discomfort are identified as a common barrier (Thomas et al., 
2004; Egan et al., 2013; Advika et al., 2017). Participant preference for cognitive training was further 
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evidenced through the evaluative feedback in which participants indicated that they found cognitive 
training more enjoyable and engaging compared to exercise training. This is important because for an 
intervention to be successful it needs to be effective, but equally engaging and enjoyable to promote the 
adherence of participants (Lewis et al., 2016; Jekauc et al., 2015; Dishman et al., 2005).     
3.4.2 Evaluation of cognitive data  
 
The neuropsychological test battery was completed successfully and provided a comprehensive 
evaluation of cognitive performance. There was a large variation in task performance with no evidence 
of a ceiling effect in any of the tasks. The majority of participants performed well and scored within the 
expected range for their age group (Abbot et al., 2019; De luca et al., 2003; Robbins et al., 1994). Below 
average task performance was observed in two participants in tasks of pattern recognition memory and 
in four participants in tasks of reaction time and working memory which may reflect the subtle deficits 
associated with T2DM often seen prior to the onset of cognitive impairment (Biessels & Despa, 2018; 
Koekkoek et al., 2015). Correlational analysis identified significant positive correlations between BMI 
and tasks of reaction time and delayed memory suggesting that as BMI increased, performance in these 
tasks worsened. Significant negative correlations were also observed between BMI and errors made in 
a working memory task suggesting that as BMI increases the number of errors made in this task reduces. 
This finding emphasises the importance for future trials to adjust for key demographic covariates that 
have been shown to influence cognitive performance including age, BMI, glycaemic control, illness 
duration (Alosco & Gunstad, 2014; Roberts et al., 2008).  
The use of both CANTAB and PEBL cognitive platforms was shown to be suitable in measuring and 
training cognition in this population. Task performance was generally worse during dual-task training 
compared to normal cognitive training conditions when using both CANTAB and PEBL cognitive 
platforms, in which a reduction in treadmill walking speed was also observed, see table 7. It is evident 
that dual task training does not produce the same physical effects as treadmill walking alone, in which 
performance on cognitive tasks may also be compromised. It is widely acknowledged that performing 
concurrent tasks incurs a cognitive cost (Kemper et al., 2003; Broeker et al., 2018; Wechsler et al., 
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2018; Zentgraf et al., 2019) in which a reduced walking speed during dual-task training has been 
suggested to indicate a diversion in attention during more intricate tasks to help improve cognitive 
performance (Patel et al., 2013). However, it is important to note that previous studies do show a 
combined additive effect of dual-task training on cognitive outcomes as opposed to exercise or cognitive 
training alone (Theill et al., 2013; Eggenberger et al., 2015; Yokoyama et al., 2015). Poorer task 
performance was particularly evident in domains identified as vulnerable to cognitive decline in T2DM 
(Monnette et al., 2014; Pelimanni et al. 2014; Palta et al., 2014), including reaction time and speed of 
processing. These deficits were observed to be greater when using the PEBL training battery, suggesting 
that the PEBL cognitive platform may not be suitable for cognitive testing in this population. However, 
it is also possible that performance using the PEBL battery was influenced by the differences in study 
equipment. Findings from evaluative feedback data suggests that participants found the press pad and 
touch screen as part of CANTAB easier to use, whilst the standard keyboard as part of the PEBL set up 
during dual-task training was reported difficult to use. The variation of responses in certain tasks in 
both the CANTAB and PEBL platform were small, and the scores were high, pointing to a potential 
ceiling effect. Previous evidence suggests that ceiling effects may lead to greater bias and uncertainty 
of findings and parameter estimations (Simkovic and Trauble, 2019; Wang et al., 2009). It is therefore 
recommended that those tasks that show a ceiling effect are removed when refining a suitable test 
battery for feasibility testing. The advantage of using CANTAB is that each task offers several different 
outcome variables. This provides the researcher with other viable measures to use without needing to 
change the task and potentially the domain measured. This is important in the context of designing a 
training battery so that there is an overlap in the cognitive domains rather than an overlap in cognitive 
tasks.   
3.4.3 Evaluative feedback of study components 
 
Evaluative feedback showed that the study processes were well received and that participants found the 
concept of exercise, cognitive, and dual-task training for targeting cognition informative. The duration 
and frequency of training was shown to be acceptable in our study cohort. Our findings suggest that 
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cognitive training was the preferred type of training with participants suggesting it was more appealing 
and enjoyable as opposed to exercise or dual task training. This finding is important in the context of 
previous evidence that points towards enjoyment as an important factor which may influence 
intervention adherence (Dishman et al., 2005; Huberty et al., 2008; Jekauc, 2015). The two participants 
that chose not to participate in the dual-task training stated that they found treadmill walking difficult 
and that they were not naturally drawn to physical activity. Issues were also evident in those who took 
part in the dual-task training, with one participant stating that they found it difficult to maintain balance 
whilst performing cognitive tasks. It is widely documented that balance and gait are impaired to a 
greater extent in individuals with T2DM compared to those without diabetes (Petrofsky et al., 2006; 
Lee & Park, 2014; Mustapa et al., 2016). This may be a potentially important factor to consider with 
respect to dual-task training in T2DM. It may be that it was the modality of exercise (treadmill walking) 
incorporated in the dual-task training that was too difficult in the current study suggesting that other 
modalities should be explored in future trials. Previous work in this area demonstrates beneficial effects 
of dual-task training that use a variety of different exercise modalities, some of which  may be more 
acceptable than treadmill walking for participants with T2DM e.g. resistance training, flexibility 
training and stepping exercises (Norouzi et al., 2019; Yokoyama et al., 2015; Morita et al., 2018; 
Shellington et al., 2018). The current study was also useful in identifying potential eligibility issues 
needing to be addressed prior to further testing. For example, several participants expressed difficulty 
when performing cognitive tasks due to complications associated with their diabetes (e.g. glaucoma and 
neuropathy). Researchers should consider the impact of T2DM complications along with other factors 
including psychiatric and neurological disorders, hearing impairments, changes in medication, and 
substance abuse (Whitelock et al., 2018; Bahar-fuchs et al., 2020) on cognitive performance when 
developing the eligibility criteria for a future trial.  
3.4.4 Evidence-based recommendations for a future intervention 
 
A detailed summary of the proposed recommendations for the development of a cognitive training 
intervention are presented in Table 3.11. Our findings from the previous systematic review and current 
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intervention development study point towards a cognitive training intervention that employs a 
multidomain approach consisting of between 12-16 hours of cognitive training with sessions performed 
twice a week lasting between 30-60 minutes in duration. This should include face to face supervised 
training conducted either in the home or university setting with participants being recruited from several 
exploratory pathways. A more restrictive eligibility criteria should be used to better manage the 
participant’s expectations and to avoid potential poor adherence or drop out. Cognitive assessment and 
training should be conducted using an engaging and valid cognitive platform e.g. CANTAB, in which 
a cognitive training group should be compared to a passive control group.  
 
Table 3.11 Summary of recommendations for the development of a cognitive training intervention. 
 
Intervention Component Recommendations 
Type - Cognitive training intervention 
 
Dose - <20 hours – recommended dose of training 12-16 hours  
 
Frequency - 1-3x/week – ideally aim for 2x/week 
 
Duration - 45-60 minutes 
 
Delivery - Supervised face-to-face 
 
Setting - University/ home visits (depending on the participant’s choice)  
 
Participants  - T2DM – HbA1c/glucose testing should be included in future trials to help better describe the 
study population.  
 
Comparison - T2DM passive control group 
 
Cognitive platform - CANTAB 
 
Outcomes - A multidomain approach should be used that targets key domains which are vulnerable to 
cognitive decline in T2DM e.g. reaction time, verbal recognition memory, visual memory, 
new learning, visuospatial working memory, pattern recognition memory, delayed memory, 
sustained attention.  
 
- Data should be adjusted for key demographic covariates including age, BMI, cognitive 
impairment, diabetes duration etc 
 
Recruitment - Explore more innovative primary recruitment pathways e.g. targeted mail outs, radio 
advertisements, media print outs etc. that are supplemented by secondary pathways e.g. 
poster/flyers, diabetes support groups, social media, student/staff university emails, word of 
mouth etc.  
 
Eligibility - A more restrictive and defined eligibility criteria should be developed based on previous 
cognitive research in T2DM e.g. the exclusion of participants with significant visual, auditory 
or neurological complications that may affect computerised cognitive performance.  
 





 Evidence gathered as part of this intervention development study points towards the implementation 
of a cognitive training study for feasibility testing. Whilst exercise and dual-task training remain as 
potential avenues for future research to explore, the greater adherence and satisfaction associated with 
cognitive training in the current study suggests that further pilot work would be needed before 
evaluating these types of interventions in T2DM. A greater number of recruitment pathways will need 
to be explored that include a more targeted approach to ensure an adequate sample size is recruited. 
Whilst the eligibility criteria for the current study was relatively broad, our findings suggest that a more 
restrictive criteria will be needed in future work to better reflect the sample population. The CANTAB 
cognitive platform was identified as an easier to use and more appropriate platform for evaluating and 
training cognition in T2DM compared to the PEBL. Based upon the evidence presented in both the 
previous review and current intervention development study, a set of recommendations for the 















Study 3 - Feasibility of a cognitive training intervention on cognition and serum 
levels of brain-derived neurotrophic factor in type 2 diabetes mellitus 
4.1 Introduction 
 
There are few trials investigating the effects of cognitive training on cognition in T2DM (Cooke et al., 
2020). Prior to the implementation of a large-scale evaluation, a feasibility trial is required to explore 
all elements of a planned intervention to determine whether a comprehensive evaluation is justified 
(Bowen et al., 2009). Conducting a feasibility study will allow the evaluation of the appropriateness of 
an intervention and assess whether the concepts and findings can be modified to be relevant and 
sustainable for further testing (Bowen et al., 2009). The conceptual framework for designing pilot and 
feasibility studies, proposed by Eldridge et al. (2016) (chapter1), suggests that feasibility exists as an 
overarching concept within which several distinct types of feasibility studies exist. A randomised pilot 
study is one of the proposed feasibility studies and involves conducting the main intervention, either in 
its entirety or parts of, but on a smaller scale, and includes the randomisation of participants (Eldridge 
et al., 2016). This type of feasibility study largely reflects the design of a future large-scale trial, but if 
needs be, may seek and employ alternative strategies to address any outstanding uncertainty (Eldridge 
et al., 2016).    
The intervention development study (chapter 3) provides evidence-based recommendations for the 
development of a cognitive training study for feasibility testing. These include using a multidomain 
approach to assess cognition, incorporating an overall training dose of between 12-16 hours, with 
sessions performed 1-3 times a week, lasting between 31-60 minutes in duration (Lampit et al., 2014; 
Kueider et al., 2012). It is recommended that a progression criteria are used and reported clearly in 
feasibility trials to help researchers decide whether to proceed or not with a large-scale evaluation 
(Avery et al., 2017; Hallingberg et al., 2018; Mbuagbaw et al., 2019). To date, the reporting of a 
progression criteria to assess the transition from feasibility testing to large scale evaluation is 
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uncommon, making it difficult for researchers to make informed decisions with regards to main trials 
post feasibility testing (Avery et al., 2017; Hillingberg et al., 2018; Mbuagbaw et al., 2019). A traffic 
light system using green (go), amber (amend), and red (stop) is recommended as opposed to a simple 
stop/go approach (Avery et al., 2017). Providing thresholds enables the researcher to identify where 
problems need to be remediated, making a definitive RCT evaluation viable (Young et al., 2019). 
Existing guidance regarding the key components of RCT progression criteria have broadly been defined 
and should ideally include trial recruitment, participant adherence and retention, outcome data, and 
randomisation (Avery et al., 2017; Shanyinde et al., 2011). 
There is also limited evidence with respect to the mechanisms underlying the effect of cognitive training 
in T2DM. Several mechanisms have previously been proposed that potentially underpin cognitive 
training improvements in healthy cohorts including enhanced cerebral blood flow (Chapman et al., 
2015; Chapman et al., 2017, Mozolic et al., 2010), greater functional connectivity and organisation of 
functional connections in the brain (Chapman et al., 2015; Lin et al., 2014; Ten Brinke et al., 2017; 
Deng et al., 2019), and enhanced structural integrity of the brain (Chapman et al., 2015). The enhanced 
availability of the neurotrophin BDNF is identified as one of the more prominent mechanisms 
associated with cognitive training (Arazi et al., 2019; Rahe et al., 2015; Damirchi et al., 2018). BDNF 
is known to play an important role in facilitating synaptic plasticity and regulating memory and new 
learning (Lu et al., 2014, Cunha et al., 2010, Leal et al., 2017) and the enhanced availability of this 
neurotrophin through cognitive training has previously been suggested to positively influence cognitive 
abilities in healthy cohorts and diseased populations (Kim et al., 2018; Arazi et al., 2019; Angelucci et 
al., 2015; Pressler et al., 2015; Ledreux et al., 2019; Damirchi et al., 2018). Whether or not BDNF acts 
as an intrinsic mechanism that drives cognitive improvement mediated through cognitive training in 





4.1.1 Aim and Objectives 
 
The aim of the quantitative element of this study was to determine the feasibility of a cognitive training 
study in individuals with T2DM. This study aimed to meet the following objectives: 
A) To investigate the feasibility of a cognitive training study in individuals with T2DM. 
B) To investigate the effect of a cognitive training study on cognition in individuals with 
T2DM.  
C) To investigate the effect of a cognitive training study on BDNF in individuals with T2DM.  
4.2 Methods 
 
4.2.1 Study design 
 
A randomised pilot study design (Aldridge et al., 2016) was used to investigate the feasibility of a 
cognitive training intervention on cognition and serum levels of BDNF in individuals with T2DM.  
Participants diagnosed with T2DM were randomised to either a computerised cognitive training group 
or a usual care control group. Participants were randomised using computer-generated random numbers 
in which the sequence allocation was concealed from the principal investigator by an independent 
researcher. Participant recruitment ran from August 2018 – July 2019 with data collection running from 
August 2018 and ending in August 2019. All baseline and post-intervention assessments were 
conducted at the University of Lincoln. Cognitive training sessions were conducted either at the 
University of Lincoln or in the participant’s own home. Ethical approval was granted by the Health 
Research Authority (Integrated research application system (IRAS) no.227672) (Appendix N – S) and 
by the School of Psychology Research Ethics Committee, University of Lincoln. (PSY1718435). 
Written and informed consent were obtained from all participants before taking part in this study. This 
study was conducted in accordance with the CONSORT 2010 extension to randomised pilot and 




4.2.2 Study population  
 
Individuals were recruited to participate in this study if they met the following inclusion criteria 1) 
diagnosed with T2DM diabetes (identified through GP registers or self-declared), 2) male or female 
aged 45+, and 3) willing to take part in a 6 week structured cognitive training programme including 
cognitive testing. Individuals were excluded from participating in this project if they met the following 
exclusion criteria 1) diagnosed with pre-diabetes or T1DM, 2) below the age of 45 years, 3)  identified 
as cognitively impaired as indicated using the MMSE, 4) in need of any support for  specific literacy or 
communication skills, 5) have any co-morbidities that may affect computer use e.g. peripheral 
neuropathy or glaucoma, 6) recently (within the last 6 months) changed diabetes treatment e.g. new 
medication, medication to insulin, or the type of insulin treatment, 7) had recently undertaken (within 
the last 3 months) a structured cognitive or physical training regime, and  8) did not speak English.  
4.2.3 Recruitment   
 
The primary recruitment pathway involved posting study information packs containing details of the 
study in stamped envelopes to local GP practices. Each GP practice screened their database whereby 
the researcher packed and posted the information packs to patients who met the study eligibility criteria. 
Potential participants registered their interest either by returning an expression of interest form 
(Appendix R) or by directly contacting the principal investigator. Secondary recruitment methods 
included the dissemination of posters and flyers (Appendix Q) in local GP practices, community centres, 
community boards, diabetic clinics, and at the University of Lincoln, Brayford Pool campus. 
Advertisement emails were sent to both staff and student mailing lists at the University of Lincoln along 
with poster invitations advertised on the staff and student news feeds. Invitation emails containing study 










An enrolment visit was conducted either at the University of Lincoln or the participant’s own home to 
determine study eligibility and obtain informed consent (Appendix P). Initially, individuals provided 
written and verbal informed consent agreeing to take part in the study. Participants were then screened 
against the study eligibility criteria, including screening for any cognitive impairments using the MMSE 
(a score of ≥23 was required for inclusion in the study).  
Baseline visit 
 
All participants visited the Department of Psychology, University of Lincoln to complete the baseline 
assessment. Initially, height and weight were measured using a standiometer and weighing scales (Seca, 
UK), respectively. Participants were then seated in a reclining chair and prepared for venous blood 
extraction. A 6ml venous blood sample was extracted for the purpose of measuring serum levels of 
BDNF using a vacutainer blood collection system (VACUETTE®, Griener Bio One, Austria). Venous 
blood samples were extracted and left to stand for one hour at room temperature before being placed in 
in a 4°C storage fridge and left to stand for a further one hour. Samples were then spun at 2000g for 10 
minutes at 4°C to separate serum and whole blood components. Serum supernatant was extracted and 
then transferred into microcentrifuge tubes and spun at 16,000g for 5 minutes at 4°C to pellet cells and 
debris. Serum supernatant was then removed, transferred into labelled microcentrifuge tubes, and 
immediately placed into a -80°C freezer for later analysis. Serum samples were assayed for BDNF at a 
later date using an enzyme-linked immunosorbent (ELISA) kit (RayBiotech, Georgia, USA). See 
Appendix U and V for human tissue research procedure and phlebotomy training certificate. 
Participants remained seated and were prepared for capillary blood extraction performed for the purpose 
of measuring HbA1c (Appendix U). The participant’s non-dominant arm was straightened in a rested 
position and angled towards the ground to aid blood flow. The index finger was then pierced using an 
automated lancet and blood was then drawn into a capillary tube incorporated as part of a HemoCue 
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HbA1c test cartridge (HemoCue, Ängelholm, Sweden). Capillary blood samples were analysed 
instantly for HbA1c measurement using a HemoCue 501 HbA1c analyser (HemoCue, Ängelholm, 
Sweden). Daily and monthly checks of the analyser function were performed in accordance with the 
manufacturer’s guidelines.  
Participants then completed a computerised cognitive test battery. For the purpose of cognitive testing, 
all participants were asked to refrain from consuming caffeine on the day of testing, and from 
consuming alcohol on both the day of testing and the previous evening. The test battery comprised of a 
selection of neuropsychological tests derived from CANTAB (Cambridge cognition Ltd, Cambridge, 
United Kingdom). The following tests were administered 1) RTI, 2) PAL, 3) SWM, 4) PRM, 5) DMS, 
and 6) RVP. These tests were chosen as they measured performance in cognitive domains that are 
sensitive to cognitive decline in a T2DM population (Palta et al., 2014; Pelimanni et al., 2018; Monette 
et al., 2014; Wong et al., 2014). The test battery was conducted using a specialist touchscreen laptop 
and press pad. The test battery took approximately 45-60 minutes to complete and denoted the end of 
the baseline assessment. Post assessment visits were conducted following the 6 week intervention 
period and replicated the same procedure outlined in the baseline visit with the exception of height, 
weight and HbA1c measurements.  
Intervention 
 
Individuals allocated to the intervention group participated in a structured computerised cognitive 
training programme. Participants were required to complete a total of 12 hours of cognitive training 
over a 6-week period, with sessions being performed 2-3 per week. Each session required the participant 
to complete a cognitive training battery comprised of a series of computerised cognitive tasks derived 
from CANTAB (Cambridge Cognition Ltd, Cambridge, United Kingdom). The following tasks were 
administered: 1) CRT, 2) VRM, 3) AST, 4) SSP, 5) SST, and 6) OTS. These tasks were chosen so as 
to provide an overlap in the domain trained, but not an overlap in tests with respect to the test battery 
described in the baseline visit. All cognitive training was conducted using the same specialist touch 
screen laptop and press pad as in the baseline assessment. Each training battery lasted approximately 
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60 minutes in duration. Participants were given a choice to complete the cognitive training sessions 
either at the University of Lincoln or in the participant’s own home. 
Control group 
 
Participants allocated to the usual care control group were asked to attend the baseline and post-
intervention assessments only. Participants were asked to continue their usual daily activities for the 6 
weeks duration between assessments visits. Participants were asked not to engage in any new structured 
exercise or cognitive training regime throughout the duration of the study.  
4.2.5 Demographic outcomes 
 
Demographic measurements including age, gender, BMI, MMSE score, diabetes duration, education 
status, and HbA1c were recorded for the purpose of describing the population.   




Efficacy and time required to co-ordinate recruitment processes, screening/eligibility visits, assessment 
visits and training visits, and any alterations made to the study design were recorded.  
Recruitment  
 
The total number of participants who enrolled onto the study in addition to those who consented to be 
contacted or expressed interest was recorded along with their recruitment pathway through which each 
potential participant was identified. The number of GP practices that consented to recruit potential 
participants was recorded. The total number of registered individuals diagnosed with T2DM at each GP 
practice along with the proportion of those individuals who met the study eligibility criteria and the 





Uptake, adherence, retention 
 
The number of individuals who attended the baseline assessment compared to the number of individuals 
who expressed interest in the study was recorded. The number of sessions attended by each individual 
enrolled onto the study and the number of individuals who dropped out of the study was also recorded. 
Data collection 
 
Outcome data from each participant was collected at predetermined time points as outlined in the study 
procedure. The completeness of outcome data along with the time point in which outcome data was 
collected was recorded.  
Motivation 
 
The motivation of individuals to participate and complete the training sessions was recorded digitally 
at the start of each training session. Motivation was recorded using the visual analogue scales (VAS), a 
set of psychometric scales that measure subjective states. A sliding scale is presented on screen, with 
two ‘extremes’ opposing answers reading at either end, the participant responded to the questions as 
they appeared on the screen by selecting the on-screen slider and moving it to the appropriate position 
on the scale. Scales were graded 0-100 in which a lower score reflected attitudes/moods associated with 
the left extreme of the scale and a higher score reflecting attitudes/moods associated with the right 
extreme of the scale. Participants completed 4 sliding scales including 1) interested or bored, 2) attentive 
or dreamy, 3) energetic or lethargic, and 4) alert or drowsy. 
4.2.7 Cognition 
 
Cognition was measured using the CANTAB neuropsychological test battery (Cambridge Cognition 
Ltd, Cambridge, United Kingdom) as described in the intervention development study (chapter 3). 
Cognition was measured at baseline and post intervention. 
4.2.8 Brain-derived neurotrophic factor 
  
Venous blood samples were extracted from participants for the purpose of measuring serum levels of 
BDNF. Blood samples were extracted at baseline and post intervention. 
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4.2.9 Progression criteria  
 
The feasibility progression criteria is outlined below in Table 4.1. Outcomes were assessed using the 
following criteria: proceed (e.g. where there are no issues of concern that threaten the success of the 
trial), amend/amber (e.g. where there are remediable issues in which modifications may be needed 
before progressing) and stop/red (e.g. when there are intractable issues that cannot be remedied) (Avery 
et al., 2017).  
 
Table 4.1 Progression criteria used to assess the proposed cognitive training intervention 
Feasibility outcome Proceed Amendments Stop 
Study design  No changes or 
recommendations 
 
Minor to major changes or 
recommendations 




 >70 over 11-month 
recruitment period 
 
>35 - <70 over 11-month 
recruitment period 




>4 GP practices 






1-4 GP practices recruited 
and/or delays experienced 
with recruitment through 
GP practices 
0 GP practices 
recruited or major 
delays experienced 
with recruited GP 
practices 
 
Retention rate >80%  50%-80%   <50%  
 
Adherence rate >80%  50%-80%  
 
<50%  
Data Collection All outcome data 
collected in timeframe  
 
>50% of outcome data 
collected in timeframe 
<50 of data collected 
in timeframe 
Motivation <30 on average scored 
on each VAS outcome 
 
>30 - <70 scored on each 
VAS outcome 
>70 scored on each 
VAS outcome 
    
 
4.2.10 Data analysis 
 
All statistical analyses were performed using SPSS (IBM SPSS statistics for Windows, version 22.0, 
Armonk, New York, USA). All outcome variables were assessed for normality using the Sharpiro -
Wilks test. To assess group differences in demographic variables between the two groups an 
independent samples t-test was used for continuous data and a chi squared test used for categorical data. 
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Pearson’s correlational coefficient was performed to identify associations between demographic 
variables, cognitive scores and serum BDNF levels at baseline. All data are reported as mean ± SD and 
an alpha value of 0.05 was set to detect significant differences between the two groups and significant 
correlations between variables. As this was a feasibility study p-values were reported for cognitive 
outcomes and serum levels of BDNF in addition to mean changes with 95% CIs for within group 
changes to provide an indication of the magnitude and direction of effect. 
4.3 Results  
 
4.3.1 Participant characteristics 
 
Seventy-five individuals expressed interest in the current study. Thirty-three were excluded for various 
reasons including: could not be contacted (n=15), declined to participate (n=8), did not meet the 
eligibility criteria (n=5), and lived too far away (n=5). Forty-six individuals enrolled onto the study but 
only 42 were randomised to either the cognitive training group or usual care control group. One 
participant who was allocated to the cognitive training group dropped out and could not be contacted. 
Forty-one participants completed the study and were included in the follow up analysis, see Figure 4.1. 
The demographic characteristics of individuals in the cognitive training group and usual care control 















































Assessed for eligibility (n=46) 
Excluded (n=4) 
• Loss of interest (n=4) 
Analysed (n= 20) 
• Excluded from analysis (n= 0) 
Lost to follow-up (n= 0) 
Discontinued intervention (n= 1 dropped out and 
could not be contacted) 
Allocated to intervention (n= 21) 
• Received allocated intervention (n= 21) 
• Did not receive allocated intervention (n=0) 
Lost to follow-up (n= 0) 
Discontinued intervention (n= 0) 
Allocated to intervention (n= 21) 
• Received allocated intervention (n= 21) 
• Did not receive allocated intervention 
 (n= 0) 
Analysed (n= 21) 









Table 4.2. Demographics of individuals in the cognitive training and control group 
Demographic Total (n=41) Intervention (n=20) Control (n=21) P value 
Age (Years) 
 
66.5 ± 9.8 66.3 ± 8.4 
 














172.0 ± 11.0 173.1 ± 11.8 
 






90.6 ± 20.0 92.7 ± 19.0 
 






30.4 ± 5.3 30.8 ± 5.3 
 






54.0 ± 13.3 52.3 ±12.4 
 






9.2 ± 5.4 8.2 ± 4.7 
 






28.1 ± 1.7 28.0 ± 1.7 28.1 ± 1.8 0.79 
GCSE 
 
n=15 n=8 n=7  
BTEC/HND 
 
n=5 n=2 n=3  
A-Levels 
 
n=4 n=1 n=3 0.77 
Degree 
 
n=10 n=6 n=4  
Postgraduate 
 
n=7 n=4 n=3  
M=male, F=female, cm=centimetre, kg=Kilograms, BMI=body mass index, Hba1c=glycated haemoglobin, 






The coordination of participant recruitment, enrolment visits, and assessment visits were performed 
without any changes to the study protocol. Difficulty was experienced recruiting GP practices in which 
delays due to the recruitment of separate successive practices, recruiting during busy periods e.g. flu 
vaccinations, and recruiting from practices with mixed research experience hindered participant 
recruitment. The inclusion of a participant enrolment visit prior to the baseline assessment was shown 
to be successful in determining eligibility and availability including those who were too busy, lived too 
far away or were unable to participate due to other health reasons. The randomisation of participants to 
either the cognitive training or usual care group was equal (n=21 vs n=21) and the baseline 
characteristics were balanced between the two groups, see Table 4.2. Only one minor change was made 
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to the training visits in that an additional 10-15 minutes was incorporated into the initial two training 
sessions to account for participant orientation of training tasks. 
Offering training visits at both the University of Lincoln and the participant’s own home resulted in an 
equal number of participants choosing both types of visits (Home visits n =10 and university visits n = 
10). Whilst this provided flexibility for participants, it did place a significant burden on the researcher 
as no limit had been established for travel distance which resulted in lengthy data collection trips. 
Venous blood samples could not be obtained from 5 of the 41 participants (Cognitive training group n= 
4 vs. Usual care control n = 1). It is recommended that modifications are made to the study design 
before proceeding with a large-scale evaluation. Alterations should be made specifically to the 
recruitment approach of GP practices, the distance travelled for home training visits, and the duration 
of training visits, see Table 4.3 for proposed modifications.  
Recruitment 
 
A total of n=75 individuals expressed interest in the current study of which n=46 (61%) enrolled onto 
the study over an 11-month period. This resulted in an enrolment rate of approximately 3.8 participants 
per month, see Figure 4.2 below for the breakdown of number of participants enrolled each month over 




Figure 4.2. Number of participants who enrolled over the study recruitment period. 
Primary recruitment through GP mail outs was the most successful recruitment approach generating 
n=25 who enrolled onto the study. Four GP practices were identified in which 3 GP practices agreed to 
assist in study recruitment. A total of n=1376 registered individuals diagnosed with T2DM were 
identified across the 3 GP practices of which n=1037 individuals met the study eligibility criteria. 
Targeted mail outs n=749 were sent from only two GP practices in which n=42 individuals expressed 
interest and n=25 individuals enrolled onto the study, see Figure 4.3 for further details. A recruitment 















































































































Figure 4.3. Flowchart showing the recruitment of participants through GP practices 
Number of GPs approached 
(n=4) 
Number of GPs enrolled onto study 
(n=3) 








Total number of individuals with 
T2DM identified on GP registers 
(n=1376) 
















Number of GPs drop-out 
(n=1) 
Number of individuals who 
expressed interest (n=42) 
Number of individuals enrolled onto 







Secondary recruitment pathways including poster/flyers, diabetes support group, social media 
advertisement, word of mouth, previous research, and radio advertisement generated a combined total 
of n=33 individuals who expressed interest of which n=21 enrolled onto the study. Figure 4.4 shows 
the number of individuals who expressed interest and enrolled through both primary and secondary 
recruitment pathways. Overall, the target recruitment rate for the current study as well as the estimated 
recruitment rate per GP practice per month was not met. Alterations will need to be made involving the 
recruitment of further GP practices as well as identifying more innovative secondary recruitment 
pathways to supplement GP mail outs, see Table 4.3 for proposed modifications.  
Figure 4.4 The number of individuals recorded through each recruitment pathway who expressed 




























































Of the 46 participants who provided written and verbal informed consent, 41 (89%) remained in the 
study at the post intervention follow up (n=20 cognitive group vs n=21 usual care group). Four 
participants withdrew before randomisation due to loss of interest whilst one participant, allocated to 
the cognitive training group, withdrew after four training sessions and could not be contacted.  
Adherence  
 
The adherence to training sessions in the 20 participants allocated to the cognitive training intervention 
was 99%, with only two participants missing the last training session. There were no differences in 
adherence in those who visited the university for training visits compared to those who preferred home 
training visits.  
Data collection  
 
There were no missing cognitive data in any of the 41 participants who were included in the follow-up 
analysis. Cognitive data was collected within the specified time frame in 36 of the 41 participants 
(intervention group n=1 vs usual care control group n=4). Difficulty was frequently experienced in 
arranging post-assessment visits with individuals who were allocated to the usual care control group. 
Blood samples could only be extracted from 35 of the 41 participants who completed the trial. 
Modifications specifically aimed at those allocated to the control group should be made to reduce data 
collection outside of the specified time frame, see Table 4.3 for proposed suggestions. 
Motivation 
 
Scores from the VAS scales indicated that participants in general were highly motivated to conduct 
cognitive training, with a group mean score of 15.3 ± 10.6 for interested/bored, 18.5 ± 11.9 for 
attentive/dreamy, 20.3 ± 14.0 for alert/drowsy, and 24.6 ± 13.9 for energetic/lethargic. These findings 
suggest that participants were highly motivated to engage in cognitive training which was sustained 
over the duration of the training period. Figure 4.5 shows the mean scores of each motivation outcome 
at each training session. There were no significant differences between individuals who conducted 
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cognitive training at the university or those who conducted training in their own home. There were also 
no significant differences between the cognitive or control group at baseline or post assessment.  
 
 
Figure 4.5 Motivation of participants at each training session. Data indicates that the interest, alertness, 
energy, and attentiveness of participants were high prior to starting the cognitive training intervention, 
as indicated by low scores on each outcome prior to session 1. The alertness, attentiveness and energy 
of participants were shown to steadily increase over the course of the 12 training sessions as reflected 
by a steady decrease in scores. Whilst the interest of participants was shown to peak at session 3, 








Table 4.3 Summary of feasibility findings showing progression decision for each feasibility outcome and proposed modifications for each outcome. 
Outcome Summary of main findings 
 
 Decision Summary of proposed modifications 
Study design • No alterations were required to either enrolment or assessment visits. Changes 
were made to initial training visits to include extra 10-15 minutes. Choice of 
training visits were split equally across home (n=10) and university (n=10) but the 
distance travelled to home visits was costly and time consuming for the researcher.  
• Include an extra 10-15 minutes during the initial 2-3 training sessions to better manage 
participant expectations and to allow familiarisation with training tasks. 
 
• Set a limit on the distance the researcher travels to and from home training visits to manage 
expectations of time management. This may include limiting home training visits to certain 







• In total n=75 expressed interest and n=46 enrolled onto the study. Recruitment rate 
of 3.8 participants enrolled a month. 4 GP practices were identified, 3 consented 
to recruit, mail outs sent from only 2. Difficulties in the recruitment of GP practices 
hindered participant recruitment. 
 
• GP mail outs identified n=42 who expressed interest, n=25 consented to 
participate. A recruitment rate of 0.92 and 1.1 participants per GP practice per 
month was estimated. Secondary recruitment pathways identified n=33 who 




• Based on study and GP recruitment rate, multiple GP practices should be recruited 
concurrently. Ideally more GP practices than needed should be shortlisted for ‘insurance’. 
 
• Supplement GP recruitment with further secondary recruitment pathways e.g. Newspaper 
advertisement, church groups, online advertisement, consultant mail outs. 
  
• Liaise with GP practices to co-ordinate recruitment searches to avoid busy periods e.g. flu 
vaccination season. Prioritise GP practices with greater research experience and allow more 
time for those GP practices with less experience. Potentially employ a dedicated researcher 
or team to manage GP recruitment and conduct follow up telephone recruitment with 








• Of the 46 participants who expressed interest in participating, 41 participants 
completed the post assessment visit equating to an 89% retention rate. The 
adherence rate to cognitive training sessions was high (99%), with only two 









• Data was collected in the allocated time limit in 36 out of the 41 participants. 
Difficulty was experienced in arranging time and date for post assessment visit with 
individuals allocated to the usual care control group.  
 
• Potentially include an active control group to keep control participants more invested and 
involved in the study e.g. educational group or passive brain training. 
 
• Agree upon time and date of the post assessment visit as early as possible and include 
telephone/text/email reminders of agreed dates with those allocated to the control group to 






• Motivation of participants to conduct cognitive training across the 12 sessions was 
high and was maintained for the duration of the study.  
 
 




4.3.3 Cognition  
 
The mean and 95% CI for all cognitive outcomes at baseline by group are presented in Table 4.4. Those 
allocated to the cognitive training group performed worst at baseline in the RTI simple reaction time 
task, RT five choice reaction time task, PAL total errors and PRM total correct compared to the usual 
care group. Significant negative correlations were observed between age and DMS total correct, RVP 
A and RVP total hits, in addition to BMI and PAL total errors and PRM correct latency, indicating that 
as age and BMI increased, performance in these tasks worsened with the exception of PAL total errors. 
Similarly, significant positive correlations were observed between age, PAL total errors, SWM strategy, 
and SWM total errors, also reflecting a worse performance in these tasks as age increased. Significant 
positive correlations were also shown between education and PRM total correct, RVP A, and RVP total 
hits, showing that higher education is associated with greater performance in these tasks. A significant 
positive correlation was observed between BMI and PRM total correct showing that as BMI increased, 
performance improved. All correlations are shown in Table 4.5 
Table 4.4. Baseline performance between the cognitive and usual care control group 
Outcome Cognitive (n=20) Usual care (n=21) P value 
RTI simple (ms) 
 
320.6 (280.0 – 361.2) 305.1 (283.1 – 327.0) 0.52 
RTI Five choice (ms) 
 
342.2 (309.4 – 374.9) 335.0 (311.9 – 358.0) 0.67 
PAL total errors 
 
31.3 (18.4 – 44.1) 23.1 (15.2 – 31.0) 0.16 
SWM strategy 
 
29.0 (24.8 – 33.2) 32.7 (29.3 – 36.0) 0.14 
SWM total errors 
 
23.0 (10.1 – 35.3) 33.1 (23.4 – 42.8) 0.14 
PRM total correct 
 
19.2 (17.9 – 20.5) 21.0 (19.8 – 22.2) 0.01* 
PRM correct latency 
(ms) 
 
1979.9 (1686.8 – 2273.0) 2018.2 (1830.2 – 2206.3) 0.89 
DMS total correct 
 
12.6 (11.8 – 13.4) 12.0 (11.1 – 12.8) 0.23 
DMS correct latency 
(ms) 
 
3202.7 (2650.6 – 3754.7) 3452.3 (3010.2 – 3894.5) 0.50 
RVP total hits  
 
16.8 (14.6 – 18.9) 16.4 (13.6 – 19.3) 0.74 
RVP A 0.90 (0.90 – 0.92) 0.89 (0.84 – 0.93) 0.51 
RTI=reaction time, PAL=paired associated learning, SWM=spatial Working Memory, PRM=pattern recognition Memory, 
DMS=delayed match to sample, RVP=rapid visual information processing. ms= milliseconds  *<0.05
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Table 4.5 Correlation analysis between age, sex, BMI, education, MMSE, disease duration, HbA1c, and cognitive outcomes at baseline 




















RVP A RVP total hits 
Age - -.193 -.432** -.276 -.129 .380* -.127 -.032 .171 .400** .335* .355* -.303 .300 -.311* .100 -.640** -.630** 
Sex - - -.054 -.002 -.098 -.240 -.206 -.071 .131 .002 .115 .254 .193 -.017 -.129 -.212 -.156 -.135 
BMI - - - -.052 .035 -.147 .062 -.075 -.211 -.371* -.142 -.058 .419** -.355* .068 -.128 .053 .042 
Education - - - - 039 -.258 -.026 -.148 -.091 -.295 -.286 -.256 .312* -.014 -.009 .083 .491** .498** 
MMSE - - - - - 012 .196 .134 .066 -.053 -.194 -.059 .305 .085 -.108 -.037 .182 .197 
Disease Duration - - - - - - 064 .040 .040 .215 .103 .084 -.162 -.024 -.057 .004 -.289 -.295 
HbA1c - - - - - - - .102 .042 -.101 .027 -.026 .140 -.067 -.052 -.002 .143 .140 
RTI simple - - - - - - - - 683** .237 .237 .299 -.097 .287 -.237 .109 -.180 -.173 
RTI Five choice - - - - - - - - - .310* .235 .328* -.066 .472** -.180 .291 -.306 -.289 
PAL total correct - - - - - - - - - - .232 .388* -.596** .352* -.400** .361* -.384* -.383* 
SWM strategy - - - - - - - - - - - .767** .013 .319* -.273 -.037 -.534** -.530** 
SWM total errors - - - - - - - - - - - - -.016 .477** -.440** .136 -.599** -.582** 
PRM total correct - - - - - - - - - - - - - -.177 -.063 -.146 .237 .243 
PRM correct latency - - - - - - - - - - - - - - -.091 .550** -.351* -.332* 
DMS total correct - - - - - - - - - - - - - - - -.160 .309* .281 
DMS correct latency  - - - - - - - - - - - - - - - - -.044 -.047 
RVP A - - - - - - - - - - - - - - - - - .995** 
RVP total - - - - - - - - - - - - - - - - - - 
RTI=reaction time, PAL=paired associated learning, SWM=spatial Working Memory, PRM=pattern recognition memory, DMS=delayed match to sample, RVP=rapid visual information processing. All data presented as mean ± SD.*<0.05,**<0.01
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The mean change from baseline scores and 95% CI by group are presented in Table 4.6. Reductions in 
RTI simple reaction time task, RTI five choice reaction time task, PAL total errors, SWM strategy, 
SWM total errors, and PRM correct latency were observed in both groups reflecting a greater 
performance in these tasks. Compared to the usual care control group, greater reductions were observed 
in the cognitive training group in the RTI simple reaction time task, RTI Five choice reaction time task, 
PAL total errors, and SWM strategy. An increase in RVP total hits and RVP A was also shown in both 
groups indicating greater performance in these tasks. A greater increase in RVP total hits was made in 
the control group whilst RVP A equally improved. Improvements in both DMS total correct and DMS 
latency were shown in the control group only, whilst the cognitive training group was shown to worsen 
both DMS total correct score and DMS correct latency score. An increase in PRM total correct score 
was shown in the cognitive training group reflecting a greater performance in this task, whilst no change 
was seen in the control group.  
Table 4.6 Mean change from baseline in cognitive task performance following cognitive training  
RTI=reaction time, PAL=paired associated learning, SWM=spatial working memory, PRM=pattern recognition memory, 
DMS=delayed match to sample, RVP=rapid visual information processing, ms= milliseconds All data presented as mean and 
95% CI, *<0.05 
 
Outcome Cognitive (n=20) Usual Care (n=21) P value 
RTI simple (ms) 
 
-14.0 (-48.7 – 20.7) 
 
-6.9 (-21.0 – 7.2) 
 
0.65 
RTI Five choice (ms) 
 
-10.5 (-41.8 – 20.8) 
 
-1.8 (-24.5 – 20.9)  
 
0.54 
PAL total errors 
 
-16.3 (-23.9 – -8.6) 
 





-3.2 (-5.3 – -1.0) 
 
-1.5 (-3.0 – -1.0) 
 
0.19 
SWM total errors 
 
-1.5 (-5.8 – 2.8) 
 
-3.9 (-9.0 – 1.2) 
 
0.42 
PRM total correct 
 
1.4 (-0.3 – 3.0) 
 
0.0 (-0.9 – 1.0) 
 
0.13 
PRM correct latency 
(ms) 
 
-149.2 (-401.3 – 102.8) 
 
-157.4 (-340.0 – 25.1) 
 
0.95 
DMS total correct 
 
-0.1 (-0.9 – 0.7) 
 
0.7 (-0.2 – 1.4) 
 
0.19 
DMS correct latency 
(ms) 
 
290.4 (-300.8 – 881.6) 
 
-232.3 (-645.7 – 181.2) 
 
0.10 
RVP total hits  
 
0.6 (-1.7 – 2.6) 
 





0.01 (-0.03 – 0.02) 
 





Participants who trained at home were shown to have a greater performance in seven of the eleven 
cognitive outcomes including PAL total errors, SWM strategy, SWM total errors, PRM correct latency, 
DMS total correct, RVP A, and RVP total hits compared to those who trained at the university. 
Participants who trained at the university showed a greater performance RTI simple reaction time, RTI 
Five choice reaction time, PRM total correct and DMS correct latency only, in which the latter was 
shown to worsen in both groups. The mean score for each training task at each training session is 
presented in Appendix W. Improvements were observed across several of the training tasks including 
the CRT, AST, SSP, SST, and OTS, reflecting the improvements observed in the assessment tasks. The 
mean score of several training tasks including RTI, ATS latency (Figure 4.6), ATS switch cost (Figure 
4.7), SSP latency, SST reaction time (Figure 4.8), OTS problems solved on first go (Figure 4.9) and 
OTS latency (Figure 4.10),  were shown to generally improve, along with a reduced variability, up until 
training session 10 & 11 before a plateau was observed.  
 
 




Figure 4.7 Mean task performance in the ATS task switch cost across the 12 training sessions 
 
 






Figure 4.9 Mean task performance in the OTS task number of problems solved on first go 





Figure 4.10 Latency until correct on the OTS task over the 12 training sessions 
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4.3.4 Brain-derived neurotrophic factor 
 
Correlational analysis between demographic variables and levels of BDNF at baseline are presented in 
Table 4.7. A significantly positive correlation was observed between BMI and levels of BDNF at 
baseline, signalling that higher BMI is associated with higher levels of BDNF, see Figure 4.11. Positive 
correlations were also observed between baseline levels of BDNF and both MMSE and HbA1C but 
were not significant. Negative correlations were observed between baseline levels of BDNF and age, 
extraction time at baseline and post intervention but were also not significant. 
Table 4.7. Correlations between baseline levels of BDNF and key demographic variables 
 Age BMI MMSE Duration HbA1c Time 
baseline 























- - -.011 -.124 .047 .032 -.154 .421* 
MMSE 
 
- - - -.002 .257 .036 -.179 0.49 
Duration 
 
- - - - .021 -.262 -.190 -.147 
HbA1c 
 
- - - - - .262 -039 .141 
Time baseline 
 
- - - - - - .431** -.041 
Time post 
 
- - - - - - - -.067 
BDNF pre 
 
- - - - - - - - 
BMI=body mass index, MMSE=mini-mental state examination, HbA1c= glycated haemoglobin, BDNF= brain derived-
neurotrophic factor, *<0.05, **<0.01 
 
Serum levels of BDNF at baseline, post intervention and the mean change from baseline are presented 
in Table 4.8. Serum samples of BDNF could only be measured 35 of the 41 participants (n=16 cognitive 
training group and n=19 in usual care control group). Baseline levels of BDNF were shown to be higher 
in the usual care control group at baseline compared to the cognitive training group but were not shown 
to be significant. Change from baseline data show that both groups reduced their serum levels of BDNF 
at post intervention with the greatest reduction shown in the cognitive training group, but these 





Table 4.8 Baseline, post, and mean change in serum levels of BDNF present with 95% CI 
BDNF Cognitive Control P value 
Baseline (ng/ml) 
 
1258.7 (487.2 – 1472.4) 1303.6 (910.2 – 1837.2) 0.63 
Post (ng/ml) 
 
1186.5 (1034.7 – 1338.4) 1283.9 (1096.9 – 1470.9)  0.41 
Change (ng/ml) 
 
-72.2 (-168.9 – 24.5) -19.7 (-182.7 – 143.2) 0.63 
BDNF=brain-derived neurotrophic factor, ng/ml=Nanograms/millilitres 
 
Correlational analysis between change cognitive data and change BDNF are presented in Table 4.9. 
None of the identified correlations were significant. Negative correlations were observed between 
BDNF and RTI simple reaction time, RTI Five choice reaction time, PAL total errors, SWM strategy, 
and PRM latency, suggesting greater performance in these tasks as BDNF levels reduced. Negative 
correlations were also observed between BDNF and PRM total correct, DMS total correct, RVP total 
hits and RVP A, reflecting worse performance in these tasks as BDNF reduced. Positive correlations 
were observed between BDNF, SWM total errors and DMS latency, also suggesting that performance 
in these tasks worsened as BDNF reduced.  
 
Figure 4.11 Scatterplot showing the relationship between BMI and baseline levels of serum BDNF
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Table 4.9. Correlational analysis between mean change in serum BDNF and mean change in cognitive outcomes 
















RVP A RVP total hits 
BDNF - -.005 -.043 -.132 -.028 .025 -.233 -.053 -.007 .189 -.277 -.324 
RTI simple - - .587** .264 0.73 .180 -.327* -.011 .124 .292 .219* .185 
RTI Five choice - - - .234 .217 .160 -.093 .046 .357* .033 .219 .020 
PAL total correct - - - - .364* .038 -.363* -.016 .081 -.239 .205 .114 
SWM strategy - - - - - .082 .133 .442* -.020 -.142 .259 .034 
SWM total errors - - - - - - -.006 .014 .060 .236 -.277 -.232 
PRM total correct - - - - - - - -.398* .071 -.066 -.090 .122 
PRM correct latency - - - - - - - - -.015 .083 .233 .187 
DMS total correct - - - - - - - - - -.071 .185 -.056 
DMS correct latency  - - - - - - - - - - .012 .082 
RVP A - - - - - - - - - - - .618* 
RVP total - - - - - - - - - - - - 





The overarching aim of the current study was to determine the feasibility of a cognitive training study 
in individuals with T2DM. Findings from the previous review (Cooke et al., 2020) (chapter 2) and 
intervention development study (chapter 3) pointed towards the implementation of a cognitive training 
study for further evaluation. Prior to undertaking a large-scale evaluation, conducting a feasibility study 
allows the researcher to evaluate whether it is appropriate to proceed with a definitive trial and 
determine whether modifications are required to the trial design before continuing. Using a traffic light 
progression criteria, the findings of the current study demonstrated feasibility in the adherence, retention 
and motivation of participants to conduct and complete the cognitive training study. Going forward, 
several remedial modifications were identified to aspects of the study design, recruitment processes, 
and data collection that should be considered before conducting a future definitive RCT. Minor 
modifications will need to be made to three key areas including 1) limiting the distance travelled by the 
researcher to and from home training visits, 2) recruiting a greater number of GP practices in addition 
to the inclusion of further secondary recruitment pathways, and 3) implementing measures to ensure 
follow up data is collected in the pre-specified time frame. Data signalled towards a positive effect of 
cognitive training compared to usual diabetes care in several cognitive domains including visual 
memory, new learning, reaction time, spatial working memory and visual pattern recognition memory. 
However, an unexpected reduction in serum levels of BDNF was observed in both groups with the 
greatest decrease shown in the cognitive training group. Overall, the findings of the present study 
suggest that it would be appropriate to conduct a definitive RCT in which only minor remedial 
modifications would be required to aspects of the trial design. Whilst the improvements in cognition 
point towards cognitive training as a potential strategy for targeting cognitive dysfunction in T2DM, 
further research would be required to determine whether this type of intervention could be effective. 
The reduction in BDNF following cognitive training was unexpected but may be indicative of a 
potential alternative mechanistic pathway in T2DM that warrants further investigation along with other 
potential cognitive training mechanisms.  
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4.4.1 Study feasibility 
 
Recruitment procedures resulted in 75 individuals registering interest over an 11 month period with 46 
individuals providing informed consent and 41 individuals included in the final analysis. Whilst the 
target sample size for feasibility studies proposed by Teare et al. (2014) was not achieved (n=70), this 
study was more concerned with the feasibility of recruitment pathways for informing future trials. GP 
mail outs yielded the greatest number of potential participants (56%), supporting previous evidence 
which suggests that a targeted mailing approach where potential participants are identified using GP 
registers, should be a primary recruitment pathway for future research trials (Silagy et al., 1991; Johnson 
et al., 2105; Carter et al., 2015). Of the 1376 registered individuals with T2DM, 1037 individuals (75%) 
met the study eligibility criteria. A total of 749 mails out were sent in which a recruitment rate of 0.92 
and 1.1 participants enrolled per month per GP practice, and is comparable to recruitment rates observed 
in several single and multicentre RCTs conducted in the UK that also recruited approximately 0.92 
participants per centre per month (Walters et al., 2017). However, delays in the recruitment of GP 
practices were experienced which consequently hindered participant recruitment. It is common for trials 
to suffer from delays in the contracting and setting-up of GP practices which may consequently lead to 
a deviation from the initial recruitment time plan (Avery et al., 2017). It is also important to consider 
that recruitment rates from GPs may fluctuate seasonally and that the range of research experience GPs 
have may also encumber recruitment (Avery et al., 2017). Our findings suggest that before proceeding 
to a large-scale evaluation, modifications need to be made to the study recruitment processes. Based on 
the extrapolation of recruitment rates, several GP practices should be recruited concurrently and more 
practices than needed should be identified as an ‘insurance’ (Avery et al., 2017). Furthermore, primary 
recruitment through GP mails out should be supplemented with further, more innovative secondary 
recruitment pathways e.g. consultant mail outs, online and newspaper advertisement, church groups etc. 
Furthermore, our findings showed that a large proportion of individuals that expressed interest through 
GP mails did not reply to initial recruitment emails. Evidence from a recent systematic review (Treweek 
et al., 2018) suggest that telephone reminders to individuals who did not respond to postal invitation 
resulted in a 6% (95% CI 3%-9%) improvement in the recruitment of participants. Future trials should 
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also consider follow up telephone calls to those individuals who expressed interest but did not respond 
to the initial recruitment emails.  
The inclusion of an enrolment visit, informed by previous research (Callisaya et al., 2017), was shown 
to be successful in determining eligibility and availability including those who were too busy, lived too 
far away or were unable to participate due to other health reasons. In line with previous evidence 
(Harris-Brown & Paterson, 2015), it is recommended that enrolment visits should be included in future 
trials as it provides vital information regarding the feasibility of studies. The inclusion of a validated 
cognitive screening tool, such as the MMSE, to help identify any cognitive impairments was also an 
important addition to the eligibility screening process as it was short, concise, and minimised the burden 
on the researcher. Despite the relatively small sample size, the baseline characteristics appeared 
balanced between the cognitive training group and usual care control group. The intervention group 
performed cognitive training based on evidence from previous meta-analyses on the moderators of the 
effectiveness of cognitive training (Lampit et al., 2014; Kueider et al., 2012). The intervention 
demonstrated a high retention of participants (89%) with only five dropouts, including four drop-outs 
prior to randomisation and one drop out after training session four. The adherence of participants was 
also high (99%) with only two participants missing the last training session. These findings fall in line 
with previous RCTs (Walters et al., 2017) and are comparable or even better than the retention and 
adherence reported in previous studies investigating cognitive and exercise training in T2DM (Espeland 
et al., 2017b; Callisaya et al., 2017, Shellington et al., 2018; Whitelock et al., 2018). Participant 
motivation has previously been identified as a putative determinant of a participant’s capacity to adhere 
to and benefit from cognitive enhancing therapies (Choi & Twamley, 2013). Our findings show that the 
motivation of participants to conduct the 12 cognitive training sessions was high, which may have 
contributed to the high adherence and retention rate.  
There were no significant differences observed in any of the motivation scores between those who 
conducted training at the university and those who trained at home. Offering the participant the choice 
with respect to timing and training locations of training visits may also have contributed to the high 
adherence and retention rates. Recent evidence suggests logistical issues e.g. travelling to and from 
124 
 
studies is an important factor in individuals who declined participation in research (Newington & 
Metcalfe, 2014), and providing patient flexibility/choice may be a successful strategy to engage and 
maintain participants in trials (Heath et al., 2018; Heijmans et al., 2015; Graziotti et al., 2012; Martin 
et al., 2005). As different recruitment rates were being explored, a wide geographical area was included, 
primarily for support group recruitment. Furthermore, home-based training enables the participation of 
frail or immobile individuals who may not be able to travel to and from research trials (Kueider et al., 
2012). However, in the present study no limit was set on the distance the researcher travelled to and 
from the participant’s home for training visits, whereby some journeys were found to be time consuming 
and expensive. It is important to consider whether this type of recruitment should be factored in or out 
of any future trial recruitment options. It is recommended that future trials restrict home visits to specific 
post codes or limits imposed on distances travelled to help minimise the burden placed on the researcher.  
4.4.2 Impact of cognitive intervention on cognition 
 
Correlational analysis was initially conducted to identify key demographic covariates that may 
influence cognitive performance in T2DM. Our findings show that age, BMI and education were 
associated with several tasks at baseline cognitive performance. More specifically, as age and BMI 
increased, performance on tasks of memory, working memory and sustained attention, were poorer. In 
contrast, greater performance in tasks relating to memory and attentional domains were linked to higher 
educational attainment. This was expected as previous evidence generally shows age, BMI, and 
education status to have a significant impact on domains of cognition (Murman, 2015; Kirton & Doston, 
2017; Arvanitakis et al., 2018; Zahodne et al., 2015). These findings are important as they suggest that 
age, BMI and education may potentially influence cognition in T2DM in which future researchers 
should consider adjusting for in future trials. 
Improvements were observed in several cognitive domains as a result of 12 one-hour sessions over 6 
weeks of cognitive training, including visual memory and new learning, reaction time, spatial working 
memory, and recognition memory. Our findings fall in agreement with previous evidence that also show 
improvements in tasks of memory and working memory in T2DM (Paulo & Yassuda, 2012; Whitelock 
et al., 2018). Noticeably, larger improvements were made in tasks of visual memory and reaction time 
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as a result of cognitive training compared to the usual diabetes care group. Visual memory has 
previously been identified as a key cognitive domain that is vulnerable to cognitive decline in 
individuals with T2DM (Palta et al., 2014). The implications of our findings are important as deficits 
in memory related behaviour in individuals with T2DM has been proposed to have a detrimental impact 
on several disease management tasks including glucose monitoring, medication use, nutritional 
planning, and the coordination of health care appointments (Hopkins et al., 2016; Munshi et al., 2017). 
Reaction time is also recognised as an important cognitive domain that is at increased risk of decline in 
T2DM (Palta et al., 2014; Monette et al., 2014; Wong et al., 2014; Pelimanni et al., 2018). Evidence 
suggests that individuals with diabetes are 1.5 to 12 times more likely to experience hip fractures in 
addition to fractures at other sites including the humerus and spine compared to those without diabetes 
(Mayne et al., 2010). Several previous studies have shown that a slower reaction time is a primary cause 
of slips and falls and is a leading contributor to the high fracture rates observed in individuals with 
T2DM (Richerson et al., 2005; Morrison et al., 2010). The improvements observed in visual memory 
and reaction time in the present study may help target cognitive decline in T2DM, which in turn may 
have a positive impact on disease management and quality of life. 
Improvements in spatial working memory and recognition memory were also evident in the cognitive 
training group, but only small gains were made compared to the usual care group. Working memory is 
a core component of executive function that plays an important role in problem solving, planning and 
organisation (Diamond, 2013). Deficits in executive function and working memory in relation to 
planning and problem-solving abilities have been proposed to have a serious impact on the management 
of T2DM (Hopkins et al., 2016; Sinclair et al., 2000). For example, an individual may remember 
instructions to carry out important self-care tasks but are unable to integrate them into practices, which 
may further exacerbate cognitive decline and vascular complication (Hopkins et al., 2016; Munshi et 
al., 2017). Similarly, memory has also been identified as a common domain affected in T2DM and may 
interfere with self-care activities and diabetes control leading to suboptimal adherence to diabetes 
treatment regimens (Hopkins et al., 2016; Cerasuolo & Izzo, 2017). Our findings indicate a positive 
effect of cognitive training on working memory and recognition memory, and although only small gains 
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were shown compared to the usual care group, these findings could potentially be used in identifying 
primary outcomes in future larger trials. Whilst positive findings were observed in several cognitive 
domains in the current study, it is also important to acknowledge findings that did not support our 
hypothesis. Greater improvements were observed in domains of attention and delayed memory in the 
usual care control group. This finding was unexpected considering that both attention and memory are 
considered susceptible to cognitive decline in T2DM (Palta et al., 2014; Pelimanni et al., 2014; Monette 
et al., 2014). Furthermore, previous meta-analyses have also shown small to moderate improvements 
in these domains following cognitive training (Chiu et al., 2017; Lampit et al., 2014). However, these 
improvements were small, and as this was a feasibility study, further work would be needed to confirm 
the effects of cognitive training on attention and delayed memory in T2DM.  
4.4.3 Brain-derived neurotrophic factor 
 
To date, this is the first study that has examined the effect of cognitive training on serum levels of 
BDNF in a T2DM population. Our findings showed that both groups had reduced serum levels of BDNF 
at follow up, with greater reductions shown in the cognitive training group. This finding is somewhat 
unexpected in context of previous evidence that show an increase in the availability of BDNF following 
cognitive training in healthy middle aged adults (Kim et al., 2018), healthy older adults (Ledreux et al., 
2019), older adults with MCI (Damirchi et al., 2018), and chronic diseased populations including in 
those with Parkinson’s disease (Angelucci et al., 2015) and heart failure (Pressler et al., 2015).  
It is interesting to think about the current findings of reduced BDNF during the testing period in this 
study in the context of previous evidence suggesting BDNF plays an integral role in glucose metabolism 
(Smith et al., 1995; Ono et al., 2000; Krabbe et al., 2007; Fujinami et al., 2008, Zhen et al., 2013; Zhen 
et al., 2017). Ono et al. (2000) observed that the availability of BDNF from the human brain was 
inhibited when blood glucose was elevated, whereas when plasma insulin was increased in the presence 
of normal glucose levels, the availability of cerebral BDNF was augmented. These findings suggest that 
low levels of available BDNF may accompany impaired glucose metabolism, indicating that decreased 
levels of BDNF may be associated with poor glucose control. In agreement, more recent evidence that 
explored the role of BDNF in glucose metabolism also show reduced levels of serum and plasma BDNF 
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in individuals with T2DM (Krabbe et al., 2007; Fujinami et al., 2008, Zhen et al., 2013; Zhen et al., 
2017), in which the availability of cerebral BDNF was also observed to be inhibited when glucose levels 
were increased (Krabbe et al., 2007). Considering the inverse relationship between BDNF and blood 
glucose previously explained, the reduction in BDNF observed at follow up may partly be attributed to 
a possible worsening / elevation in glucose levels over the 6-week study period. However, this can only 
be speculated at this point as no measures of blood glucose were taken beyond baseline HbA1c. 
Our findings of reduced BDNF may also be explained in the context of evidence presented by Passaro 
et al., (2017) suggesting that an increase in levels of BDNF could be viewed as a neuroprotective 
mechanism in response to insult, and that cognitive training may act as a superseding neuroprotective 
mechanism that suppresses or delays the need for enhanced levels of BDNF. Specifically, Passaro et 
al., (2017) evaluated the effect of daily computerised cognitive training during horizontal bed rest (n=8 
mean age 59.1 ± 3.9) over a 14-day period compared to horizontal bed rest without cognitive training 
(n=8 59.1 ± 2.5) in healthy older adults. Post intervention findings revealed that BDNF levels remained 
similar to baseline values in the cognitive training group whilst BDNF levels were shown to increase in 
the bed rest control group. In the present study, it could be speculated that the greater reduction in levels 
of BDNF shown in the intervention group may reflect cognitive training acting as an external overriding 
neuroprotective mechanism; which seems to modify the standardised response, thus potentially 
reducing the need for increased levels of BDNF, or possibly modifying it’s time course. Our findings 
also revealed a significant positive correlation between baseline BDNF levels and BMI, suggesting that 
an increased BMI was associated with increased levels of BDNF. This finding makes sense in the 
context of previous evidence (Passaro et al., 2017) in that the elevated levels of BDNF may act as a 
neuroprotective mechanism is response to insult e.g. obesity and the inflammatory response associated 
with T2DM. This is further supported by evidence that shows greater circulating levels of BDNF in 
obese individuals compared to controls (Golden et al., 2010; Slusher et al., 2015). However, it is 
important to point out that there is evidence to suggest a negative correlation between circulating levels 
of BDNF and obesity across several population groups including children (Roth et al., 2013), middle 
aged female adults (Celik Guzel et al., 2014), and middle aged adults with T2DM (Krabbe et al., 2007). 
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Regardless, our findings highlight the importance of adjusting for important covariates such as BMI 
when examining the impact of future interventions on levels of BDNF in T2DM.   
4.4.4 Strengths and limitations 
 
The present study was executed well using a rigorous methodology that was underpinned by previous 
pilot work to develop and test the feasibility of a cognitive training intervention for future testing (Cooke 
et al., 2020). The use of a traffic light progression criteria was useful in identifying aspects of the study, 
including the design, recruitment processes, and data collection that require modifications prior to 
further testing, potentially making a large-scale intervention more viable as opposed to using a simple 
stop/go criteria (Avery et al., 2017). The inclusion of several neuropsychological tests provides 
preliminary information which may guide future researchers in identifying key primary outcomes for 
future cognitive intervention trials in diabetes. This is also the first study to evaluate the effect of 
cognitive training on BDNF in T2DM, providing a preliminary insight into the biological effects of 
cognitive training in a T2DM population. 
The author acknowledges that higher serum levels of BDNF were observed in the current study 
compared to those reported in previous trials in T2DM (Fujinami et al., 2008; Zhen et al., 2013). Issues 
with the absolute quantification of samples using ELISA techniques were experienced that may have 
contributed towards this finding. However, it is important to note that previous studies using the same 
ELISA kit also show abnormal serum BDNF levels in healthy control participants (Oral et al., 2012; 
Sahin et al., 2014; Oral et al., 2015). There is also evidence that suggests several factors including the 
circadian rhythm and fasting state may have potentially influenced levels of serum BDNF (Cain et al., 
2017; Mattson, 2005; Begliuomini et al., 2008; Giese et al., 2014). As this research was primarily 
focused on the feasibility of a cognitive training study controlling these factors was difficult due to 
providing participant choice with respect to the timings of visits. However, no correlation was found 
between time of day and BDNF and there are several existing studies that measure BDNF and do not 
control for time of day or fasting state (Kalbe et al., 2018; Rahe et al., 2015; Baker et al., 2010a; Casoli 
et al., 2014; Vedovelli et al., 2017; Nuechterlin et al., 2016). 
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Another limitation of the present study was that the cognitive training battery comprised of several 
neuropsychological tasks that were designed for end point measurement only. Although these 
neuropsychological tests can function as training tasks, as demonstrated in the current study, it is 
important to note that these tasks have only been validated at this point in time, for end point 
measurement use. However, CANTAB was previously compared against PEBL, a free open source 
cognitive platform during preliminary pilot work (chapter 3) with evidence indicating that CANTAB 
was more engaging and easier to use compared to open source platforms. Furthermore, several previous 
cognitive training studies have also employed in-house training batteries (Colzato et al., 2011; Casutt 
et al., 2014; Buschkuel et al., 2008; Muijden et al., 2012), similar to CANTAB, in addition to CANTAB 
being routinely used for training purposes as part of undergraduate and postgraduate research projects 
at the University of Lincoln. The added benefit of using CANTAB is that 1) each task is designed and 
validated to target specific cognitive domains which is useful to begin to understand the potential 
mechanistic pathways that may underpin the effects of cognitive training on cognition in T2DM, 2) 
CANTAB is more accessible and cost effective than other commercially available platforms, and 3) 
participants in the intervention development study (chapter 3) were shown to favour CANTAB as 
opposed to PEBL.  
Whilst there are merits in using CANTAB for training purposes, it is acknowledged that this may have 
potential implications in the context of informing the recommendations for the development of larger 
interventions. Furthermore, because these tasks are designed primarily for end point measurement there 
may be a greater risk of experiencing ceiling effects compared to validated adaptive training tasks. 
However, there was no evidence of a ceiling effect within the current study, see training data presented 
in appendix W. There are several alternative cognitive training platforms available that have been 
validated for training use including commercially available platforms e.g. CogniFIt, Elevate, Lumosity, 
Peak etc as well as open source platforms that allow researchers to design and run cognitive training 
batteries e.g. PEBL. Future researchers may want to consider developing a similar training battery based 




A further limitation of this feasibility study was the uncertainty in ensuring that those allocated to the 
control group did not take on new behaviours during the study period. Whilst participants were asked 
to refrain from undertaking any new structured exercise of cognitive training this was not monitored or 
reported during the study. By taken part in research, participants will be more aware of the importance 
of maintaining good brain health and as such may be more likely to engage in cognitive enhancing 
activities which may affect the study result (Ng et al., 2020; Goghari & Lawlor-Savage, 2018). This is 
problematic as data collected from those allocated to the control group may potentially mask or 
underestimate the impact of the effects of cognitive training on cognition in T2DM when compared 
against the interventional group (Torgerson, 2001; Magill et al., 2019). It has previously been 
highlighted that control group participants may benefit from greater study involvement (Kemmler et 
al., 2005; Steins Bisschop et al., 2015; Cramer et al., 2016), which may prevent control participants 
initiating new behaviours during the study period. This may involve asking participants to keep diaries 
of any activities that may influence study results e.g. cognitive training or exercise / physical activity. 
This could be facilitated through the use of phone or tablets using text messaging / cross platform 
messaging applications e.g. WhatsApp or even an using an application specifically developed for the 
study control group. Finally, the exclusion of a healthy control group is also considered a limitation of 
this study. Similar to previous cognitive trials in diabetes (Espeland et al., 2017), including a healthy 
control would provide broader comparison and potentially provide a greater insight into the impact 
cognitive training may have in T2DM, and should be considered when designing a future RCT. 
4.5 Conclusion 
 
The aim of the current study was to determine the feasibility of a cognitive training study in individuals 
with T2DM. Using a traffic light progression criteria, the findings demonstrated feasibility in the 
adherence, retention, and motivation of participants to complete the cognitive training study. Whilst 
these findings provide evidence to support the implementation of future RCTs, minor remedial 
modifications are recommended to aspects of the study design, recruitment, and data collection 
processes. Improvements in visual memory, new learning, reaction time, spatial working memory, and 
recognition memory were identified as a result of cognitive training, indicating that this type of 
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intervention could be a potential strategy for targeting cognitive dysfunction in T2DM. The reduction 
in serum BDNF following cognitive training, whilst unexpected, points towards an alternate 
mechanistic pathway in T2DM compared to those mechanisms observed in healthy populations. Based 
on the findings of this feasibility study, researchers should proceed with a future definitive RCT and 


























Study 3 - Exploring the experiences and acceptability of a cognitive training 




The findings from chapter 4 confirmed the feasibility of conducting a cognitive training study with only 
minor amendments to the current methodology. However, it is becoming increasingly important to 
consider acceptability when designing, evaluating, and implementing healthcare interventions (Sekhon 
et al., 2017). Developing an intervention to target cognitive dysfunction in T2DM that is acceptable to 
participants is essential for the success of future trials, as participants will be more likely to adhere to 
proposed guidelines and benefit from improved clinical outcomes (Fisher et al., 2006; Hommel et l., 
2013). The MRC has made available numerous publications that aim to guide researchers as to the most 
appropriate methods for designing and evaluating complex interventions (MRC, 2000; Craig et al., 
2008; Moore et al., 2015), in which the emphasis on the acceptability of interventions has increased 
with each publication (Sekhon et al., 2017). The use of cognitive training to target cognitive dysfunction 
in T2DM is still an emerging area of research (Cooke et al., 2020), and only few previous trials have 
considered the acceptability as part of their study design (Whitelock et al., 2018; Cuevas et al., 2018).  
 
Whitelock et al. (2018) explored the acceptability of a working memory training intervention in T2DM 
using semi-structured interviews. The main findings suggested that participants felt their enthusiasm 
for training declined as the trial progressed and that training was a considerable commitment which was 
perceived as intrusive of their daily routines (Whitelock et al., 2018). Retired individuals reported 
finding it easier to find time to train whilst others found it difficult to manage training around work 
commitments (Whitelock et al., 2018). Participants also expressed a lack of understanding as to how 
improving working memory may influence dietary self-care, which was suggested to be potentially 
linked to the decline in enthusiasm (Whitelock et al., 2018). Comparable findings were also observed 
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in a similar qualitative study by Cuevas et al., (2018) that explored the use of cognitive strategies and 
training in T2DM. Participants suggested that the intervention helped improve their cognition in 
addition to increasing the flexibility with cognitive strategy plans, but the lack of time and discipline to 
training were identified as prominent training barriers (Cuevas et al., 2018). It was noted by participants 
that whilst this type of intervention did not have a direct impact on glucose control, it provided them 
with a greater sense of control and self-efficacy with respect to diabetes self-management (Cuevas et 
al., 2018). However, some participants did express the need for greater practice of tasks and strategies 
in the context of ‘real-life’ situations related to diabetes self-management (Cuevas et al., 2018). 
 
Evidence gathered from previous acceptability studies have been influential in informing the 
development of the current cognitive training study (chapter 4). For example, greater preference with 
respect to the timings and locations of training was incorporated to address common issues including 
finding the time to train and managing training around work commitments (Whitelock et al., 2018; Wu 
et al., 2018). Similarly, to strengthen the participants understanding of the purpose and direction of 
training (Whitelock et al., 2018; Stuifbergen et al., 2011), supervised visits were also included to 
provide greater support for participants. It is clear that exploring the acceptability of a study can provide 
important insight with regards to informing and developing future trials.  
 
5.1.1 Aim and objectives 
 
The aim of the qualitative element of this study was to determine the acceptability of a cognitive training 
study in T2DM. This study aimed to meet the following objectives: 
A) To explore the perceptions of the participant’s experience of taking part in the cognitive 
training study.  
B) To explore and describe the acceptability of the cognitive training study. 
5.2 Methods 
  




A qualitative study design using face-to-face semi-structured interviews was used to assess the 
acceptability of a cognitive training intervention for targeting cognitive dysfunction in people with 
T2DM. This study was conducted, in accordance with aspects of the consolidated criteria for reporting 
qualitative research (Appendix X) (Tong et al., 2007). 
5.2.2 Participant recruitment  
 
 A subset of participants who took part in the feasibility aspect of the cognitive training study (chapter 
4 - cognitive training group n= 10; usual care control group n=3) were invited to take part in a semi-
structured interview. The recruitment procedures and study eligibility criteria are previously described 
in chapter 4. A sample size of 10-15 participants was deemed appropriate based on previous 
recommendations by Braun & Clarke (2006) for conducting a medium sized project (e.g. masters, 
professional doctorate, PhD chapter work) using semi-structured interviews and thematic analysis.  
5.2.3 Data collection  
 
All participants provided written consent as part of the informed consent procedure outlined in chapter 
4 in addition to verbal consent recorded during the interview. Data was collected using face-to-face 
semi-structured interviews which were conducted after the cognitive training study post assessment 
visit. Interviews took place either at the University of Lincoln or in the participant’s own home based 
on participant preference. All interviews were audio-recorded (using a Dictaphone) and transcribed 
verbatim.  
5.2.4 Semi-structured interview protocol 
 
A semi-structured interview guide was developed informed by the evidence gathered from previous 
chapters (chapters 3 and 4), and the wider qualitative literature concerning the acceptability of cognitive 
training in T2DM (Whitelock et al., 2018; Cuevas et al., 2018); in addition to theory-linked interview 
approaches (Ayala & Elder, 2013; DeJonckheere & Vaughn, 2019). Questions were orientated around 
4 main topics including 1) assessment visits, 2) cognitive training, 3) usual care control, and 4) study 
locations, see Table 5.1 regarding the semi-structured interview guide. Those included in the cognitive 
training group were interviewed on topics 1, 2 & 4, whilst those included in the usual care control group 
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were interviewed on topics 1, 3 & 4. An example semi-structured interview including field notes is 
included in Appendix Y. 
 
Table 5.1 Semi-structured interview guide 
1. Assessment visits 
• What were your thoughts and feelings prior to the initial cognitive assessment?  
• How did you find the difficulty of assessment tasks?  
• Did you find the length of the assessment visit appropriate?  
• What were your thoughts and feelings with regards to giving blood samples?  
• Did you think it is appropriate to extract blood samples in adults with T2DM? 
2. Cognitive training 
• What were your thoughts and feeling towards being allocated to the cognitive training group? 
• How did you find the difficulty of tasks throughout the training period? 
• Was the length of training visits appropriate?  
• Was the number of training visits a week suitable?  
• Was the overall length of the training intervention appropriate?  
• How did you find using the study equipment?  
• Did you find using the brain training sessions enjoyable? 
3. Usual care control 
• What were your thoughts and feelings prior to the initial cognitive assessment? 
• What were your thoughts and feelings when allocated to the control group? 
• What were your thoughts and feelings prior to the follow up visits?  
• Was your motivation influenced by the randomisation to the control group? 
• Do you have any suggestions for improving the control group experience?  
4. Study location 
• How did you find travelling to and from the university?  
• What were your thoughts and feelings towards been given the choice of training locations and timings? 
• Did you prefer home or university visits?  




5.2.5 Data analysis  
 
Audio-data were transcribed verbatim, entered into NVivo 12 quantitative data analysis software system 
(QRS International Pty Ltd) to organize data and facilitate analysis. Analysis of data was conducted in 
accordance with the six phases of thematic analysis outlined by Braun and Clarke (2006). Thematic 
analysis was chosen as it allows for flexibility and has been identified as an accessible tool for providing 
rich and detailed qualitative data (Brain & Clarke, 2006; Green et al., 2007). Phase 1 (familiarisation) - 
interview transcripts and audio-recordings were repeatedly read and listened to, to facilitate an in-depth 
knowledge of, and engagement with the data set. Phase 2 (coding) - a systematic process of searching, 
identifying, and coding data into subcategories within NVivo was completed to help identify emerging 
patterns throughout the data set. Phase 3 (searching for themes) - major categories were then formed by 
clustering together similar codes/subcategories to create a plausible mapping of key patterns in the data. 
Phase 4 (reviewing themes) - potential themes were reviewed to ensure that themes exhibit a good fit 
with coded data and with the entire data set, and each had a clear distinct or organizing concept. Phase 
5 (defining and naming themes) - a thematic map was then created in which theme names were defined 
ensuring the conceptual clarity of each theme. Phase 6 (writing the report) – themes were then used to 
provide a framework for the analysis in which the researcher combined the analytic narrative and data 
extracts to form the final report.  
5.3 Results  
 
5.3.1 Participant characteristics  
 
Face-to-face semi-structured interviews were conducted with 13 participants who had taken part in the 
feasibility aspect of this study (chapter 4), including 10 participants from the cognitive training group 
and 3 participants from the usual care control group. Participant characteristics for both groups are 
presented in Table 5.2. Each interview lasted approximately between 20 - 30 minutes depending on 





Table 5.2 Participant characteristics  
 
Demographic Cognitive training (n=10) Usual control (n=3) 
Age (years) 69.4 ± 7.0 67.0 ± 12.0 
Sex (m/f) 5/5 2/1 
BMI 29.9 ± 5.7 25.8 ± 2.9 
MMSE 28.0 ± 1.7 28.0 ± 2.0 
HbA1c  53.1 ± 14.3 71.3 ± 27.4 
Diabetes duration  7.1 ± 2.8 17.0 ± 7.9 
m=male, f=female, BMI=body mass index, MMSE=mini-mental state examination, HbA1c=glycated haemoglobin 
 
 
5.3.2 Identification of themes 
 
In total, six overarching themes were identified relating to the acceptability of a cognitive training 
intervention in individuals with T2DM; 1) motivation to participate in research, 2) research 
communication, 3) feelings about the research, 4) facilitators and barriers to cognitive training, 5) 
delivery of training, and 6) desire to continue training.  The six overarching themes and subthemes are 
provided in Table 5.3 along with supporting quotes.   
 
Theme 1: Motivation to participate in research  
 
A subtheme identified regarding the motivation to participate in a cognitive training intervention was 
the participants’ past experiences of family illness. Participants made specific references to the 
cognitive deterioration of family members due to illnesses such as dementia and Alzheimer’s and 
expressed concerns that this could happen to them. Directly linked to the worry associated with the 
experiences of family illness, was the desire to improve brain health. Participants suggested that if 
cognitive training could potentially help prevent or slow the development of such diseases as dementia 
or Alzheimer’s, then they would be willing to try it. Another subtheme linked to the desire to improve 
brain health, was improving diabetes research. Several participants expressed that they were happy to 
take part to help further enhance research into the side effects of diabetes such as cognitive impairment. 
Other subthemes identified that influenced motivation to participate was that the study offered 
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something different to the participants’ usual routine and therefore viewed as an opportunity to get out 
of the house, experience new places, and meet new people.  
Theme 2: Research Communication  
Two subthemes were identified relating to the communication of research including understanding the 
aims and study processes, and the need for better communication. Most participants stated that they 
understood the aims of the study and found the study processes easy to understand and coordinate. 
However, several participants stated that they did not initially fully understand the aims and study 
processes and that the researcher could have made them clearer.  In addition to this, some participants 
were also surprised to learn that the study was not a discrete session and in fact a 6 week intervention, 
further highlighting the need for clarity of communication with respect to the study aims and processes. 
Theme 3: Feelings about the research    
Eight subthemes were identified in the context of the participants’ feelings about the research. 
Apprehension, nervousness, worried about brain health, and not knowing what to expect were common 
feelings expressed by participants prior to the study. Other participants felt relaxed and intrigued, in 
addition to feeling positive about taking part. No concerns were expressed by participants regarding the 
tasks of the assessment visit. Whilst the majority of participants stated that they were used to giving 
blood and found blood extraction acceptable as part of the study, a few did highlight their dislike 
towards needles and blood extraction but did recognise that it was important in the context of research. 
Those allocated to the cognitive training group found cognitive training enjoyable, with some 
participants reporting improved confidence after taking part. Initially participants did describe training 
as frustrating and it was suggested to be a shock to the system at first. However, it was suggested that 
this initial frustration motivated participants to perform better whilst some participants suggested that 
the repetitive nature of tasks made training easier as they could remember answers and knew what to 
expect. Those allocated to the control group group were disappointed not to be able take part in the 
cognitive training arm of the intervention. Participants felt that their motivation decreased throughout 
the trial as being a part of the control group made them feel as if they were not an integral part of the 
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study. Consequently, these individuals suggested that greater involvement is needed for those allocated 
to the study control groups. Finally, the programme length, session duration, and frequency were found 
to be acceptable in the population with the majority of participants having no issues when conducting a 
cognitive training intervention lasting 6 weeks, with sessions performed 2-3 times a week lasting 60 
minutes in duration.  
Theme 4: Facilitators and barriers to cognitive training 
Several subthemes regarding the facilitators and barriers of cognitive training in T2DM were identified. 
Retirement was identified as a prominent facilitator of training in which participants suggested that the 
study was easily managed and did not pose any burden because of the spare time associated with 
retirement. Short travel distances to and from the university in addition to working from home were 
also factors identified by participants as facilitators. Having to travel longer distances to the university 
in addition to managing training around work were considered barriers to training. It was also suggested 
that the university environment could be a barrier to training as some felt out of place in this 
environment. They also described finding it difficult navigating obstacles including students, stairs and 
directions. Providing an option for home or university training visits in addition to the timings of visits 
was perceived as beneficial as it provided flexibility; helping to overcome barriers such a travelling to 
the university, the university environment and work commitments. Other factors that were identified as 
barriers to training included unavoidable commitments such as holidays and family illnesses that were 
suggested to disrupt the rhythm of training.  
Theme 5: Delivery of training  
Several subthemes emerged regarding the delivery of training, some focused on study participation 
experiences, and some considered alternative options for future cognitive training. The participants who 
preferred home training visits suggested that they felt more comfortable in their own environment and 
that they felt more relaxed not having to experience the obstacles associated with visiting the university. 
Home visits were also favoured by some participants because of the convenience associated with not 
having to travel to and from the university. University training visits were preferred by some 
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participants as it was suggested that the university provided more of an academic environment that 
presented less distractions compared to home training visits. Linked to the motivation to participate, 
participants felt that the university training visits also presented an opportunity to get out the house, 
experience new environments, and meet new people. The concept of group training sessions was also 
discussed, some participants liked the idea because of the potential camaraderie, as well as being able 
to compare themselves to others. However, individual supervised training was also perceived as 
advantageous as it would enable greater concentration compared to a group setting, potentially leading 
to greater adherence. Participants also preferred individual supervised training because of the guidance 
with respect to explaining the tasks and support if something went wrong. The idea of a potential brain 
training app that participants could log into at home during their own time was also discussed. Whilst 
participants thought it may be advantageous to use on a phones or tablets, other participants suggested 
that adherence may become an issue, and that participants may become more distracted.  
Theme 6: Desire to continue training  
The final overarching theme identified was the desire to continue brain training in which a common 
subtheme identified was the continuation of training through the use of apps and puzzles at home. 
Participants discussed actively searching for training apps in addition to receiving brain training apps 
as gifts from family members. In addition, participants suggested that they had become more aware of 
their brain health as a result of brain training and have since recommended this type of training to friends 
and family. A factor that was shown to have played a role in the participants desire to continue training 
was the associated enjoyment. The enjoyment of cognitive training had already been identified as a 
subtheme regarding the participants’ feelings towards cognitive training, and participants suggested that 







Table 5.3 Analytical themes, descriptive themes, subthemes and supporting quotes 
 
Analytical theme Descriptive theme Sub-theme  Supporting quote 















Wanting to improve 












“To be absolutely truthful I found it worrying because my mum has got dementia 
and since I’ve been going to visit her and seeing all these guys I am terrified, I 
am terrified of getting dementia, so because when this came up I thought well this 
would be interesting to see if you could do anything to help or alleviate it” 
 
“I was concerned, certainly. Undoubtedly as you get older you slow down your 
brain definitely and because of that you want to know how much you slowed 














study aims and 
processes 
 
Aims could have 






“I didn't fully understand the aims of the exercises maybe that could have been 
clearer.”  
 
“I understood perfectly the aim of the study, we had various people in my group 
that were interested, we had 2 or 3 sessions, didn’t we? I think where you 
explained the purpose of the study and yes, I understood.” 
 
3. Feelings about 

















“Oh yes, yes it was enjoyable. Yes, I certainly would carry on doing it.” 
 
“I found it quite frustrating especially the ones that I wasn’t progressing in so 
much” 
 
“Yeah there could have been something else. Yeah, I don't know what, but it 
would have been nice for there to be something else instead of sort of just being 
left alone” 
 


















Easy to manage 
when retired 
 
Travel to and 
from university 
 
Essential part of 
the study 
 
“I mean ok I’m fortunate because obviously being retired meant that my time is 
easier to organise” 
 
“I mean the problem is always from anywhere in Lincolnshire is getting into 
Lincoln”  
 
“The fact that you give people the opportunity, either they come here or you go to 
them. I think that’s an essential part of the study.” 
 






























visit new place 
and meet new 
people 
 
Felt more relaxed 




to train at home  
“I think if it’s practical it would be better if they came here (university), the more 
academic environment” 
 
“Yeah, I quite enjoy coming into different environments and meeting new people 
and seeing the big wide world rather than sitting at home moping around, 
especially in the wintertime there's not a lot I can do outside.” 
 
 
“A bit more relaxed, you’re not a little bit hyper because you had to rush through 
traffic or run out of breath because you had to run up the stairs of anything like 
that you’re in your own zone, your own environment I think it’s very useful.” 
 
“Yeah, I mean it’s easier for me, it’s as simple as that really but particularly if 
you were going to do that number of home visits” 
 
6. Desire to 
continue 
training 
Continuing training Using apps and 
puzzles at home 
“I have been using the sudoku, (name of participant) has been busy using an app 
at the moment where you’re given so many letters and how many words can you 
find out of it.”  
 
“It's made me a lot more aware of it and I tend to do crosswords at home and try 
and keep my brain active probably more so now after those training sessions than 
I did before.” 
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5.4 Discussion  
 
The aim of this research was to determine the acceptability of a cognitive training study in T2DM. Six 
overarching themes emerged; the motivation to participate, research communication, feelings about the 
research, facilitators and barriers to cognitive training, delivery of training, and the desire to continue 
training, see Figure 5.1. The participants’ motivation to take part was driven predominantly by past 
experiences of family illness, specifically dementia and Alzheimer’s, in addition to wanting to improve 
brain health and contributing to diabetes research. The level of understanding with regards to the study 
procedures and aims varied amongst participants, suggesting that clearer communication strategies 
should be adopted in future trials. The programme length, assessment visits, session frequency and 
duration were well received and cognitive training whilst challenging was perceived as enjoyable. 
Those allocated to the control group felt disappointed not to take part in the cognitive training which 
consequently reduced their enthusiasm and motivation to engage in the study. Several barriers to 
cognitive training were identified including travelling to the university, the university environment and 
managing training around work. Providing choice with respect to the training time and location was 
perceived as an important aspect of this study that helped mitigate the perceived barriers to training. 
The participants’ enjoyment in conducting cognitive training was further reflected by their desire to 
continue training and actively search for training apps and puzzles post intervention. The findings from 
this qualitative stream of research suggest that the current cognitive training study may be acceptable 
in T2DM. Prior to implementing a definitive RCT remedial modifications should be considered 
regarding better participant communication and greater involvement for control participants. The 
findings of this study, together with the previous feasibility findings (chapter 4), will form a 
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Figure 5.1 Overarching themes and subthemes identified regarding the acceptability of a cognitive training intervention in T2DM 
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5.4.1 Comparison to existing literature and theory  
 
Only a limited number of trials exist that evaluate the impact of cognitive interventions in T2DM 
(Cooke et al., 2020), of which only few explore the acceptability of these types of interventions. Our 
findings are consistent with recent evidence presented by Ceuvas et al., (2018) suggesting individuals 
with T2DM may be motivated to participate in mentally stimulating activities due to their fears and 
concerns with regards to the development of dementia and Alzheimer’s. The development of dementia 
and Alzheimer’s is shown to be a prevalent concern among older adults (Tang et al., 2017; Cutler, 2015; 
Roberts et al., 2014b), and there is evidence to suggest that individuals with greater worry are more 
likely to change their behaviour in an effort to try and reduce their risk (Tang et al., 2017). This finding 
may be explained in the context of the health belief model developed by Becker & Maiman, (1987) that 
suggests an individual’s belief regarding whether they are at risk of disease, in addition to their belief 
regarding the benefits of taking action to lessen or prevent that risk, influences their readiness to take 
action (Becker & Maiman, 1987). It is most likely that the participants’ perceived risk of developing 
cognitive dysfunction, in addition to their perception of the benefits of cognitive training in alleviating 
that risk, influenced the motivation of participants to take part in the cognitive training study (Becker 
& Maiman, 1987). 
Whilst the majority of participants understood the study aims and processes in the current study, in line 
with previous acceptability findings (Whitelock et al., 2018; Smith et al., 2019; Stuifbergen et al., 2011), 
several participants expressed initial difficulty in understanding the study aims and processes. The lack 
of participant understanding is a common problem in research. This has previously been demonstrated 
in a review by Falagas et al. (2009) who analysed the clinical informed consent literature from 1961-
2006 and reported that only 54% of patients and research participants sufficiently understood the aim 
of their respective study. Whilst the aims and study processes of the cognitive training study were 
communicated using information and consent sheets, only brief opportunity was given to discuss the 
study in greater detail. Several strategies have previously been identified to help further facilitate greater 
participant understanding including enhanced consent forms in addition to extended discussions 
(Nishimura et al., 2013). The implementation of better communicative strategies is important for 
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development of future trials, as the participants’ lack of understanding and comprehension of the 
research aims and processes may potentially have adverse effects on trial outcomes. This is evidenced 
by Whitelock et al. (2018) who suggested that the lack of participant understanding likely influenced 
the participants’ decline in enthusiasm to continue training. 
The programme length, frequency and duration of training sessions were considered appropriate in the 
current study and in line with previous research (Wu et al., 2018; Smith et al., 2019) cognitive training 
was found to be challenging, but enjoyable. Enjoyment has previously been identified as a key 
determinant of intervention acceptability and has directly been linked to the increased adherence and 
long-term compliance to positive health behaviours (Jekauc et al., 2015; Lewis et al., 2016; Huberty et 
al., 2008; Dishman et al., 2005). It is most likely that the enjoyment associated with cognitive training 
influenced the participants’ desire to continue training and actively search for training apps and puzzles. 
Participants also expressed becoming more familiar with tasks as the study progressed whereby several 
participants suggested that cognitive training improved their confidence in attempting complex 
cognitive tasks. The improvement in confidence as a result of cognitive training could be interpreted in 
the context of self-efficacy, a key construct linked to the social cognitive theory proposed by Bandura 
(1986). Self-efficacy refers to the individual’s belief in their ability to execute or complete a set of 
specific tasks or behaviours (Bandura, 1986). The improved confidence expressed by participants may 
reflect improvements in cognitive self-efficacy which could have important implications in relation to 
health behaviour change (Guicciardi et al., 2014) and diabetes self-management (Yao et al., 2019; Al-
Khawaldeh et al., 2012). This is further supported by previous evidence which reported that the use of 
cognitive training and strategies gave individuals a greater sense of control and self-efficacy with 
respect to assisting diabetes self-management tasks (Cuevas et al., 2018). 
Several training barriers were discussed by participants including travelling to the university, work and 
the university environment. Whitelock et al. (2018) also described similar barriers to cognitive training 
in T2DM, in which travel distance and lack of time are amongst acknowledged barriers that are 
proposed to influence participation and adherence (Schweitzer et al., 2015; Garmendia et al., 2013; 
Morgan et al., 2016). Providing preference with respect to the location of training and timings was 
146 
 
recognised as an important feature of this study that helped mitigate the identified training barriers in 
the current study. This is supported by previous trials that show similar findings (Heijmans et al., 2015; 
Health et al., 2018), for example Heijmans et al., (2015) showed that the willingness to participate was 
higher in the group that was provided with choice of participation between interviews and 
questionnaires compared to the no choice participation group that were offered interviews only (90% 
vs 72%, P < 0.01). 
As expected, participants expressed disappointment in being allocated to the control group which 
reportedly led to a decrease in motivation in some participants. This finding further supports earlier 
evidence that suggests that participants allocated to the control group may experience a loss in 
motivation especially if the interventional group is perceived as more beneficial (Kisner et al., 2013). 
Furthermore, the reduced enthusiasm and motivation experienced in control participants may possibly 
explain why difficulties were experienced organising and scheduling post assessment visits in those 
allocated to the control group in the feasibility element of this study (chapter 4). Previous evidence in 
both drug and health interventions point towards greater retention of participants when employing an 
active control group approach (Kemmler et al., 2005; Steins Bisschop et al., 2015; Cramer et al., 2016). 
For example, a meta-analysis investigating dropout rates in RCTs investigating the use of antipsychotic 
drugs (Kemmler et al., 2005) identified greater dropout rates in placebo-controlled trials (48.1%) 
compared to active controls (28.3%). Similarly, a systematic review that reviewed the effects of 
different control group designs in exercise oncology trials (Steins Bisschop et al., 2015) reported low 
dropout rates in control groups in those trials that offered the intervention after the initial intervention 
period ceased. In line with recommendations proposed in the quantitative phase of the current study, an 
active control group as opposed to a passive control group could be implemented to help retain control 
group participants in future studies.  
5.4.2 Implications and recommendations for future research. 
 
The findings identified in this qualitative phase of the research may have important implications for the 
implementation of future trials. Whilst this is still a developing area of research (Cooke et al., 2020), 
the acceptability of the study components (e.g. intervention length, duration, frequency, blood 
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extraction etc) suggests that this evidence could be used as a basis for the development of future 
cognitive trials aimed at targeting cognitive dysfunction in T2DM. Furthermore, providing flexibility 
with respect to the time and location of training visits may be an important characteristic that underpins 
the success of future trials especially in those that conduct research in rural settings or include younger 
cohorts who may need to manage the study around work and family commitments. The enjoyment and 
desire to continue training indicates that this type of study may have significant potential for 
implementing the foundations for long term compliance in maintaining brain health and may 
subsequently have important implications related to diabetes self-management skills. The loss of 
motivation and enthusiasm associated with using a standard care / usual practice control group in the 
current study represents an important issue that needs serious consideration in future trials in order to 
maximise the acceptability, adherence, and success of interventions. Furthermore, the lack of 
understanding of the study aims and processes observed in some participants in the current study 
emphasised poor communication as a potential barrier to the recruitment and retention of participants 
in future trials. Based on the findings from this qualitative stream of work, the following 
recommendations have been developed.  
 
1. Greater communication strategies should be adopted in future trials to better inform the 
participants understanding of the study aims and processes. Potential strategies should include 
more in-depth discussions with potential participants throughout the recruitment, screening, 
and consent stages of the trial. This should also be supplemented by enhanced participant 
information sheets and informed consent documentation in addition to supervised training 
sessions to help provide support for participants in future trials.  
 
2. Whilst supervised training was perceived as important to participants with respect to providing 
guidance and instruction for both the assessment and training tasks, group training was 
discussed as a potential alternative mode of training that appealed to participants. To further 
enhance our understanding of the use of cognitive training as a potential strategy to target 
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cognitive dysfunction in individuals with T2DM, group training should also be explored in 
future trials. 
 
3. To retain individuals who are allocated to the control group engaged and motivated in future 
trials an active control should be considered as opposed to a passive usual care control. This 
may include educational sessions based upon cognitive decline in diabetes and its importance 
in the context of diabetes self-management and the development / progression of diabetes-
associated complications. Another potential avenue may involve using a wait list type control 
group where individuals will eventually be given the opportunity to complete the brain training 
intervention after the initial study period.  
 
4. Providing choice with respect to the timing and location of training visits was perceived as an 
important characteristic of the cognitive training study that provided flexibility for those who 
lived far away or found it difficult to manage training around work and family commitments. 
Despite the recommendations made to limit the distance travelled for home training visits in 
the feasibility phase of this study (chapter 4), providing preference should be considered 
wherever possible to help provide participants with greater access to future trials. 
 
5. The length (6 weeks), duration (60 minutes), and frequency (2 x per week) of the cognitive 
training intervention were perceived as acceptable by study participants. Future research should 
aim to further evaluate the effectiveness of the proposed cognitive intervention in T2DM as 
part of a RCT.   
 
6. The enjoyment and desire to continue training points towards the potential of this type of 
intervention in implementing long term compliance to positive health behaviour. However, the 
continuation of training beyond the initial study period and its impact on important long-term 
health behaviours was not measured in the current study. To further enhance the understanding 
of the impact of cognitive training on improving and maintaining the long-term compliance to 
diabetes related health behaviours should also be evaluated in future trials.  
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5.5 Conclusion  
 
This chapter formed the qualitative element of the main exploratory trial of this thesis. Semi-structured 
interviews were used to explore the experiences and acceptability of a cognitive training study in 
individuals with T2DM. Six overarching themes emerged; 1) motivation to participate, 2) research 
communication, 3) feelings about the research, 4) facilitators and barriers to cognitive training, 5) 
delivery of training, and 6) desire to continue training. Overall the study procedures and cognitive 
intervention were well received with only few recommendations for future research. With regards to 
the trial design, an active control group may address the decreased motivation and poor engagement in 
control group participants. The understanding of the study aim and processes varied throughout 
participants suggesting that better communication strategies should be adopted in future trials. Whilst 
several training barriers were identified including travel and work commitments, providing participant 
choice with respect to the timing and location of training was described as an important aspect of the 
study that helped manage the potential training barriers and should be considered in future trials. 
Participants found the intervention enjoyable and discussed potential strategies to maintain some form 
of cognitive training activities which is indicative of the longer-term potential of this type of 














6.1 Summary of findings 
 
The overarching aim of this PhD research was to develop and evaluate exercise, cognitive, and dual-
task interventions for targeting cognitive dysfunction in individuals with T2DM. The series of studies 
presented in this thesis (chapters 2-5) were conducted using a systematic phased approach in accordance 
with the MRC’s framework for the development and evaluation of complex interventions (Craig et al., 





Figure 6.1 The systematic phased methodological approach of the current thesis based on the MRC’s 
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6.1.1 Study 1: Systematic review and meta-analysis 
 
The initial study (chapter 2) involved conducting a systematic review and meta-analysis that aimed to 
systematically review the evidence, and estimate the effect of exercise, cognitive, and dual-task 
interventions on cognition in T2DM (Cooke et al., 2020). Nine trials were retrieved that met the study 
eligibility criteria; six exercise interventions, two cognitive interventions and one dual-task 
intervention. Meta-analysis of exercise trials showed small to moderate effects of exercise for 
improving domains of executive function (inhibitory control SMD = -0.31) and memory (immediate 
recall SMD = 0.20) but were not statistically significant. A narrative summary was presented for 
cognitive and dual-task trials that reported positive effects of these types of interventions on tasks of 
global cognition, executive function, and memory (Cooke et al., 2020). The overall quality of included 
trials was mixed, with most trials being judged as having moderate to high risk of bias. The findings of 
this systematic review and meta-analysis suggested that larger, more robust trials were needed to further 
elucidate the effects of these types of interventions in T2DM (Cooke et al., 2020). 
6.1.2 Study 2: Intervention development study  
 
The intervention development study (chapter 3) aimed to pilot exercise, cognitive, and dual-task 
interventions, in addition to the study processes and outcomes to help identify and inform the 
development of a suitable intervention for feasibility testing. Participants completed a 4-week 
programme comprised of treadmill walking, computerised cognitive training, and the simultaneous 
combination of the two. Whilst the cognitive intervention was well received amongst participants, this 
study confirmed that further acceptability and intervention development work is required for both 
exercise and dual-task interventions. The results from this study also highlighted areas for refinement 
in relation to study processes and outcomes (e.g. study eligibility, recruitment pathways, and cognitive 
test batteries). The accumulative evidence identified in both the systematic review and meta-analysis 
(chapter 2) and intervention development study (chapter 3) were used to inform the recommendations 




6.1.3 Study 3: Feasibility and acceptability  
 
The final study of this thesis involved conducting a randomised pilot study that investigated the 
feasibility (chapter 4) and acceptability (chapter 5) of a cognitive training study in T2DM. The findings 
demonstrated feasibility in the adherence, retention, and motivation of participants to conduct and 
complete the trial. Using a traffic light progression criteria, only minor remedial modifications to the 
study design, data collection procedures, and recruitment were proposed that contributed to the 
development of recommendations for a future definitive trial. Evidence from the semi-structured 
interviews suggested that the type of cognitive training and the dose (frequency, duration, and length) 
of training was broadly acceptable. Analysis of secondary outcomes showed improvements in several 
cognitive domains as a result of cognitive training compared to the usual care control group, including 
tasks of executive function, visual memory, recognition memory, and reaction time. However, greater 
improvements were observed in domains of attention and delayed memory in the usual care control 
group. The reduced levels of serum BDNF were unexpected and suggest that further work is needed to 
explore the potential neurobiological mechanisms that underlie any changes in cognition following 
cognitive training in T2DM. Overall, the findings of this thesis provide convincing systematic evidence 
for the feasibility, acceptability, and potential effectiveness of a cognitive training study for targeting 
cognitive dysfunction in T2DM.  
6.2 Identifying and developing interventions 
 
Only a limited number of exercises, cognitive, and dual-task trials were identified in the systematic 
review and meta-analysis (chapter 2) (Cooke et al., 2020). Whilst the small to moderate effects of 
exercise identified in domains of executive function and memory add to the growing evidence base 
advocating the use of exercise training for targeting cognitive dysfunction in T2DM (Hsieh et al., 2015; 
Podolski et al., 2017), these findings were limited by the poor quality and precision of trials (Cooke et 
al., 2020). The largest effect was observed in inhibitory control, a core domain of executive function 
(Diamond, 2013). This finding is in agreement with numerous previous studies in healthy cohorts that 
have linked exercise to the prevention of cognitive decline, especially the deterioration of executive 
functions (Kramer et al., 1999; Hollamby et al., 2017; Colombe & Kramer, 2003, Smiley-Oyen et al., 
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2008, Hall et al., 2001). Early research suggests that exercise, specifically aerobic, may accumulate in 
selective rather than generalised improvements in cognition, in which tasks associated with frontal-lobe 
executive control may be expected to show larger improvement (Kramer et al., 1999). This is further 
supported by more recent evidence that suggests that the magnitude of this effect is shown to increase 
with age (Stern et al., 2019) suggesting that exercise may become increasingly more important with age 
in mitigating cognitive decline. However, the underreporting of adherence data across the majority of 
included exercise trials was a limiting factor, and in those that did report data, the adherence was poor 
(Cooke et al., 2020).  
Poor adherence to exercise was observed in the intervention development study (chapter 3) where worse 
adherence was evident in exercise and dual-task training when compared to cognitive training in 
individuals with T2DM. Participants expressed interest with respect to the concept of exercise training 
but experienced physical discomfort during training which subsequently discouraged them from 
participating in the dual-task training. As previously discussed in chapter 3, the poor uptake and 
adherence to exercise is a common problem in T2DM (Thomas et al.,  2004; Egan et al., 2013; Advika 
et al., 2017; Alzahrani et al., 2019; Pati et al., 2019). Whilst the findings from the meta-analyses 
highlight the potential of exercise for targeting cognitive dysfunction in T2DM (Cooke et al., 2020), 
the intervention development study suggested that more work is required around the acceptability of 
this type of intervention. Poor acceptability would potentially impact the recruitment and adherence of 
participants (Sekhon et al., 2017) and limit the potential of this type of intervention in T2DM.  
This was the first review to evaluate the effect of cognitive and dual-task interventions in T2DM, 
however, the lack of trials and comparable outcome measures limited the interpretation of these types 
of intervention to a narrative synthesis only (Cooke et al., 2020). Whilst the narrative synthesis of 
cognitive trials described a positive effect of these types of intervention on several cognitive domains,  
the limited number of trials (Paulo & Yassuda, 2012, Whitelock et al., 2018) suggested that cognitive 
training is still an emerging area of research in T2DM that warrants further exploration (Cooke et al., 
2020). The findings from the intervention development study further advocated the investigation of a 
cognitive trial. Participants clearly favoured the cognitive training as opposed to exercise and dual-task 
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training. Previous evidence suggests that conducting cognitive activities is one of the most common 
behaviours undertaken by individuals in an effort to reduce dementia risk (Low & Anstey, 2009; 
Anderson et al., 2011; Roberts et al., 2014b; Smith et al., 2014; Smith et al., 2015), and in line with the 
findings observed in the intervention development study (chapter 3), there is also evidence to suggest 
that individuals perceive cognitive activities as much more beneficial in reducing dementia risk 
compared to physical activity, healthy eating and other cardiovascular health behaviours (Smith et al., 
2014; Smith et al., 2015). 
The review identified only one dual-task trial in T2DM (Shellintgon et al., 2018), which reported 
significant improvements in tasks of planning, a sub-domain of executive function. Previous dual-task 
trials in healthy cohorts have also shown improvements in executive functions (Yokoyama et al., 2015; 
Nishiguchi et al., 2015; Barcelos et al., 2015; Theill et al., 2013; Eggenberger et al., 2015), and further 
highlight the potential of this type of training in demonstrating that the additive effects of exercise and 
cognitive training elicit greater cognitive improvements as opposed to single exercise or cognitive 
training (Eggenberger et al., 2015; Yokoyama et al., 2015; Theill et al., 2013). Whilst the simultaneous 
effect of exercise and cognitive training is yet to be compared to either underlying component, alone in 
T2DM, the limited evidence identified within this thesis suggests that the exploration of a dual-task 
intervention would have been premature at this stage and more evidence is needed for both components, 
particularly cognitive interventions. 
The accumulative evidence gathered from the systematic review and meta-analysis (chapter 2) and 
intervention development study (chapter 3) was also integral with respect to informing the 
modifications to the study processes and outcomes. For example, findings from the intervention 
development process indicated that a more targeted approach to recruitment is needed to help recruit a 
greater number of participants. Consequently, a targeted mail-out approach was implemented as a 
recommendation for exploring the feasibility. Similarly, findings from the evaluative feedback also 
highlighted the need to refine and modify the study eligibility criteria to better reflect the intended study 
population in line with previous evidence (Whitelock et al., 2018; Bahar-Fuchs et al., 2020). Trials have 
previously shown the importance in modifying and refining the eligibility criteria to help optimise trial 
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participation. For example, Jin et al., (2017) show that overly restrictive eligibility limited participants 
in oncology trials and recommended broadening the criteria to help better reflect the study population, 
improve participation and enhance patient access to new therapeutic treatments. Furthermore, the 
adaptive nature of this design allowed for the identification and comparative evaluation of two cognitive 
platforms, CANTAB and PEBL. The use of both cognitive platforms has previously been advocated by 
earlier research, for instance studies have shown CANTAB useful in predicting the development of 
cognitive impairment in preclinical populations whilst also differentiating between different types of 
dementia (Blackwell et al., 2004; Swainson et al., 2001; Lee et al., 2003).  The PEBL testing platform 
has shown to be advantageous as it is a free open-source software that allows researchers to design and 
modify specific tests that can be distributed to other researchers (Mueller & Piper, 2014). The findings 
from the intervention development process showed worse performance when using the PEBL platform, 
and in line with the growing acceptability surrounding touch screen technology in older adults (Joddrell 
& Astell, 2016; Vaportzis et al., 2017) participants suggested CANTAB was more enjoyable and easier 
to use. These findings allowed the development and optimisation of an appropriate cognitive test and 
training battery that was recommended for feasibility testing. 
6.3 Feasibility and acceptability of a cognitive training study  
 
The final study conducted as part of this thesis aimed to determine the feasibility (chapter 4) and 
acceptability (chapter 5) of a cognitive training study in individuals with T2DM. A randomised pilot 
study (Eldridge et al., 2016) was conducted in accordance with the exploratory phase of the MRC’s 
framework (Craig et al., 2008) and was developed based on the continuum of evidence accumulated 
from the systematic review and meta-analysis (chapter 2) and intervention development study (chapter 
3). A traffic light progression criteria (Avery et al., 2017) was employed to identify areas of uncertainty 
and inform the recommendations for the development of a definitive trial. Feasibility was shown in the 
adherence, retention, and motivation of participants whilst modifications were recommended to the 
study design, recruitment, and data collection procedures. The high adherence and retention of 
participants demonstrates the potential feasibility and acceptability of the cognitive training intervention 
in T2DM (Zhang et al., 2014b). Similar to exercise training and medication regimens, cognitive training 
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is unlikely to produce significant benefit unless individuals adhere to them (Bloom et al., 2017; 
Bandura, 1977). Aside from reducing the generalisability of findings, poor compliance is often viewed 
as an adverse outcome that reflects the weakness of a trial independent of any treatment effect (Horwitz 
& Horwitz, 1993; Hayes & Dantes, 1987).  
The success of this cognitive intervention was further evidenced by the findings observed in the 
qualitative interviews. Participants described the intervention as highly enjoyable and reported 
improved confidence with a desire to continue training post intervention. It is widely acknowledged 
that enjoyment is an important factor associated with adherence and long-term compliance of health 
behaviour (Ryan et al., 1997; Salmon et al., 2003; Huberty et al., 2008; Lewis et al., 2016). The 
improved confidence as described by participants possibly reflects greater cognitive self-efficacy in the 
study participants. Improvements in self-efficacy is an important determinant related to adherence in 
health interventions (Sheeran et al., 2016), in which enhanced self-efficacy in T2DM has previously 
been associated with improved disease self-management behaviour (Yao et al., 2019; Sarkar et al., 
2006). The acceptability of this intervention is further highlighted by the high levels of motivation 
maintained throughout the trial. High levels of intrinsic motivation have also been linked to greater 
enjoyment and compliance in participants (Alfosson et al., 2017; Thogersen-Ntoumani et al., 2016), 
and in line with previous qualitative evidence in T2DM (Ceuvas et al., 2018), the motivation of 
participants in the current study was driven initially by the participants’ concerns in developing brain 
related illnesses such as dementia and Alzheimer’s.  
Providing flexibility with regard to the way in which participants can take part in research has 
previously been shown to positively influence recruitment and adherence in trials whilst also improving 
the participants’ access to research (Heath et al., 2018; Heijmans et al., 2015). Providing choice with 
respect to the timing and setting of cognitive training was viewed by participants as an important aspect 
of the cognitive training study, which may have helped participants manage the perceived training 
barriers identified in the qualitative interviews including travel, work, family commitments, and training 
environment. However, whilst the implementation of home training visits met the researcher’s 
expectations in providing preference for the participant, travelling long distances limited the 
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productivity and efficiency of the trial, see Figure 6.2 showing distance travelled to conduct training 
and recruitment visits by the researcher. As pointed out by Pribulick et al. (2010), travelling to wider 
geographical areas to recruit and conduct research activities often requires increased efforts and costs 
for the researcher. The willingness of the researcher to continually travel long distances to recruit and 
train, despite the associated limitations, may have perhaps reflected the researcher’s anxiety in trying 
to obtain an adequate sample size. The importance of obtaining an adequate sample size is frequently 
emphasised in research (Biau et al., 2008; Faber & Fonseca, 2014), and it is widely acknowledged that 
the recruitment of  participants is negatively affected by the distance and duration travelled in addition 
to the associated costs (Schweitzer et al., 2015 Newington & Metcalfe, 2014; Naidoo et al., 2020; Ross 
et al., 1999).  
 
Figure 6.2 Locations in Lincolnshire and Nottinghamshire travelled to and from by the researcher to 
conduct home-based cognitive training visits and recruitment visits. 
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Due to difficulties experienced in arranging post assessment visits, it was not possible to collect post 
intervention data from 5 of the 41 participants within the study timeline. Whilst post assessment data 
was collected for these participants within a week of the originally planned assessment visit, it is 
acknowledged that missing or excluded data may have significant implications regarding the 
generalisability of trial findings (Akl et al., 2012; Woodlard et al., 2004; Kang, 2013). The challenges 
experienced regarding the arrangement of assessment visits during the cognitive training study (chapter 
4) highlight the need to adopt more robust strategies to maximise data collection in future trials 
(Robinson et al., 2007; Brueton et al., 2013). However, as it was a feasibility study, participants were 
still invited to complete the post intervention assessment. The difficulties coordinating post intervention 
assessments were unexpected and predominantly observed in those allocated to the control group. This 
finding may be explained in the context of our acceptability findings in which those allocated to the 
usual care control group expressed becoming less motivated throughout the trial and would have liked 
more involvement in the study. Previous evidence suggests that individuals allocated to a control group 
may become less motivated to remain in a trial if they view the experimental intervention as more 
efficacious compared to their usual care received (Kisner et al., 2013) Whilst the use of a usual care 
control group is advocated for testing interventions that are characteristically different to usual care 
practice (Thompson & Schoenfield, 2007), evidence presented in previous drug and health interventions 
do show greater retention of participants when employing an active control group approach, and should 
be considered in future trials (Kemmler et al., 2005; Steins Bisschop et al., 2015; Cramer et al., 2016).  
Arguably the most important remedial issue identified was the poor recruitment of GP practices to help 
facilitate participant recruitment. The recruitment of GP practices was more challenging than expected, 
and the delays ultimately resulted in suboptimal recruitment of participants. Recruiting GP practices 
and healthcare professionals to assist trial recruitment has previously been shown to be difficult 
(McDonald et al., 2006; Foster et al., 2015; Bower et al., 2007; Williamson et al., 2007), in which trials 
often report experiencing delays in initiating recruitment sites (Avery et al., 2017). Several barriers with 
respect to the recruitment of healthcare professionals to participate in research have previously been 
documented. For instance, Brodaty et al., (2013) identified the lack of time as a main barrier that 
159 
 
discouraged GPs from participating in research studies. This is further supported by previous qualitative 
research (Newington & Metcalfe, 2014) and systematic reviews (Fletcher et al., 2012; Ngune et al., 
2012) that highlight the difficulty GPs experience in incorporating research recruitment into the day to 
day practice. Other barriers to GP practice recruitment identified in the existing literature include: not 
being approached in person (Brodaty et al., 2013), lack of interest in the research topic (Pringle & 
Churchill, 1995; Askew et al., 2002; Mason et al., 2007), overwhelming responsibilities and paperwork 
(Brodaty et al., 2013), and inadequate explanation / confusion about the research (Brodaty et al., 2013; 
Foster et al., 2015). 
Research into the facilitators of  GP recruitment suggest that optimal communication between the 
researcher and GP (Williamson et al., 2007; Bell-Syer & Moffett, 2000), reducing the responsibilities 
placed on GP practices  (Foster et al., 2015), and proving benefits and incentives for both the GP practice 
and participant (Williamson et al., 2007; Pringle & Churchill, 1995) are all important factors. 
Furthermore, an earlier study conducted by Bell-Syer et al. (2011) showed that successful participant 
recruitment can also be achieved by recruiting GP practices as early as possible and not relying on the 
initial recruitment of few key practices with additional practices recruited later in the trial (Bell-syer et 
al., 2011). The study reported that those GP practices that were recruited later in the trial recruited fewer 
patients, which was suggested to be a result of practices feeling undervalued and less involved in the 
trial (Bell-syer et al., 2011). It is imperative that future trials aim to recruit and enrol GP practices early, 
and whilst care was taken to reduce the burden and responsibilities placed on GP practices and ensure 
clear study communication, it is evident that these areas needs improvement in future research. 
6.4 Impact on cognition and mechanistic insight 
 
Whist the primary focus of this thesis was concerned with the development and feasibility testing of a 
cognitive training study in T2DM, it also aimed to examine its impact on outcomes of cognition and 
serum BDNF. T2DM and cognition dysfunction are both multidimensional phenomena, in which the 
underlying mechanisms connecting the two are most likely indirect and multidimensional (Biessels & 
Despa, 2018; McFall et al., 2010). For example, research has previously shown that cognitive deficits 
observed in T2DM, especially in older adults, may be exacerbated in the context of more direct 
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biological complications (Nilsson & Wahlin, 2009; Ryan & Geckle, 2000) in addition to more distal 
lifestyle and health factors (Stewart & Liolista, 1999; Cholerton et al., 2016). It was therefore important 
to firstly identify the potential factors that may have influenced cognition in our study population. 
Correlational analysis conducted in chapter 3 and 4 identified several key factors associated with 
cognitive performance in T2DM, including BMI, age and education. Specifically, increasing BMI and 
age were related to worse performance in reaction time, spatial working memory, visual memory, 
delayed memory, and sustained attention whilst higher levels of education was related to greater 
performance in recognition memory and sustained attention. Whilst it is acknowledged that these are 
common factors known to influence cognition in more general populations (Murman, 2015; Bischof & 
Park, 2015; Zahodne et al., 2014), our findings further contribute towards the limited evidence that 
attempts to identify the key factors that possibly underpin cognition dysfunction in T2DM. For example, 
McFall et al. (2010) identified six factors that were shown to influence the cognitive-T2DM relationship 
including BMI, systolic blood pressure, gait-balance integrity, depression, negative affect, and 
subjective health composite. Likewise, BMI in addition to intelligence were also shown to influence 
cognition in middle-aged adults with T2DM (Van Germert et al., 2018). Evidence presented by 
Mallorqui-Bague et al. (2018) showed no association between BMI and sex whilst age, illness duration, 
and sleep duration did predict cognitive performance in T2DM. Mansur et al. (2018) reported no 
association between cognition, BMI and illness duration but did show that HbA1c significantly 
moderated cognition in T2DM. Whilst the relationship between T2DM and cognitive dysfunction 
remains complex, the findings presented in this thesis, in addition to previous literature, may help guide 
and inform future researchers with respect to adjusting for key variables that may influence cognition 
in T2DM.  
As expected, greater cognitive improvements were observed following cognitive training in comparison 
to the usual care group in several domains including reaction time, visual memory, spatial working 
memory, and recognition memory. These findings further add to the accumulating evidence that point 
towards cognitive training as a potential strategy for enhancing cognitive functions in T2DM 
(Whitelock et al., 2018; Paulo & Yassuda, 2012; Bahar-Fuchs et al., 2020). The improvements in spatial 
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working memory, visual and recognition memory complement previous RCTs that also show 
improvements made in executive function and memory (Whitelock et al., 2018; Paulo & Yassuda, 2012) 
whilst the observed improvements in reaction time present a promising novel finding in T2DM. These 
findings may be of great importance with respect to targeting diabetes-associated cognitive dysfunction, 
especially when interpreted in the context of previous meta-analytical evidence that highlight several 
key domains that are sensitive to decline in T2DM including working memory, visual memory, 
recognition memory and reaction time (Palta et al., 2014; Monette et al., 2014; Pelimanni et al., 2018). 
More importantly, a previous review by Tomlin & Sinclair (2016) also reports deficits in several 
cognitive domains in T2DM most notably global cognition, executive function, and memory in which 
worse scores on tasks of global cognition were shown to significantly correlate with several diabetes 
self-management tasks. Adequate cognition is needed to execute even the basic disease management 
behaviours in T2DM including glycaemic monitoring, medication management, foot care, exercising, 
adhering to dietary guidelines and coordinating health care appointments (Munshi et al., 2017; Hopkins 
et al., 2016). Whilst deficits in cognition are known to compromise diabetes self-management, untreated 
diabetes and poor diabetes self-management can lead to the progressive worsening of cognition (Feil et 
al., 2012). Based on the positive findings presented in chapter 4, a conceptual framework is presented 






Figure 6.3 Conceptual framework for the potential role of cognitive training in targeting cognitive 
dysfunction in T2DM (adapted from Bloom et al., 2017). 
 
To further enhance our understanding of the positive effects of cognitive training in T2DM, a purposeful 
investigation was conducted into the impact of cognitive training on serum levels of BDNF. 
Correlational analysis showed a positive association between BDNF and BMI at baseline, suggesting 
that increasing levels of BDNF were related to increasing levels of BMI in our study sample. This 
finding is plausible if interpreted in the context of evidence concerning the anti-inflammatory effects of 
BDNF (Xu et al., 2017; Amoureux et al., 2008). It is widely acknowledged that obesity induced 
inflammation plays a significant role in the development of insulin resistance and thus T2DM (Lee et 
al., 2013b; van Greevenbroek et al., 2013). Previous evidence has shown that the administration of 
BDNF suppresses the expression of inflammatory markers including tumour necrosis factor and 
interleukin-6, whilst also increasing the expression of anti-inflammatory markers such as interleukin-
10 (Xu et al., 2017). It is possible that the positive association between BDNF and BMI may reflect the 
anti-inflammatory nature of BDNF in response to increased obesity induced inflammation. Whilst this 
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hypothetical interpretation refutes previous findings showing reduced levels of BDNF in T2DM cohorts 
(Krabbe et al., 2007; Fujinami et al., 2008, Zhen et al., 2013; Zhen et al., 2017), it may be plausible 
when considering evidence that report enhanced levels of BDNF in cohorts that exhibit metabolic or 
biological insult e.g. obesity (Golden et al., 2010; Slusher et al., 2015), spinal cord injury (Garraway & 
Huie, 2016) and traumatic brain injury (Kazanis et al., 2004; Failla et al., 2016). Future work would 
benefit greatly in investigating the relationship between inflammatory markers and BDNF to help 
further elucidate the biological mechanisms linking cognitive dysfunction and T2DM. 
Several neurobiological mechanisms have been proposed that provide insight into the adaptations at the 
molecular, synaptic, and cortical levels that underlie improvements in cognition through cognitive 
training (Chapman et al., 2015; Chapman et al., 2017; Valenzuela et al., 2007). Increased availability 
in BDNF has been identified as one of the more prominent cognitive training mechanisms in several 
cohorts including MCI, Parkinson's and healthy populations (Kim et al., 2018; Arazi et al., 2019; 
Angelucci et al., 2015; Pressler et al., 2015; Ledreux et al., 2019; Damirchi et al., 2018). Unexpectedly 
our findings showed that serum levels of BDNF reduced in both groups at follow up, with the greatest 
reduction observed in the cognitive training group. Whilst this finding contradicts evidence presented 
in other populations, our findings perhaps highlight the inherently unique interaction between BDNF 
and T2DM.  BDNF is known to play an integral role in glucose metabolism including regulating glucose 
levels and food intake, preventing beta-cell exhaustion and reducing hepatic gluconeogenesis 
(Nakagawa et al., 2000; Yamanaka et al., 2007; Jo & Chua, 2013; Rozanska et al., 2020), see Figure 
6.4. As previously speculated in chapter 4, taking into consideration the inverse relationship observed 
between BDNF and HbA1c (Smith et al., 1995; Ono et al., 2000; Krabbe et al., 2007; Fujinami et al., 
2008, Zhen et al., 2013; Zhen et al., 2017), the reduction in serum BDNF observed in chapter 4 may be 
attributed to a possible worsening of glycaemic control over the study period, most notably in the 
intervention group. Whilst the absence of HbA1c measurements at post intervention limits the 
interpretation of this findings, the role of HbA1c in context of BDNF should be considered in the 




Figure 6.4 Functions of BDNF in T2DM (Rozanska et al., 2020). 
 
Another interesting interpretation of this finding in relation to glycaemic control is the use of metformin. 
Metformin is a common drug used to help lower and manage glucose levels in T2DM (Nasri & Rafieian-
Kopaei, 2014; Rena et al., 2017). Several previous trials have shown the actions of metformin to 
increase circulating levels of serum BDNF (Smieszek et al., 2017; Eyileten et al., 2019 Fang et al., 
2020).  It may be conceivable that the already high baseline levels of serum BDNF shown in the study 
cohort may have been attributed to medication use, specifically metformin, and that cognitive training 
is acting in a positive manner by facilitating the reduction and normalisation of BDNF levels. This may 
make sense in the context of previous evidence that suggests cognitive training may act as an important 
neuroprotective mechanism that is shown to negate or delay the need for elevated levels of BDNF 
(Passaro et al., 2017). However, there is also evidence to suggest that elevations in BDNF may also 
represent an initial adaptation of BDNF to training (Enette et al, 2020). In line with our findings, several 
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previous trials have shown exercise training to unexpectedly reduce the availability of BDNF in 
differing population groups, including those similar to T2DM such as glucose intolerance (Babaei et 
al., 2014; Baker et al., 2010a; Enette et al., 2020). Most interesting were the recent findings presented 
by Enette et al. (2020) that examined the effects of continuous and interval aerobic training on plasma 
BDNF in individuals with Alzheimer’s disease. The continuous training group were shown to increase 
BDNF levels at post intervention which were then shown to further increase at the 4 weeks follow up. 
However, the interval training group who were shown to reduce their BDNF levels at post intervention 
were then shown to increase BDNF levels beyond baseline values at the 4 weeks follow up. It may be 
possible that the reductions in serum BDNF following cognitive training shown in chapter 4 may 
represent an initial adaptive response to cognitive training that is subsequently followed by an increase 
in serum BDNF beyond baseline values after a period of detraining or rest. 
6.5 Strengths and limitations  
 
This thesis employed a systematic phased approach based upon a validated framework that built a 
continuum of increasing evidence allowing for the efficient development and evaluation of a cognitive 
training study in T2DM. The adaptive nature of this approach continually allowed for the identification 
and remediation of areas of weakness that helped develop more suitable and informative 
recommendations for the implementation of a future trial, see Figure 6.5. The systematic review and 
meta-analysis (chapter 2) formed the basis of this research and is the first to quantitatively evaluate the 
effects of exercise on cognition in T2DM in addition to providing a narrative synthesis of the effects of 
cognitive and dual-task interventions. The intervention development study (chapter 3) was integral in 
bridging the gap between the formal identification of the evidence base through to feasibility testing by 
rigorously screening exercise, cognitive, and dual-task training in addition to the study processes and 
outcomes. A strength of the intervention development process was recognising that the implementation 
of a dual-task intervention would be premature at this stage, in which further exploration of exercise 
and cognitive trials would be required first before developing and testing the feasibility and 
acceptability of a dual-task intervention in T2DM. The use of a mixed methods approach was essential 
in gaining a greater understanding of the strengths and areas of improvement concerning the feasibility 
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(chapter 4) and acceptability (chapter 5) of a cognitive training study in T2DM. Most importantly, the 
data obtained from both methods has allowed the researcher to provide more powerful and impactful 
recommendations for future research compared to either approach alone. Furthermore, the use of a 
progression criteria as opposed to using a simple stop / proceed approach has provided the researcher 
with opportunity to reflect on the feasibility of the cognitive training study by allowing study processes 
to be formally reviewed to decide as to whether it is necessary to modify the operational aspect of the 
design to promote its success in a future trial.   
 
Figure 6.5. Schematic diagram showing the difference between a traditional fixed-sample design and 
the adaptive design (Pallman et al., 2018). Using a systematic phased approach to develop and evaluate 
complex interventions has allowed the researcher to adopt an adaptive approach enabling the continual 
modification and improvement of study components at each phase. 
 
The absence of validated cognitive test batteries comprising of key neuropsychological tests for 
evaluating cognition in diabetes research means that future trials will continue to employ outcome 
measures that differ in their design and complexity. The inconsistency in the outcome measures used 
across studies may reduce the comparison of findings by meta-analysis which will greatly diminish the 
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strength of the conclusion that can be drawn from the area of research. The practical reality of this 
problem is exemplified by the systematic review and meta-analysis (chapter 2) (Cooke et al., 2020), 
which showed large heterogeneity between the cognitive outcome measures employed across included 
trials. Consequently, several trials were excluded from the meta-analyses of exercise trials whilst 
cognitive trials were limited to a qualitative comparison only. This was not only an inherent limitation 
of chapter 2, but it also presented wider implications in the context of this thesis as it significantly 
reduced the quantity and quality of evidence available for informing the development of a training 
intervention for feasibility testing. The intervention development study was as a crucial ‘stepping-stone' 
that helped to develop the rationale and methods for a suitable training intervention for feasibility 
testing. However, the lack of comparative efficacy testing between exercise, cognitive, and dual-task 
trials was considered a limitation that perhaps would have provided a more insightful and informative 
comparison of these types of interventions. Furthermore, the decision to implement a cognitive training 
intervention for feasibility testing was in part attributed to difficulties that participants experienced 
when conducting exercise training. However, only treadmill walking was performed as part of the 
exercise and dual task set up. It is therefore unclear if exercise in general was problematic in the 
intervention development study (chapter 3) or whether it was issues surrounding the design of exercise 
training e.g. the modality or experimental set up. The limited exploration of different exercise 
modalities in the developmental phase was considered a limitation of this thesis.  
It is acknowledged that the inclusion of different recruitment pathways can introduce bias. Recruitment 
pathways will always need consideration to minimise sampling bias where possible. However, when 
considering the development and evaluation of interventions it is important to trial a variety of 
recruitment pathways, informed by the target population, to help identify the most optimal recruitment 
pathways for future trials. For example, individuals recruited predominately from a university setting 
in chapter 3 may not have been entirely representative of the wider T2DM target population. Those 
recruited from the university setting would be expected to have a greater level of educational attainment, 
and evidence suggests that those with higher education attainment are more likely to actively seek and 
engage in healthy behaviour change and adhere to them (Margolis, 2013; Yu et al., 2019). Furthermore, 
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T2DM is shown to be more prevalent within deprived communities with lower socioeconomic / 
educational attainment (Rabi et al., 2006; Suwannaphant et al., 2017).  Chapter 4 addressed this by 
employing a wider approach to include multiple recruitment pathways such as recruitment through 
primary care e.g. GP practices, university, local community flyers/posters, social media, radio, and word 
of mouth etc. The inclusion of recruitment via GP practices is considered an ideal pathway for this 
population going forward as the majority of individuals with T2DM will be included withing GP 
databases as they will have engaged with primary care to receive a diagnosis and subsequent diabetes 
care. Including such a broad range of recruitment approaches was considered a strength of this research 
and this data will inform recruitment strategies for future research in T2DM. It is important, however, 
to consider the bias that this approach may introduce as a result of participants volunteering to take part 
in this research. Where a sample of a target population comprises of only those who are willing to 
participate in a study, systematic differences may occur between those who volunteered to take part and 
those who decline to participants, introducing bias with regards to the population characteristics (Jordan 
et al., 2013). The high adherence, retention, and acceptability of participants to conduct and complete 
the cognitive training study reflects the potential success of this type of intervention as a strategy used 
to target cognitive dysfunction in T2DM. This is further supported by the improvements made in several 
important cognitive domains as a result of cognitive training. Furthermore, whilst the feasibility study 
was not powered to detect significance differences, improvements were observed in a key cognitive 
domain that was shown to be statistically significant. This research was also the first to explore the 
impact of cognitive training on serum levels of BDNF in T2DM (chapter 4). However, the reduced 
levels of serum BDNF were unexpected in the context of the extant literature (Krabbe et al., 2007; 
Fujinami et al., 2008; Zhen et al., 2013; Zhen et al., 2017) and were higher than serum levels observed 
in previous studies (Fujinami et al., 2008; Zhen et al., 2013). It is acknowledged that issues with the 
absolute quantification using ELISA techniques were experienced that potentially led to this finding. 
Whilst the manufacturer’s guidelines were followed to the best of the researcher’s ability, several factors 
may have played a role in the high levels of BDNF including poor reagent preparation and poor washing 
technique that may have caused cross-over contamination. There is some evidence that suggests BDNF 
levels are potentially regulated by the circadian rhythm (Begliuomini et al., 2008; Giese et al., 2014) 
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and the extraction of blood samples in the morning is widely practiced (Polacchini et al., 2015; 
Hakansson et al., 2017; Mackay et al., 2017; Figueiredo et al., 2019). The inconsistency in the timings 
of blood sample collection at baseline and post intervention could be a limitation of this thesis possibly 
contributing towards the high levels of BDNF observed in chapter 4.  
6.6 Recommendations for future research 
 
The overarching aim of this thesis was to develop and evaluate exercise, cognitive, and dual-task 
interventions for targeting cognitive dysfunction in individuals with T2DM. Based on the accumulated 
evidence from each study conducted in this thesis a set of general recommendations for cognitive 
research in T2DM are proposed in addition to a set of feasibility / acceptability recommendations for 
the development of a specific future cognitive training study. 
6.6.1 General recommendations 
 
1. Based on the findings identified in the systematic review and meta-analysis (chapter 2), well 
designed interventional trials are needed that explore the effects of exercise, cognitive, and dual-
task interventions on cognition in T2DM. Trials should adhere to clear reporting guidelines (e.g. 
CONSORT). Trials must be sufficiently powered to detect small significant differences and should 
aim to conduct and report a priori sample size calculation. For example, based on a small to 
moderate ES (0.31) identified in the meta-analysis for the effects of exercise on inhibitory control 
(chapter 2), a sample size of 352 (176 in each group) is proposed for future exercise trials to detect 
between group differences using a power of 0.8 and significance level of 0.05.  
 
2. If significant scientific advancement is to be achieved in this area of research, the development and 
application of a set of core neuropsychological test batteries is needed and is pivotal for future 
studies that aim to examine cognition in T2DM. As the manifestation of T2DM is known to differ 
according to age, it may not be appropriate to employ the same core battery for children, young 
adults, and older adults. Likewise, cognition may be altered not only by acute metabolic 
disturbances but also by the more chronic effects of T2DM. Considering the complex and diverse 
relationship between cognition and T2DM, it may be appropriate to employ different test batteries 
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in trials that study different cohorts in addition to those trials that investigate the short and long 
term effects of T2DM on cognition. Assessment batteries should aim to include a diverse set of 
tests focusing on those domains that have been shown most susceptible to cognitive decline in a 
T2DM population, including executive function, attention, visual memory, verbal memory, reaction 
time and motor function.  
 
3. The findings from chapters 3 and 4 identified demographic variables such as age, BMI, and 
education that may potentially influence cognition and BDNF in T2DM. Future research should 
look to advance the current understanding of the T2DM-cognition relationship by further exploring 
the possible predictive and moderating nature of health-related indicators on cognition in T2DM. 
This research will help further clarify the multilateral, and dynamic, relationship between the 
potential mechanisms, comorbidities, and cognition in T2DM.  
 
4. Supervised individual training was perceived as important to participants with respect to providing 
guidance and instruction for both the assessment and training tasks (chapter 5). Participants did 
discuss group training as a potential alternative mode of training. To further enhance our 
understanding of the use of cognitive training as a potential strategy for targeting cognitive 
dysfunction in individuals with T2DM, alternative delivery modes such as group training could also 
be explored in future trials. 
 
5. The components of the proposed cognitive training study (6 weeks, 2-3 sessions a week, 60 minutes 
session duration, assessment visits, blood extraction etc.) were broadly perceived as acceptable by 
study participants. Whilst future trials should continue to explore the proposed cognitive training 
study, future research should also aim to evaluate interventions with different underlying 
components e.g. short-term interventions (e.g. 4 weeks, 4-5 sessions a week, 30 minutes duration) 
as well as long-term interventions (e.g. 24 weeks, 1-2 session a week, 60 minute duration) to help 




6. The improvements observed in cognitive outcomes in chapter 4 highlights the potential of cognitive 
training as a promising strategy for targeting diabetes-associated cognitive dysfunction.  To further 
enhance the ecological validity and applicability of future findings, research would greatly benefit 
from investigating whether improvements in cognition are ‘clinically meaningful’ by examining 
the transfer of trained domains to daily activities and diabetes self-management tasks. Consideration 
should be given to those cognitive domains and sub-domains that have been proposed to potentially 
moderate diabetes self-management e.g. global cognition, executive function and memory in 
addition to those management tasks that are pertinent to diabetes e.g. glucose monitoring, co-
ordination of health care appointments, medication management, nutrition, etc.  
 
7. Findings from chapter 4 showed serum levels of BDNF to unexpectedly reduce in individuals with 
T2DM following the completion of a cognitive training intervention. To further elucidate our 
understanding of the role BDNF may play in response to cognitive training, further research into 
this area is needed. Future researchers should aim to ensure that BDNF samples are extracted in the 
morning and that participants have fasted for a sufficient amount of time prior to blood extraction. 
Future trials should also aim to identify other potential biological or neural mechanisms that may 
potentially mediate improvements in cognition through cognitive training. This should include a 
purposeful investigation into the role that inflammation may play in the context of BMI, BDNF and 
cognitive function in T2DM.  
6.6.2 Recommendations for the development of a future trial 
 
The final study conducted in this thesis aimed to determine the feasibility (chapter 4) and acceptability 
(chapter 5) of a cognitive training study in individuals with T2DM. Feasibility and acceptability were 
demonstrated in several key aspects of the study which will help inform important decisions for future 
research. Based on the quantitative and qualitative elements of this study the following 






Table 6.1. Proposed feasibility / acceptability recommendations for a future cognitive training study. 
 
Feasibility recommendations Acceptability recommendations 
 
I. A travel limit should be set to help reduce the burden placed on 
the researcher when travelling to and from home training visits. 
This may include restricting travel to homes in certain postcodes 
or setting an upper travel limit.   
 
 
II. A greater number of GP practices must be recruited to help boost 
participant recruitment. Specifically, GP practices should be 
recruited simultaneously and as early as possible and should be 
supplemented by further secondary recruitment pathways e.g. 
online and newspaper advertisement, church groups/religious 
groups, and consultant mail outs. 
 
 
III. Participant recruitment through GP practices should also be 
coordinated to avoid busy periods e.g. flu vaccination season in 
which priority should be given to those GP practices with greater 




IV. Follow up telephone contact should be made with those 
individuals who expressed initial interest in participating through 
the expression of interest form but did not reply to the initial 
recruitment email.  
 
 
V. To avoid delays in data collection, especially in those allocated 
to the control group, strategies should be implemented to keep 
participants aware of important study visits e.g. assessment visits. 
This should include adopting management techniques such as 
agreeing upon timings and dates early which should be 








I. Greater communication strategies should be adopted in future 
trials to better inform the participants understanding of the study 
aims and processes. Potential strategies should include more in-
depth discussions throughout the recruitment, screening, and 
consent stages of the trial in addition to enhanced participant 
information sheets and supervised training sessions. 
 
 
II. An active control group should be considered as opposed to 
usual / standard care to keep individuals allocated to the control 
group engaged and motivated. This may include educational 
sessions based upon cognitive decline in T2DM. Alternatively 
a wait list could be used where control participants would be 
given the opportunity to complete intervention after the initial 
study period.  
 
 
III. Future trials should consider a flexible approach to data 
collection visits by providing participant choice with respect to 
the timing and location of training.  
 
 
IV. The length (6 weeks), duration (60 minutes), and frequency (2 
x per week) in addition to the assessment visits and blood 
extraction were perceived as acceptable. Researchers should 
continue to develop an appropriate cognitive training study 
specifically building upon these study components. 
 
 
V. The enjoyment and desire to continue training points towards 
the potential of this type of intervention in implementing long 
term compliance to positive health behaviour.  However, the 
continuation of training beyond the initial study period and its 
impact on important long-term health behaviours was not 
measured. Future trials would also benefit greatly in measuring 
the long-term impact of this type of intervention especially in 




6.7 Concluding remarks  
 
The general findings of this thesis provide robust and systematic evidence for the feasibility and 
acceptability of a cognitive training study for targeting cognitive dysfunction in individuals with T2DM. 
The limited number of trials identified in the systematic review and meta-analysis suggests that use of 
exercise, cognitive, and dual-task interventions for addressing cognitive dysfunction in T2DM is still 
an emerging area of research. Whilst positive effects were observed across each type of intervention 
with meta-analyses showing small to moderate effects of exercise on executive function (0.31) and 
memory (0.20), these findings should be interpreted with caution as trials were of poor quality and low 
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precision. The findings of the systematic review and meta-analysis (chapter 2) were integral in 
informing the design of future pilot and feasibility work. The subsequent intervention development 
study (chapter 3) piloted exercise, cognitive, and dual-task training in which the findings pointed 
towards cognitive training as the most suitable and preferred type of intervention to be further developed 
and tested for feasibility. Findings from this study suggest that further developmental work would be 
required before implementing and evaluating exercise or dual task interventions in T2DM. The evidence 
gathered from this study was also used to refine important study processes. This included the 
identification of more targeted recruitment pathways, refining the study eligibility criteria, and 
identifying a suitable cognitive training platform and battery. The intervention development process 
was a crucial ‘stepping-stone’ that bridged the gap between identifying the existing evidence base and 
evaluating the feasibility and acceptability of a cognitive training intervention.  The systematic review 
and meta-analysis (chapters 2) and intervention development study (chapter 3) provided important 
accumulated evidence that helped inform the development of a cognitive training study that would be 
implemented for feasibility (chapter 4) and acceptability (chapter 5) testing.  
The final study as part of this doctoral thesis (chapter 4 and 5) demonstrated good feasibility in several 
important areas of the cognitive training study including the adherence, retention and motivation of 
participants which largely reflected the success of this type of intervention in this population. Only 
minor modifications were proposed to aspects of the study design, recruitment pathways, and data 
collection that represent remedial situations in that if addressed early enough in accordance with the 
proposed recommendations future researchers should be able to progress with implementing and 
evaluating a definitive trial. The potential feasibility of this type of intervention was further supported 
by preliminary data that showed positive improvements in several cognitive domains highlighting the 
potential effectiveness of this type of intervention for targeting cognitive dysfunction in T2DM (chapter 
4). Whilst the reduction in serum BDNF following cognitive training was unexpected, this finding 
proposes a potential alternative mechanistic pathway that demonstrates the complex interaction between 
BDNF and T2DM in the context of cognitive training that may differ to BDNF mechanisms observed 
in healthy populations (chapter 4). The potential of the cognitive training intervention was further 
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reflected through the acceptability findings (chapter 5). Participants found the cognitive training 
intervention highly enjoyable and expressed their desire to continue training post intervention. The 
study components were found to be acceptable in which providing choice with respect to the time and 
location of training was viewed as an important aspect of the study that helped manage training barriers 
including work and travel. Whilst the experiences of this cognitive training study were largely positive, 
our findings pointed towards greater research communication to better help participants to understand 
the study aims and processes in addition to greater involvement for control participants to help those 
participants maintain interest in this study. Together, the findings from this exploratory study highlight 
the potential feasibility and acceptability of a cognitive training study in T2DM in which important 
recommendations based upon both the quantitative and qualitative aspect of this study are proposed 
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